0001836833FALSE2025Q3--01-310.2xbrli:sharesiso4217:USDiso4217:USDxbrli:sharespl:segmentxbrli:pureutr:Ypl:providerpl:tranchepl:tradingDay00018368332024-02-012024-10-310001836833us-gaap:CommonClassAMember2024-02-012024-10-310001836833us-gaap:WarrantMember2024-02-012024-10-310001836833us-gaap:CommonClassAMember2024-12-030001836833us-gaap:CommonClassBMember2024-12-0300018368332024-10-3100018368332024-01-310001836833us-gaap:CommonClassAMember2024-10-310001836833us-gaap:CommonClassAMember2024-01-310001836833us-gaap:CommonClassBMember2024-10-310001836833us-gaap:CommonClassBMember2024-01-310001836833us-gaap:CommonClassCMember2024-10-310001836833us-gaap:CommonClassCMember2024-01-3100018368332024-08-012024-10-3100018368332023-08-012023-10-3100018368332023-02-012023-10-310001836833us-gaap:CommonStockMember2023-01-310001836833us-gaap:AdditionalPaidInCapitalMember2023-01-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-310001836833us-gaap:RetainedEarningsMember2023-01-3100018368332023-01-310001836833us-gaap:CommonStockMember2023-02-012023-04-300001836833us-gaap:AdditionalPaidInCapitalMember2023-02-012023-04-3000018368332023-02-012023-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-02-012023-04-300001836833us-gaap:RetainedEarningsMember2023-02-012023-04-300001836833us-gaap:CommonStockMember2023-04-300001836833us-gaap:AdditionalPaidInCapitalMember2023-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-300001836833us-gaap:RetainedEarningsMember2023-04-3000018368332023-04-300001836833us-gaap:CommonStockMember2023-05-012023-07-310001836833us-gaap:AdditionalPaidInCapitalMember2023-05-012023-07-3100018368332023-05-012023-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-05-012023-07-310001836833us-gaap:RetainedEarningsMember2023-05-012023-07-310001836833us-gaap:CommonStockMember2023-07-310001836833us-gaap:AdditionalPaidInCapitalMember2023-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-310001836833us-gaap:RetainedEarningsMember2023-07-3100018368332023-07-310001836833us-gaap:CommonStockMember2023-08-012023-10-310001836833us-gaap:AdditionalPaidInCapitalMember2023-08-012023-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-08-012023-10-310001836833us-gaap:RetainedEarningsMember2023-08-012023-10-310001836833us-gaap:CommonStockMember2023-10-310001836833us-gaap:AdditionalPaidInCapitalMember2023-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-310001836833us-gaap:RetainedEarningsMember2023-10-3100018368332023-10-310001836833us-gaap:CommonStockMember2024-01-310001836833us-gaap:AdditionalPaidInCapitalMember2024-01-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-310001836833us-gaap:RetainedEarningsMember2024-01-310001836833us-gaap:CommonStockMember2024-02-012024-04-300001836833us-gaap:AdditionalPaidInCapitalMember2024-02-012024-04-3000018368332024-02-012024-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-012024-04-300001836833us-gaap:RetainedEarningsMember2024-02-012024-04-300001836833us-gaap:CommonStockMember2024-04-300001836833us-gaap:AdditionalPaidInCapitalMember2024-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-300001836833us-gaap:RetainedEarningsMember2024-04-3000018368332024-04-300001836833us-gaap:CommonStockMember2024-05-012024-07-310001836833us-gaap:AdditionalPaidInCapitalMember2024-05-012024-07-3100018368332024-05-012024-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-012024-07-310001836833us-gaap:RetainedEarningsMember2024-05-012024-07-310001836833us-gaap:CommonStockMember2024-07-310001836833us-gaap:AdditionalPaidInCapitalMember2024-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-310001836833us-gaap:RetainedEarningsMember2024-07-3100018368332024-07-310001836833us-gaap:CommonStockMember2024-08-012024-10-310001836833us-gaap:AdditionalPaidInCapitalMember2024-08-012024-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-08-012024-10-310001836833us-gaap:RetainedEarningsMember2024-08-012024-10-310001836833us-gaap:CommonStockMember2024-10-310001836833us-gaap:AdditionalPaidInCapitalMember2024-10-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-310001836833us-gaap:RetainedEarningsMember2024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-02-012024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-02-012024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-08-012024-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-08-012023-10-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-02-012023-10-3100018368332024-11-012024-10-310001836833country:US2024-08-012024-10-310001836833country:US2023-08-012023-10-310001836833country:US2024-02-012024-10-310001836833country:US2023-02-012023-10-310001836833us-gaap:NonUsMember2024-08-012024-10-310001836833us-gaap:NonUsMember2023-08-012023-10-310001836833us-gaap:NonUsMember2024-02-012024-10-310001836833us-gaap:NonUsMember2023-02-012023-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-10-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:MeasurementInputPriceVolatilityMember2024-10-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:MeasurementInputPriceVolatilityMember2024-01-310001836833pl:SaloSciencesMemberus-gaap:MeasurementInputExpectedTermMember2024-10-310001836833pl:WarrantsPrivatePlacementMember2023-01-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-01-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-01-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-01-310001836833pl:WarrantsPrivatePlacementMember2023-02-012023-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-02-012023-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-02-012023-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-02-012023-04-300001836833pl:WarrantsPrivatePlacementMember2023-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-04-300001836833pl:WarrantsPrivatePlacementMember2023-05-012023-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-05-012023-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-05-012023-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-05-012023-07-310001836833pl:WarrantsPrivatePlacementMember2023-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-07-310001836833pl:WarrantsPrivatePlacementMember2023-08-012023-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-08-012023-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-08-012023-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-08-012023-10-310001836833pl:WarrantsPrivatePlacementMember2023-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-10-310001836833pl:WarrantsPrivatePlacementMember2024-01-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-01-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-01-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-01-310001836833pl:WarrantsPrivatePlacementMember2024-02-012024-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-02-012024-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-02-012024-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-02-012024-04-300001836833pl:WarrantsPrivatePlacementMember2024-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-04-300001836833pl:WarrantsPrivatePlacementMember2024-05-012024-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-05-012024-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-05-012024-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-05-012024-07-310001836833pl:WarrantsPrivatePlacementMember2024-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-07-310001836833pl:WarrantsPrivatePlacementMember2024-08-012024-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-08-012024-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-08-012024-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-08-012024-10-310001836833pl:WarrantsPrivatePlacementMember2024-10-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-10-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-10-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-10-310001836833pl:CustomerConsentEscrowMemberpl:SinergiseMember2024-08-012024-10-310001836833pl:SinergiseMember2023-08-042023-08-040001836833pl:SinergiseMember2024-04-012024-04-300001836833pl:IndemnityEscrowMemberpl:SinergiseMember2023-08-042023-08-040001836833pl:CustomerConsentEscrowMemberpl:SinergiseMember2023-08-042023-08-040001836833pl:SinergiseMemberpl:CustomerConsentEscrowContingentConsiderationMember2023-08-042023-08-040001836833pl:SinergiseMember2023-08-040001836833pl:SinergiseMemberus-gaap:DevelopedTechnologyRightsMember2023-08-040001836833pl:SinergiseMemberus-gaap:CustomerRelationshipsMember2023-08-040001836833pl:SinergiseMemberus-gaap:OtherIntangibleAssetsMember2023-08-040001836833pl:SinergiseMember2024-08-012024-10-310001836833pl:SinergiseMember2024-02-012024-10-310001836833pl:SinergiseMember2023-08-042023-10-310001836833pl:SinergiseMemberpl:CostOfRevenueMember2023-02-012023-10-310001836833pl:SinergiseMemberpl:CostOfRevenueMember2023-08-012023-10-310001836833pl:SinergiseMemberus-gaap:ResearchAndDevelopmentExpenseMember2023-02-012023-10-310001836833pl:SinergiseMemberus-gaap:ResearchAndDevelopmentExpenseMember2023-08-012023-10-310001836833pl:SinergiseMemberus-gaap:SellingAndMarketingExpenseMember2023-08-012023-10-310001836833pl:SinergiseMemberus-gaap:SellingAndMarketingExpenseMember2023-02-012023-10-310001836833pl:SinergiseMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-02-012023-10-310001836833pl:SinergiseMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-08-012023-10-310001836833pl:SinergiseMember2023-02-012023-10-310001836833pl:SinergiseMember2023-08-012023-10-310001836833pl:SinergiseMember2024-10-310001836833us-gaap:MoneyMarketFundsMember2024-10-310001836833pl:SinergiseMember2024-01-310001836833us-gaap:MoneyMarketFundsMember2024-01-310001836833us-gaap:USTreasurySecuritiesMember2024-10-310001836833us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-10-310001836833us-gaap:CorporateBondSecuritiesMember2024-10-310001836833us-gaap:CertificatesOfDepositMember2024-10-310001836833us-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:CertificatesOfDepositMember2024-01-310001836833pl:SatellitesMember2024-10-310001836833pl:SatellitesMember2024-01-310001836833pl:SatellitesInProcessAndNotPlacedIntoServiceMember2024-10-310001836833pl:SatellitesInProcessAndNotPlacedIntoServiceMember2024-01-310001836833us-gaap:LeaseholdImprovementsMember2024-10-310001836833us-gaap:LeaseholdImprovementsMember2024-01-310001836833pl:GroundStationAndGroundStationEquipmentMember2024-10-310001836833pl:GroundStationAndGroundStationEquipmentMember2024-01-310001836833us-gaap:FurnitureAndFixturesMember2024-10-310001836833us-gaap:FurnitureAndFixturesMember2024-01-310001836833pl:ComputerEquipmentAndSoftwareMember2024-10-310001836833pl:ComputerEquipmentAndSoftwareMember2024-01-310001836833country:US2024-10-310001836833country:US2024-01-310001836833us-gaap:NonUsMember2024-10-310001836833us-gaap:NonUsMember2024-01-310001836833pl:SatellitesMember2024-08-012024-10-310001836833pl:SatellitesMember2024-02-012024-10-310001836833pl:SatellitesMember2023-08-012023-10-310001836833pl:SatellitesMember2023-02-012023-10-310001836833us-gaap:DevelopedTechnologyRightsMember2024-10-310001836833us-gaap:DevelopedTechnologyRightsMember2024-02-012024-10-310001836833us-gaap:DevelopedTechnologyRightsMember2024-01-310001836833us-gaap:DevelopedTechnologyRightsMember2023-02-012024-01-310001836833us-gaap:AcquiredFilmLibrariesMember2024-10-310001836833us-gaap:AcquiredFilmLibrariesMember2024-02-012024-10-310001836833us-gaap:AcquiredFilmLibrariesMember2024-01-310001836833us-gaap:AcquiredFilmLibrariesMember2023-02-012024-01-310001836833us-gaap:CustomerRelationshipsMember2024-10-310001836833us-gaap:CustomerRelationshipsMember2024-02-012024-10-310001836833us-gaap:CustomerRelationshipsMember2024-01-310001836833us-gaap:CustomerRelationshipsMember2023-02-012024-01-310001836833us-gaap:TrademarksAndTradeNamesMember2024-10-310001836833us-gaap:TrademarksAndTradeNamesMember2024-02-012024-10-310001836833us-gaap:TrademarksAndTradeNamesMember2024-01-310001836833us-gaap:TrademarksAndTradeNamesMember2023-02-012024-01-3100018368332023-02-012024-01-3100018368332024-04-012024-04-3000018368332024-06-012024-06-300001836833us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:CostOfSalesMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:CostOfSalesMember2024-08-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2024-08-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMember2024-08-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberpl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2024-08-012024-10-310001836833us-gaap:EmployeeSeveranceMember2024-08-012024-10-310001836833pl:StockBasedCompensationMember2024-08-012024-10-310001836833us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:CostOfSalesMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:CostOfSalesMember2024-02-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2024-02-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:SellingAndMarketingExpenseMember2024-02-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberpl:StockBasedCompensationMember2024-02-012024-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2024-02-012024-10-310001836833us-gaap:EmployeeSeveranceMember2024-02-012024-10-310001836833pl:StockBasedCompensationMember2024-02-012024-10-310001836833pl:HeadcountReduction2024Member2023-02-012023-10-310001836833pl:HeadcountReduction2024Member2023-08-012023-10-3100018368332023-08-012023-08-310001836833us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:CostOfSalesMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:CostOfSalesMember2023-08-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2023-08-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMember2023-08-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberpl:StockBasedCompensationMember2023-08-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2023-08-012023-10-310001836833us-gaap:EmployeeSeveranceMember2023-08-012023-10-310001836833pl:StockBasedCompensationMember2023-08-012023-10-310001836833pl:HeadcountReduction2023Member2024-08-012024-10-310001836833pl:HeadcountReduction2023Member2024-02-012024-10-310001836833pl:RDServicesAgreementMember2020-12-310001836833pl:RDServicesAgreementMember2024-08-012024-10-310001836833pl:RDServicesAgreementMember2024-02-012024-10-310001836833pl:RDServicesAgreementMember2023-08-012023-10-310001836833pl:RDServicesAgreementMember2023-02-012023-10-310001836833pl:RDServicesAgreementMember2023-02-012024-01-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2022-08-012022-08-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2024-08-012024-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2024-02-012024-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-08-012023-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-02-012023-10-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-02-012024-01-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-07-012023-07-310001836833pl:DMYIVLLCMember2021-03-092021-03-090001836833us-gaap:CommonClassAMemberpl:DMYIVLLCMember2021-03-090001836833pl:RedeemableWarrantMemberpl:DMYIVLLCMember2021-03-090001836833pl:WarrantsPublicMemberus-gaap:CommonClassAMember2021-03-090001836833pl:WarrantsPrivatePlacementMemberpl:DMYIVLLCMember2021-03-090001836833pl:WarrantsPrivatePlacementMember2021-12-0700018368332021-12-070001836833pl:DerivativeInstrumentPeriod1Member2021-12-070001836833pl:DerivativeInstrumentPeriod2Member2021-12-070001836833pl:DerivativeInstrumentPeriod3Member2021-12-070001836833pl:DerivativeInstrumentPeriod4Member2021-12-0700018368332021-12-072021-12-070001836833pl:WarrantsPublicMember2024-01-310001836833pl:WarrantsPublicMember2024-10-310001836833pl:WarrantsPrivatePlacementVestingMember2024-10-310001836833pl:WarrantsPrivatePlacementVestingMember2024-01-310001836833pl:A2020ConvertibleNotesMemberus-gaap:SeriesDPreferredStockMember2024-10-310001836833pl:A2020ConvertibleNotesMemberus-gaap:SeriesDPreferredStockMember2024-01-310001836833pl:A2020ConvertibleNotesMemberus-gaap:ConvertibleDebtMemberus-gaap:SeriesDPreferredStockMember2024-10-310001836833pl:A2020ConvertibleNotesMemberus-gaap:ConvertibleDebtMemberus-gaap:SeriesDPreferredStockMember2024-01-310001836833pl:A2020ConvertibleNotesMember2024-10-310001836833pl:PlanetLabsPBCMemberpl:GoogleMemberus-gaap:CommonClassAMember2024-10-310001836833pl:PlanetLabsPBCMemberpl:GoogleMemberus-gaap:CommonClassAMember2024-01-310001836833pl:PlanetLabsPBCMemberpl:GoogleMember2024-01-310001836833pl:PlanetLabsPBCMemberpl:GoogleMember2024-10-310001836833us-gaap:RelatedPartyMember2017-04-012017-04-300001836833us-gaap:RelatedPartyMember2022-04-012022-04-300001836833us-gaap:RelatedPartyMemberpl:ContentLicensingMember2023-02-012023-10-310001836833us-gaap:RelatedPartyMember2023-07-012023-07-310001836833us-gaap:RelatedPartyMember2023-07-310001836833us-gaap:RelatedPartyMembersrt:MaximumMember2023-07-310001836833us-gaap:RelatedPartyMember2024-08-310001836833us-gaap:RelatedPartyMember2024-02-012024-10-310001836833us-gaap:RelatedPartyMember2024-08-012024-10-310001836833us-gaap:RelatedPartyMember2023-08-012023-10-310001836833us-gaap:RelatedPartyMember2023-02-012023-10-310001836833pl:GoogleMember2024-10-310001836833pl:GoogleMember2024-01-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2024-08-012024-10-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2024-02-012024-10-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2023-08-012023-10-310001836833us-gaap:RelatedPartyMemberpl:HostingAndOtherServicesMember2023-02-012023-10-310001836833us-gaap:RelatedPartyMember2021-06-280001836833us-gaap:CostOfSalesMember2023-02-012023-10-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2023-02-012023-10-310001836833us-gaap:SellingAndMarketingExpenseMember2023-02-012023-10-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2023-02-012023-10-310001836833us-gaap:EmployeeStockOptionMember2024-10-310001836833us-gaap:EmployeeStockOptionMember2024-02-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-01-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-02-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-08-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-08-012023-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-02-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMembersrt:MinimumMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMembersrt:MaximumMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-08-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-08-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-02-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-10-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-04-012024-04-300001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-08-012024-10-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-02-012024-10-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-10-310001836833pl:EarnOutSharesMember2024-08-012024-10-310001836833pl:EarnOutSharesMember2024-02-012024-10-310001836833pl:EarnOutSharesMember2024-10-310001836833pl:EarnOutSharesMember2023-08-012023-10-310001836833pl:EarnOutSharesMember2023-02-012023-10-310001836833pl:VanderSatBVMemberus-gaap:StockCompensationPlanMemberus-gaap:CommonClassAMember2021-12-132021-12-130001836833pl:VanderSatBVMember2021-12-132021-12-130001836833pl:VanderSatBVMember2023-08-012023-10-310001836833pl:VanderSatBVMember2023-02-012023-10-310001836833pl:WarrantsClassACommonStockMember2024-02-012024-10-310001836833pl:WarrantsClassACommonStockMember2023-02-012023-10-310001836833us-gaap:EmployeeStockOptionMember2024-02-012024-10-310001836833us-gaap:EmployeeStockOptionMember2023-02-012023-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-02-012024-10-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-02-012023-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-02-012024-10-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-02-012023-10-310001836833us-gaap:EmployeeStockMember2024-02-012024-10-310001836833us-gaap:EmployeeStockMember2023-02-012023-10-310001836833pl:EarnOutSharesMember2024-02-012024-10-310001836833pl:EarnOutSharesMember2023-02-012023-10-310001836833pl:SponsorEarnOutSharesMember2024-02-012024-10-310001836833pl:SponsorEarnOutSharesMember2023-02-012023-10-310001836833pl:WarrantsPublicMember2024-02-012024-10-310001836833pl:WarrantsPublicMember2023-02-012023-10-310001836833pl:WarrantsPrivatePlacementMember2024-02-012024-10-310001836833pl:WarrantsPrivatePlacementMember2023-02-012023-10-310001836833pl:StockOptionsEarlyExercisedSubjectToFutureVestingMember2024-02-012024-10-310001836833pl:StockOptionsEarlyExercisedSubjectToFutureVestingMember2023-02-012023-10-310001836833pl:SharesIssuedInAcquisitionSubjectToFutureVestingMember2024-02-012024-10-310001836833pl:SharesIssuedInAcquisitionSubjectToFutureVestingMember2023-02-012023-10-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________  to _______________.
Commission file number 001-40166
Planet Labs PBC
(Exact name of registrant as specified in its charter)
Delaware
85-4299396
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
645 Harrison Street, Floor 4, San Francisco, California
 94107
(Address of principal executive offices)
(Zip Code)
(415) 829-3313
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, par value $0.0001 per sharePLNew York Stock Exchange
Warrants to purchase Class A common stock, at an exercise price of $11.50 per sharePL WSNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes  ☒    No  ☐ 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒   No  ☐ 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer
Accelerated filer
Non-accelerated filer  
Smaller reporting company
Emerging growth company
                
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No  

The registrant had 275,551,243 outstanding shares of Class A common stock, and 21,157,586 outstanding shares of Class B common stock, as of December 3, 2024.

2

TABLE OF CONTENTS
Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
3


Unless the context otherwise requires, the “Company”, “Planet”, “we”, “our”, “us” and similar terms refer to Planet Labs PBC, a Delaware public benefit corporation (f/k/a dMY Technology Group, Inc. IV, a Delaware corporation), and its consolidated subsidiaries.

Cautionary Note Regarding Forward Looking Information

This Quarterly Report on Form 10-Q for the quarter ended October 31, 2024 (the “Form 10-Q” or “this report”) includes statements that express Planet’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements.” Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “seek,” “may,” “will,” “could,” “can,” “should,” “would,” “believes,” “predicts,” “potential,” “strategy,” “opportunity,” “aim,” “continue,” and similar expressions or the negative thereof, or discussions of strategy, plans, objectives, intentions, estimates, forecasts, outlook, assumptions, or goals, are intended to identify such forward-looking statements. Forward-looking statements appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the markets in which Planet operates. Factors that may impact such forward-looking statements include:
our future financial performance, including expectations regarding our revenue, cost of revenue, operating expenses, capital expenditures, cash flows and our ability to achieve profitability;
our ability to attract and retain customers, including our ability to renew existing contracts and expand our relationships with existing customers;
our expectations regarding the value of our offerings to our customers over time;
our expectations regarding market growth, including our ability to grow in existing markets and expand into new markets;
our ability to continue to improve our data and offer software and analytic solutions to improve the value of our data;
our ability to continue to invest in our sales and marketing, software platform development, machine learning and analytic tools as well as our applications and new satellite technologies;
our relationships with third-party partners, vendors and solution providers;
our ability to manage risks and challenges associated with our financial condition and results of operations;
our expectations regarding the future impact of seasonality on our business;
our management of future growth and business operations, as well as the expected results of our workforce reduction;
our expectations regarding the realization of our U.S. and foreign deferred tax assets;
our ability to maintain, protect and enhance our intellectual property; and
the increased expenses associated with being a public company.
The foregoing list may not contain all of the forward-looking statements made in this Form 10-Q. Such forward-looking statements are based on available current market material and our current expectations, beliefs and forecasts concerning future events and their potential effects on Planet. The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties, and other factors, including those described in the “Risk Factors” section of our most recent Annual Report on Form 10-K, this Form 10-Q, as well as the other documents filed by us from time to time with the U.S. Securities and Exchange Commission (“SEC”). We operate in a rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Form 10-Q. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
4

The forward-looking statements contained in this Form 10-Q are based on information available to us at the time of filing of this Form 10-Q and relate only to events as of the date on which the statements are made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

5

Part I. - Financial Information
Item 1. Financial Statements.
Planet Labs PBC
Condensed Consolidated Balance Sheets (Unaudited)
 
(in thousands, except share and par value amounts)
October 31, 2024January 31, 2024
Assets 
Current assets 
Cash and cash equivalents$138,969 $83,866 
Restricted cash and cash equivalents, current6,5258,360
Short-term investments103,255215,041
Accounts receivable, net of allowance of $446 and $1,539, respectively
38,85343,320
Prepaid expenses and other current assets13,99219,564
Total current assets301,594370,151
Property and equipment, net116,920113,429
Capitalized internal-use software, net18,25914,973
Goodwill137,411136,256
Intangible assets, net29,23132,448
Restricted cash and cash equivalents, non-current4,4379,972
Operating lease right-of-use assets20,82922,339
Other non-current assets2,0832,429
Total assets$630,764 $701,997 
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable$3,572 $2,601 
Accrued and other current liabilities43,67044,779
Deferred revenue66,46272,327
Liability from early exercise of stock options6,2758,964
Operating lease liabilities, current9,1057,978
Total current liabilities129,084136,649
Deferred revenue11,2305,293
Deferred hosting costs6,6657,101
Public and private placement warrant liabilities1,8352,961
Operating lease liabilities, non-current13,81916,952
Contingent consideration2,8715,885
Other non-current liabilities6559,138
Total liabilities166,159183,979
Commitments and contingencies (Note 10)
Stockholders’ equity
Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at October 31, 2024 and January 31, 2024, 275,274,858 and 268,117,905 Class A shares issued and outstanding at October 31, 2024 and January 31, 2024, respectively, 21,157,586 Class B shares issued and outstanding at October 31, 2024 and January 31, 2024, 0 Class C shares issued and outstanding at October 31, 2024 and January 31, 2024
2828
Additional paid-in capital1,631,0771,596,201
Accumulated other comprehensive income1,3471,594
Accumulated deficit(1,167,847)(1,079,805)
Total stockholders’ equity464,605518,018
Total liabilities and stockholders’ equity$630,764 $701,997 

See accompanying notes to unaudited condensed consolidated financial statements.
6

Planet Labs PBC
Condensed Consolidated Statements of Operations (Unaudited)

 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands, except share and per share amounts)
2024202320242023
Revenue$61,266 $55,380 $182,798 $161,844 
Cost of revenue23,749 29,350 81,288 81,375 
Gross profit37,517 26,030 101,510 80,469 
Operating expenses
Research and development25,216 33,002 78,055 87,929 
Sales and marketing16,795 20,774 62,013 66,209 
General and administrative18,114 20,112 58,198 62,161 
Total operating expenses60,125 73,888 198,266216,299 
Loss from operations(22,608)(47,858)(96,756)(135,830)
Interest income2,414 3,445 8,292 11,753 
Change in fair value of warrant liabilities198 6,833 1,126 14,004 
Other income (expense), net(60)(69)660 894 
Total other income, net2,552 10,209 10,078 26,651 
Loss before provision for income taxes(20,056)(37,649)(86,678)(109,179)
Provision for income taxes25 355 1,364 1,244 
Net loss$(20,081)$(38,004)$(88,042)$(110,423)
Basic and diluted net loss per share attributable to common stockholders$(0.07)$(0.13)$(0.30)$(0.40)
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders293,338,324284,197,733290,674,554277,252,951
                        

See accompanying notes to unaudited condensed consolidated financial statements.
7

Planet Labs PBC
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands)2024202320242023
Net loss$(20,081)$(38,004)$(88,042)$(110,423)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment52 (1,667)(159)(1,543)
Change in fair value of available-for-sale securities48 89 (88)(970)
Other comprehensive income (loss), net of tax100 (1,578)(247)(2,513)
Comprehensive loss$(19,981)$(39,582)$(88,289)$(112,936)

See accompanying notes to unaudited condensed consolidated financial statements.
8

Planet Labs PBC
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

(in thousands, except share amounts)
 Common Stock Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Total
Stockholders’
Equity
 Shares Amount
Balances at January 31, 2023271,783,561$27 $1,513,102 $2,271 $(939,296)$576,104 
Issuance of Class A common stock from the exercise of common stock options1,018,3853,2953,295
Issuance of Class A common stock upon vesting of restricted stock units1,278,161
Vesting of early exercised stock options91,911896896
Class A common stock withheld to satisfy employee tax withholding obligations(472,136)(1,896)(1,896)
Stock-based compensation15,98315,983
Net unrealized loss on available-for-sale securities, net of taxes(544)(544)
Change in translation(45)(45)
Net loss(34,444)(34,444)
Balances at April 30, 2023273,699,882$27 $1,531,380 $1,682 $(973,740)$559,349 
Issuance of Class A common stock from the exercise of common stock options1,383,4133,0633,063
Issuance of Class A common stock upon vesting of restricted stock units2,597,964
Vesting of early exercised stock options91,910896896
Class A common stock withheld to satisfy employee tax withholding obligations(827,964)(2,857)(2,857)
Stock-based compensation17,43817,438
Net unrealized loss on available-for-sale securities, net of taxes(515)(515)
Change in translation169169
Net loss(37,975)(37,975)
Balances at July 31, 2023276,945,205271,549,9201,336(1,011,715)539,568
Issuance of Class A common stock from the exercise of common stock options226,505412412
Issuance of Class A common stock upon vesting of restricted stock units2,349,577
Issuance of Class A common stock related to business combination6,745,438121,62121,622
Vesting of early exercised stock options91,910896896
Class A common stock withheld to satisfy employee tax withholding obligations(825,928)(2,359)(2,359)
Stock-based compensation13,04113,041
Net unrealized gain on available-for-sale securities, net of taxes8989
Change in translation(1,667)(1,667)
Net loss(38,004)(38,004)
Balances at October 31, 2023285,532,707281,583,531(242)(1,049,719)533,598

See accompanying notes to unaudited condensed consolidated financial statements.
9

 Common Stock Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Total
Stockholders’
Equity
 Shares Amount
Balances at January 31, 2024289,275,491$28 $1,596,201 $1,594 $(1,079,805)$518,018 
Issuance of Class A common stock from the exercise of common stock options35,3182020
Issuance of Class A common stock upon vesting of restricted stock units2,334,916
Vesting of early exercised stock options896896
Class A common stock withheld to satisfy employee tax withholding obligations(908,417)(2,015)(2,015)
Stock-based compensation13,74513,745
Net unrealized loss on available-for-sale securities, net of taxes(512)(512)
Change in translation(534)(534)
Net loss— (29,293)(29,293)
Balances at April 30, 2024290,737,308$28 $1,608,847 $548 $(1,109,098)$500,325 
Issuance of Class A common stock from the exercise of common stock options234,443280280
Issuance of Class A common stock upon vesting of restricted stock units3,834,734
Vesting of early exercised stock options896896
Class A common stock withheld to satisfy employee tax withholding obligations(1,330,082)(2,470)(2,470)
Stock-based compensation12,18512,185
Net unrealized gain on available-for-sale securities, net of taxes376376
Change in translation323323
Net loss— (38,668)(38,668)
Balances at July 31, 2024293,476,403$28 $1,619,738 $1,247 $(1,147,766)$473,247 
Issuance of Class A common stock from the exercise of common stock options54,6143232
Issuance of Class A common stock upon vesting of restricted stock units3,757,861
Issuance of Class A common stock for employee stock purchase program487,557924924
Vesting of early exercised stock options896896
Class A common stock withheld to satisfy employee tax withholding obligations(1,343,991)(2,843)(2,843)
Stock-based compensation12,33012,330
Net unrealized gain on available-for-sale securities, net of taxes4848
Change in translation5252
Net loss(20,081)(20,081)
Balances at October 31, 2024296,432,444281,631,0771,347(1,167,847)464,605

See accompanying notes to unaudited condensed consolidated financial statements.
10

Planet Labs PBC
Condensed Consolidated Statements of Cash Flows (Unaudited)

 Nine Months Ended October 31,
(in thousands)2024 2023
Operating activities 
Net loss$(88,042)$(110,423)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization36,365 36,033 
Stock-based compensation, net of capitalized cost of $1,793 and $1,851, respectively
36,467 44,611 
Change in fair value of warrant liabilities(1,126)(14,004)
Change in fair value of contingent consideration3,161 (923)
Other(932)(3,538)
Changes in operating assets and liabilities
Accounts receivable5,487 (3,872)
Prepaid expenses and other assets8,499 9,483 
Accounts payable, accrued and other liabilities(7,731)(20,706)
Deferred revenue71 19,557 
Deferred hosting costs(298)(92)
Net cash used in operating activities(8,079)(43,874)
Investing activities
Purchases of property and equipment(32,694)(29,086)
Capitalized internal-use software(4,145)(3,266)
Maturities of available-for-sale securities57,046 142,903 
Sales of available-for-sale securities162,341 40,072 
Purchases of available-for-sale securities(105,582)(166,169)
Business acquisition, net of cash acquired(1,068)(7,542)
Purchases of licensed imagery intangible assets(4,558) 
Other(300)(944)
Net cash provided by (used in) investing activities71,040 (24,032)
Financing activities
Proceeds from the exercise of common stock options332 6,770 
Payments for withholding taxes related to the net share settlement of equity awards(7,328)(7,112)
Proceeds from employee stock purchase program1,083  
Payments of contingent consideration for business acquisitions(8,783) 
Other(606)(15)
Net cash used in financing activities(15,302)(357)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents74 (65)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents47,733 (68,328)
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period102,198 188,076 
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period$149,931 $119,748 

See accompanying notes to unaudited condensed consolidated financial statements.


11

Planet Labs PBC
Notes to Unaudited Condensed Consolidated Financial Statements

(1)Organization

Planet Labs PBC (“Planet,” or the “Company”) was founded to design, construct, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers via an online platform. The Company’s mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. The Company is headquartered in San Francisco, California, with operations throughout the United States (U.S.”), Canada, Asia and Europe.
On July 7, 2021, Planet Labs Inc. (“Former Planet”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with dMY Technology Group, Inc. IV (“dMY IV”), a special purpose acquisition company (“SPAC”) incorporated in Delaware on December 15, 2020, Photon Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of dMY IV (“First Merger Sub”), and Photon Merger Sub Two, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of dMY IV (“Second Merger Sub”). Pursuant to the Merger Agreement, upon the favorable vote of dMY IV’s stockholders on December 3, 2021, on December 7, 2021, First Merger Sub merged with and into Former Planet (the “Surviving Corporation”), with Former Planet surviving the merger as a wholly owned subsidiary of dMY IV (the “First Merger”), and pursuant to Former Planet’s election immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into dMY IV, with dMY IV surviving the merger (the “Business Combination”). Following the completion of the Business Combination, dMY IV was renamed Planet Labs PBC.
Former Planet was incorporated in the state of Delaware on December 28, 2010. Former Planet was originally incorporated as Cosmogia Inc., and the name was subsequently changed to Planet Labs Inc. on June 24, 2013.

(2)Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three and nine months ended October 31, 2024 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2025 or any other future period.
The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31.
Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 (the “2024 Form 10-K”).
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, the Company’s incremental borrowing rate for operating leases, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of private placement warrant liabilities, the fair value of assets acquired and liabilities assumed from business combinations, the fair value of contingent consideration for business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies.
12

These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material.
Due to current geopolitical events, including the war in Ukraine and the Israel-Hamas conflict, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained.
Segments
Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
See Note 3, Revenue, for revenue by geographic region. See Note 6, Balance Sheet Components, for long-lived assets by geographic region.
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands, Slovenia, Austria, and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at October 31, 2024 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $239.8 million.
Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. One customer accounted for 10% of accounts receivable as of October 31, 2024. As of January 31, 2024, no customer accounted for 10% or more of accounts receivable.
For the three and nine months ended October 31, 2024, one customer accounted for 19% of revenue. For the three and nine months ended October 31, 2023, one customer accounted for 21% and 22% of revenue, respectively.
The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations.
Significant Accounting Policies
The Company’s significant accounting policies are included in Note 2 of its Consolidated Financial Statements included in the 2024 Form 10-K.
Recent Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures, which clarifies that entities with a single reportable segment are subject to both new and existing segment reporting requirements under ASC 280, and modifies certain segment disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
13

In December 2023, the FASB issued ASU 2023-09, Income Taxes (“Topic 740”): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures, primarily through changes around the effective tax rate reconciliation and income taxes paid information. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.

(3)Revenue
Deferred Revenue
During the nine months ended October 31, 2024 and 2023, the Company recognized revenue of $61.6 million and $45.7 million, respectively, that had been included in deferred revenue as of January 31, 2024 and 2023, respectively.

Remaining Performance Obligations
The Company often enters into multi-year imagery licensing arrangements with its customers, whereby the Company generally invoices the amount for the first year of the contract at signing followed by subsequent annual invoices. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. The Company’s remaining performance obligations were $145.9 million as of October 31, 2024, which consists of both deferred revenue of $77.7 million and non-cancelable contracted revenue that will be invoiced in future periods of $68.2 million. The Company expects to recognize approximately 82% of the remaining performance obligation over the next 12 months, approximately 98% of the remaining obligation over the next 24 months, and the remainder thereafter.
Remaining performance obligations do not include unexercised contract options, written orders where funding has not been appropriated and contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty.

Disaggregation of Revenue
The following table disaggregates revenue by major geographic region:
 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands)2024202320242023
United States$25,294 $23,348 $83,109 $73,513 
Rest of world35,97232,03299,68988,331
Total revenue$61,266 $55,380 $182,798 $161,844 
No single country other than the U.S. accounted for more than 10% of revenue for the three and nine months ended October 31, 2024 and 2023.

Costs to Obtain and Fulfill a Contract
Commissions paid to the Company’s direct sales force are considered incremental costs of obtaining a contract with a customer. Accordingly, commissions are capitalized when incurred and amortized to sales and marketing expense over the period of benefit from the underlying contracts. The period of benefit from the underlying contract is consistent with the timing of transfer to the performance obligations to which the capitalized costs relate, and is generally consistent with the contract term.
During the three and nine months ended October 31, 2024, the Company capitalized $0.7 million and $1.4 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.8 million and $2.1 million for the three and nine month periods ended October 31, 2024, respectively.
During the three and nine months ended October 31, 2023, the Company capitalized $0.6 million and $1.1 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.4 million and $1.7 million for the three and nine month periods ended October 31, 2023, respectively.
14

As of October 31, 2024 and January 31, 2024, deferred commissions consisted of the following:
(in thousands)October 31, 2024January 31, 2024
Deferred commission, current$1,884 $2,296 
Deferred commission, non-current1,2321,578
Total deferred commission$3,116 $3,874 
The current portion of deferred commissions are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The non-current portion of deferred commissions are included in other non-current assets on the condensed consolidated balance sheets.

(4)Fair Value of Financial Assets and Liabilities
Assets and liabilities recognized or disclosed at fair value in the financial statements are categorized based upon the level of judgment associated with the inputs used to measure their respective fair values.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for recognition or disclosure purposes as of October 31, 2024 and January 31, 2024 by level within the fair value hierarchy. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability.
 October 31, 2024
(in thousands)Level 1 Level 2 Level 3
Assets
Cash equivalents:
Money market funds$38,503 $ $ 
Restricted cash equivalents: money market funds9,439   
Short-term investments:
U.S. Treasury securities19,466 $ $ 
Commercial paper 2,943 $ 
Corporate bonds 78,732 $ 
Certificates of deposit 2,114 $ 
Total assets$67,408 $83,789 $ 
Liabilities
Public Warrants$1,242 $ $ 
Private Placement Warrants $ 593 
Contingent consideration for acquisitions $ 7,282 
Total liabilities$1,242 $ $7,875 
15

 January 31, 2024
(in thousands)Level 1Level 2Level 3
Assets
Cash equivalents:
Money market funds$28,722 $ $ 
Restricted cash equivalents: money market funds17,301
Short-term investments:
U.S. Treasury securities46,211
Commercial paper11,126
Corporate bonds144,340
U.S. government agency securities9,933
Certificates of deposit3,431
Total assets$92,234 $168,830 $ 
Liabilities
Public Warrants$1,656 $ $ 
Private Placement Warrants1,305
Contingent consideration for acquisitions  12,891 
Total liabilities$1,656 $ $14,196 
The fair value of cash held in banks and accrued and other current liabilities approximate the stated carrying value due to the short time to maturity and are excluded from the tables above.
Money Market Funds
The fair value of the Company’s money market funds is based on quoted active market prices for the funds and is determined using the market approach. There were no realized or unrealized gains or losses on money market funds for the three and nine months ended October 31, 2024 and 2023.
Short-term Investments
The fair value of the Company’s short-term investments classified within Level 1 are valued using quoted active market prices for the securities. The fair value of the Company’s short-term investments classified within Level 2 are valued using third-party pricing services. The pricing services utilize industry standard valuation models. Inputs utilized include market pricing based on real-time trade data for the same or similar securities and other significant inputs derived from or corroborated by observable market data.
Public and Private Placement Warrants
The Public Warrants are classified within Level 1 as they are publicly traded and had an observable market price in an active market.
The Private Placement Warrants (excluding the Private Placement Vesting Warrants) were valued based on a Black-Scholes option pricing model. Due to the market condition vesting requirements, the fair value of the Private Placement Vesting Warrants were valued using a model based on multiple stock price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the market condition targets may not be satisfied. The Private Placement Warrants were collectively classified as a Level 3 measurement within the fair value hierarchy because these valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility. The expected volatility input utilized for the fair value measurements of the Private Placement Warrants as of October 31, 2024 and January 31, 2024 was 70%.
Contingent Consideration for Acquisitions
The Company has recorded contingent consideration liabilities in connection with its acquisitions of Salo Sciences and Sinergise (see Note 5, Acquisitions, for the acquisition of Sinergise. See Note 6 of the Company’s Consolidated Financial Statements included in the 2024 Form 10-K). The Company measures the fair value of the contingent consideration liabilities based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy.
16

The fair value of the contingent consideration liability for the Salo Sciences technical milestone payments is determined based on the present value of the probability-weighted payments for each of the two milestones. The significant unobservable inputs used in the fair value measurement are management’s estimate of the probability to achieve the technical milestone criteria and the discount rate. The Company determined that both of the technical milestone criteria were achieved during the nine months ended October 31, 2024.
The fair value of the contingent consideration liability for the Salo Sciences customer contract earnout payments is determined using a Monte Carlo simulation. The fair value estimate involves a simulation of future customer contract cash collections during the four-year performance period, the probability of entering into contracts with the named customers and discounting the probability-weighed earnout payments to present value. The significant unobservable inputs used in the fair value measurement are management’s estimate of obtaining the customer contracts, including probabilities, timing and contract values, and management’s estimate of the discount rate.
The fair value of the contingent consideration liability for the Sinergise customer consent escrow is determined based on the present value of the probability-weighted payments based on the likelihood of the customer consent being achieved. The significant unobservable input used in the fair value measurement is management’s estimate of the likelihood of the customer consent being achieved.
17

Level 3 Disclosures
The following is a roll-forward of Level 3 liabilities measured at fair value for the three and nine months ended October 31, 2024 and 2023:
(in thousands)Private Placement WarrantsTechnical Milestone Contingent Consideration*Customer Contract Earnout Contingent Consideration*Customer Consent Escrow Contingent Consideration*
Fair value at end of year, January 31, 2023$9,701 $4,433 $3,597 $ 
Change in fair value(3,323)5(428)
Fair value at April 30, 2023$6,378 $4,438 $3,169 $ 
Change in fair value(1,364)211(315)
Fair value at July 31, 2023$5,014 $4,649 $2,854 $ 
Additions5,842
Payments(160)
Change in fair value(3,590)6(478)76
Fair value at October 31, 20231,4244,6552,2165,918
Fair value at end of year, January 31, 2024$1,305 $5,114 $1,926 $5,851 
Payments(180)
Change in fair value(771)(183)1369
Fair value at April 30, 2024$534 $4,931 $1,759 $5,920 
Payments(1,090)
Change in fair value3265791551,291
Fair value at July 31, 2024$860 $5,510 $824 $7,211 
Payments$ $ $ $(7,500)
Change in fair value$(267)$362 $586 $289 
Fair value at October 31, 2024$593 $5,872 $1,410 $ 
* The current portion of the contingent consideration liabilities balances of $4.4 million and $7.0 million as of October 31, 2024 and January 31, 2024, respectively, are included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for the Salo Sciences technical milestone payments are included within research and development expenses. Changes in fair value of the Salo Sciences contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Changes in fair value of the contingent consideration liability for the Sinergise acquisition customer consent escrow payments are included within general and administrative expenses. During the three months ended October 31, 2024, evidence of the Sinergise acquisition customer consent was received and the $7.5 million in escrow was released to Sinergise.
Other
The Company measures certain non-financial assets including property and equipment, and other intangible assets at fair value on a non-recurring basis in periods after initial measurement in circumstances when the fair value of such assets are impaired below their recorded cost. As of October 31, 2024 and January 31, 2024, there were no material non-financial assets recorded at fair value.

(5)Acquisition
Sinergise
On March 26, 2023, the Company entered into an asset purchase agreement with Holding Sinergise d.o.o., a company existing under the laws of Slovenia (“Sinergise”), and its subsidiaries and certain shareholders of Sinergise, to acquire the cloud-based geo-spatial analysis products, platforms and solutions business from Sinergise. On August 4, 2023, the Company completed the acquisition.
18

The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The acquisition date fair value of the consideration transferred was approximately $41.1 million, and consisted of the following:
(in thousands)Fair Value
Cash$8,609 
Class A common stock issued
21,622 
Liabilities for cash consideration placed in escrow account10,842 
Total$41,073 
The common stock issued consisted of 6,745,438 shares of the Company’s Class A common stock. The fair value of the Class A common stock was determined based on the closing market price on the date of the acquisition.
In April 2024, the Company paid $1.1 million of additional consideration in connection with the finalization of the net working capital adjustment relating to the Company’s acquisition of Sinergise. The additional amount was accounted for as a measurement period adjustment and resulted in a $1.1 million addition of goodwill during the nine months ended October 31, 2024.
Pursuant to the terms of the asset purchase agreement, the Company placed $5.0 million of cash consideration into an escrow account to secure potential indemnification obligations and any customary post-closing adjustments for working capital and indebtedness (the “Indemnity Escrow”). The amount held in the escrow account is to be released to Sinergise upon the two-year anniversary of the acquisition close date. The Company recorded a liability of $5.0 million for the Indemnity Escrow.
Pursuant to the terms of the asset purchase agreement, the Company placed an additional $7.5 million of cash consideration into an escrow account related to obtaining customer consent for a contract acquired in connection with the acquisition (the “Customer Consent Escrow”). The amount held in the escrow account is to be released to Sinergise upon the Company receiving evidence of the customer consent. If evidence of the customer consent is not received on or prior to the two year anniversary of the acquisition close date, the amount held in the Customer Consent Escrow is to be released to the Company. Additionally, the amount held in the Customer Consent Escrow is to be released to the Company if the customer contract is terminated or suspended on or prior to the two year anniversary of the acquisition close date. The Company determined that the customer consent contingency represents contingent consideration. The fair value of the contingent consideration liability as of the acquisition date was determined to be $5.8 million. Refer to Note 4 for information relating to the valuation of the Customer Consent Escrow contingent consideration.
Cash held in escrow related to the acquisition is recorded within restricted cash and cash equivalents in the Company’s condensed consolidated balance sheets.

19

The following table summarizes the fair value of the assets acquired and liabilities assumed as of the date of acquisition, after considering the measurement period adjustment described above:

(in thousands)
Goodwill$24,815 
Identifiable intangible assets acquired
Developed technology11,811
Customer relationships2,208
Other110
Accounts receivable3,013
Other assets, current652
Other assets, non-current414
Total assets acquired$43,023 
Deferred revenue, current(585)
Accrued and other current liabilities(984)
Other liabilities, current(213)
Other liabilities, non-current(167)
Total liabilities assumed$(1,949)
Net assets acquired$41,074 

The identifiable intangible assets were measured at fair value. The developed technology was valued using the royalty method under the income approach. The customer relationships were valued using the excess earnings method under the income approach. The developed technology was assigned an estimated useful life of 8 years and the customer relationships were assigned an estimated useful life of 9 years.
The excess of purchase consideration over the fair value of other assets acquired and liabilities assumed was recorded as goodwill. The goodwill primarily represents the value expected from the synergies created through the operational enhancement benefits resulting from the integration of Sinergise into the Company and the combination of Sinergise’s products and solutions with the Company’s existing products. Approximately $0.7 million of the goodwill is deductible for tax purposes.
The financial results of Sinergise are included in the condensed consolidated financial statements from the date of acquisition. Pro forma results of operations have not been presented as the effect of this acquisition was not material to the condensed consolidated financial statements.
Acquisition-related costs associated with the transaction were $0.2 million and $2.1 million for the three and nine months ended October 31, 2023, respectively. These costs were recorded within selling, general and administrative expenses.

Certain employees of Sinergise, which became employees of the Company, were paid cash transaction bonuses totaling $2.3 million in connection with the closing of the acquisition. The transaction bonuses were accounted for as a transaction separate from the business combination. Accordingly, $2.3 million of the consideration paid by the Company was allocated to the transaction bonuses and was recorded within the Company’s condensed consolidated statements of operations as summarized in the table below:

(in thousands)Three and Nine Months Ended October 31, 2023
Cost of revenue$267 
Research and development1,891 
Sales and marketing41 
General and administrative118 
Total$2,317 


20

(6)Balance Sheet Components
Cash and Cash Equivalents, and Restricted Cash and Cash Equivalents
Cash and cash equivalents include interest-bearing bank deposits, money market funds and other highly liquid investments with maturities of 90 days or less at the date of purchase.
The Company had restricted cash and cash equivalents balances of $11.0 million and $18.3 million as of October 31, 2024 and January 31, 2024, respectively.
The restricted cash and cash equivalents balances as of October 31, 2024 primarily consisted of $5.0 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases. The restricted cash and cash equivalents balances as of January 31, 2024 primarily consisted of $12.5 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases.
A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of October 31, 2024 and January 31, 2024 is as follows:
 
(in thousands)October 31, 2024January 31, 2024
Cash and cash equivalents$138,969 $83,866 
Restricted cash and cash equivalents, current6,525 8,360
Restricted cash and cash equivalents, non-current4,437 9,972
Total cash, cash equivalents, and restricted cash and cash equivalents$149,931 $102,198 
Short-term Investments
Short-term investments consisted of the following as of October 31, 2024 and January 31, 2024:
October 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$19,533 $2 $(69)$19,466 
Commercial paper2,943   2,943 
Corporate bonds78,502 265 (35)78,732 
Certificates of deposit2,114   2,114 
Total short-term investments$103,092 $267 $(104)$103,255 
January 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$46,185 $118 $(92)$46,211 
Commercial paper11,126   11,126 
Corporate bonds144,119 376 (155)144,340 
U.S. government agency securities9,928 17 (13)9,932 
Certificates of deposit3,432   3,432 
Total short-term investments$214,790 $511 $(260)$215,041 
21

The following table summarizes the contracted maturities of the Company’s short-term investments as of October 31, 2024 and January 31, 2024:
October 31, 2024January 31, 2024
(in thousands)Amortized CostFair ValueAmortized CostFair Value
Due in 1 year or less$69,910 $70,127 $148,396 $148,296 
Due in 1-2 years33,182 33,128 66,394 66,745 
$103,092 $103,255 $214,790 $215,041 
Property and Equipment, Net
Property and equipment, net consists of the following:
(in thousands)October 31, 2024January 31, 2024
Satellites$244,501 $300,203 
Satellites in process and not placed into service55,979 32,468 
Leasehold improvements17,125 17,089 
Ground stations and ground station equipment20,048 19,098 
Office furniture, equipment and fixtures10,146 8,044 
Computer equipment and purchased software9,657 9,446 
Total property and equipment, gross$357,456 $386,348 
Less: Accumulated depreciation(240,536)(272,919)
Total property and equipment, net$116,920 $113,429 
Property and equipment, net as of October 31, 2024 included $2.8 million of satellite manufacturing costs that were previously classified as prepaid expenses and other current assets as of January 31, 2024.
The Company’s long-lived assets by geographic region are as follows:
(in thousands)October 31, 2024January 31, 2024
United States$110,901 $107,070 
Rest of world
6,0196,359
Total property and equipment, net$116,920 $113,429 
The Company concluded that satellites in service continue to be owned by the U.S. entity and accordingly are classified as U.S. assets in the table above. No single country other than the U.S. accounted for more than 10% of total property and equipment, net, as of October 31, 2024 and January 31, 2024.
Total depreciation expense for the three and nine months ended October 31, 2024 was $8.0 million and $30.3 million, respectively, of which $7.2 million and $27.9 million, respectively, was depreciation expense specific to satellites. Total depreciation expense for the three and nine months ended October 31, 2023 was $11.9 million and $31.4 million, respectively, of which $11.1 million and $29.5 million, respectively, was depreciation expense specific to satellites.
Capitalized Internal-Use Software Development Costs
Capitalized internal-use software costs, net of accumulated amortization consists of the following:
(in thousands)October 31, 2024January 31, 2024
Capitalized internal-use software$50,074 $45,010 
Less: Accumulated amortization(31,815)(30,037)
Capitalized internal-use software, net$18,259 $14,973 
Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2024 was $0.6 million and $1.8 million, respectively. Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2023 was $0.5 million and $1.4 million, respectively.
22

Goodwill and Intangible Assets
Goodwill and Intangible assets consists of the following:
 October 31, 2024
January 31, 2024
(in thousands)Gross
Carrying
Amount
Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
 Gross
Carrying
Amount
 Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
Developed technology$30,429 $(13,131)$(195)$17,103 $30,429 $(11,085)$(220)$19,124 
Image library19,949(13,008)3467,28719,324(11,852)2187,690
Customer relationships7,143(4,160)(63)2,9207,143(3,715)(42)3,386
Trade names and other6,389(4,499)311,9216,089(3,877)362,248
Total intangible assets$63,910 $(34,798)$119 $29,231 $62,985 $(30,529)$(8)$32,448 
Goodwill$135,981 $— $1,430 $137,411 $134,914 $— $1,342 $136,256 
Amortization expense for intangible assets for the three and nine months ended October 31, 2024 was $1.5 million and $4.3 million, respectively. Amortization expense for intangible assets for the three and nine months ended October 31, 2023 was $1.3 million and $3.3 million, respectively.
The change in the carrying amount of goodwill during the nine months ended October 31, 2024 and 2023 is as follows:
Nine Months Ended
October 31,
(in thousands)20242023
Beginning of period$136,256 $112,748 
Addition1,068 23,747 
Currency translation adjustment87 (794)
End of period$137,411 $135,701 
In April 2024, the Company paid $1.1 million of additional consideration in connection with the finalization of the net working capital adjustment relating to the Company’s acquisition of Sinergise. The additional amount was accounted for as a measurement period adjustment and resulted in a $1.1 million addition of goodwill during the nine months ended October 31, 2024.
Accrued and Other Current Liabilities
Accrued liabilities and other current liabilities consist of the following:
(in thousands)October 31, 2024January 31, 2024
Deferred R&D service liability (see Note 9)$8,237 $9,923 
Payroll and related expenses6,636 6,859 
Deferred hosting costs5,145 5,007 
Withholding taxes and other taxes payable1,560 3,152 
Contingent consideration
4,4117,006
Severance and other employee termination costs91123
Other accruals
16,77012,809
Total accrued and other current liabilities$43,670 $44,779 

(7)Restructuring
2024 Headcount Reduction
In June 2024, the Company announced a plan to reduce its global headcount by approximately 17% of the Company’s total number of employees prior to the reduction (the “2024 headcount reduction”). This action was taken consistent with the Company’s ongoing focus on aligning its resources to the market opportunity, improving operational efficiency, and supporting the long-term growth of the business.
23

As a result of the 2024 headcount reduction, the Company recognized costs for one-time employee termination benefits consisting of severance and other employee costs. The Company also recognized a stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. A summary of the restructuring charges recognized during the three and nine months ended October 31, 2024 is provided in the tables below:
Three Months Ended October 31, 2024
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$128 $(176)$(48)
Research and development(76)(426)(502)
Sales and marketing24 (680)(656)
General and administrative(51)(71)(122)
Total restructuring charges$25 $(1,353)$(1,328)
Nine Months Ended October 31, 2024
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$1,312 $(176)$1,136 
Research and development3,464 (426)3,038 
Sales and marketing4,457 (680)3,777 
General and administrative1,291 (71)1,220 
Total restructuring charges$10,524 $(1,353)$9,171 
There were no restructuring charges recognized during the three and nine months ended October 31, 2023 related to the 2024 headcount reduction.
The following table summarizes the Company’s liability recognized in connection with the 2024 headcount reduction, which is recorded within accrued and other current liabilities in the condensed consolidated balance sheets:
(in thousands)
Balance as of January 31, 2024$ 
Severance and other employee costs10,524 
Cash payments(9,613)
Balance as of October 31, 2024$911 
The headcount reductions, including the remaining cash payments, are expected to be substantially complete by the end of the fiscal year ending January 31, 2025.
2023 Headcount Reduction
In August 2023, the Company announced a plan to reduce its global headcount by approximately 10% of the Company’s total number of employees prior to the reduction (the “2023 headcount reduction”). This action was taken to increase the Company’s focus on its high priority growth opportunities and operational efficiency.
24

As a result of the 2023 headcount reduction, the Company recognized costs for one-time employee termination benefits consisting of severance and other employee costs. The Company also recognized a stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. A summary of the restructuring charges recognized during the three and nine months ended October 31, 2023 is provided in the table below:
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$563 $(62)$501 
Research and development3,297 (398)2,899 
Sales and marketing1,943 (815)1,128 
General and administrative1,538 (253)1,285 
Total restructuring charges$7,341 $(1,528)$5,813 
There were no restructuring charges recognized during the three and nine months ended October 31, 2024 related to the 2023 headcount reduction.
The 2023 headcount reduction, including cash payments, was substantially complete as of January 31, 2024.

(8)Leases
The Company’s leasing activities primarily consist of real estate leases for its operations, including office space, and certain ground station service agreements that convey the right to control the use of specified equipment and facilities. The Company assesses whether each lease is an operating or finance lease at the lease commencement date. As of October 31, 2024, the Company had no finance leases.
Operating lease costs were $2.4 million and $7.1 million for the three and nine months ended October 31, 2024, respectively. Operating lease costs were $2.1 million and $6.1 million for the three and nine months ended October 31, 2023, respectively. Variable lease expenses and short-term lease expenses were immaterial for the three and nine months ended October 31, 2024 and 2023.
Operating cash flows from operating leases were $2.6 million and $7.5 million for the three and nine months ended October 31, 2024, respectively. Operating cash flows from operating leases were $2.3 million and $5.0 million for the three and nine months ended October 31, 2023, respectively.
Right of use assets obtained in exchange for operating lease liabilities were $1.2 million and $4.3 million for the three and nine months ended October 31, 2024, respectively. Right of use assets obtained in exchange for operating lease liabilities were $0.3 million and $6.5 million for the three and nine months ended October 31, 2023, respectively.
Maturities of operating lease liabilities as of October 31, 2024 were as follows:
(in thousands)
Remainder of Fiscal Year 2025$2,629
202610,217
20277,104
20282,951
20291,837
Thereafter817
Total lease payments$25,555
Less: Imputed interest(2,630)
Total lease liabilities$22,925
Weighted average remaining lease term (years)3.0
Weighted average discount rate8 %

25

(9)Research and Development Arrangements
Research and Development Services Agreement
In December 2020, the Company entered into a development services agreement, whereby the Company agreed to provide the technical knowledge and services to design and develop certain prototype satellites and deliver and test early data collected (the “R&D Services Agreement”). The R&D Services Agreement, including subsequent amendments to such agreement, provides for funding of $46.4 million to be paid to the Company as specified milestones are achieved. The R&D Services Agreement is unrelated to the Company’s ordinary business activities. The Company has discretion in managing the activities under the R&D Services Agreement and retains all developed intellectual property. The Company has no obligation to repay any of the funds received regardless of the outcome of the development work; therefore, the arrangement is accounted for as funded research and development pursuant to ASC 730-20, Research and Development. As ASC 730-20 does not indicate the accounting model for research and development services, the Company determined the total transaction price is recognized over the agreement term as a reduction of research and development expenses based on a cost incurred method.
During the three and nine months ended October 31, 2024, the Company recognized $2.9 million and $7.2 million of funding and incurred $2.9 million and $6.5 million of research and development expenses, respectively, in connection with the R&D Services Agreement. During the three and nine months ended October 31, 2023, the Company recognized $6.8 million and $14.8 million of funding and incurred $7.6 million and $15.6 million of research and development expenses, respectively. As of October 31, 2024 and January 31, 2024, the Company had received a total of $46.4 million and $45.8 million, respectively, of funding under the R&D Services Agreement.
NASA Communication Services Project
In connection with its Communication Services Project (“CSP”), the National Aeronautics and Space Administration (“NASA”) selected certain satellite communications providers that NASA will fund to develop and demonstrate near-Earth space communication services that may support future NASA missions using commercial technology. In June 2022 and August 2022, the Company entered into separate agreements with two of the satellite communications providers selected by NASA whereby the Company agreed to participate in the NASA CSP as a subcontractor. The agreements provide for the Company to receive aggregate funding of $40.5 million to be paid as milestones are completed. The Company determined that the agreements are in the scope of ASC 912-730, Contractors – Federal Government – Research and Development (“ASC 912-730”). In accordance with ASC 912-730, funding is recognized over the term of each agreement as a reduction of research and development expenses based on a cost incurred method.
During the three and nine months ended October 31, 2024, the Company recognized $2.5 million and $7.6 million of funding, respectively, and incurred $2.5 million and $7.6 million of research and development expenses, respectively, in connection with the NASA CSP. During the three and nine months ended October 31, 2023, the Company recognized $1.2 million and $9.2 million of funding, respectively, and incurred $1.2 million and $8.4 million of research and development expenses, respectively, in connection with the NASA CSP. As of October 31, 2024 and January 31, 2024, the Company had received a total of $27.6 million and $13.9 million, respectively, of funding in connection with the NASA CSP.
In July 2023, projected costs related to certain of our research and development arrangements were revised down as a result of operational decisions. This change in estimate resulted in a $2.2 million cumulative increase of funding recognized for certain of our research and development arrangements for the nine months ended October 31, 2023.

26

(10)Commitments and Contingencies
Other
The Company has minimum purchase commitments for hosting services from Google through January 31, 2028 (see Note 12). Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of October 31, 2024 are as follows:
(in thousands) 
Remainder of Fiscal Year 2025$9,428 
202631,190 
202732,725 
202833,427 
Total purchase commitments$106,770 

Legal Proceedings
Delaware Class Action
A stockholder class action was filed in the Court of Chancery of the State of Delaware on August 19, 2024, against the former officers and directors of dMY IV and the Company. The complaint alleges that the individual defendants breached various fiduciary duties to the dMY IV stockholders and that the Company aided and abetted such breaches. The case is brought on behalf of a purported class of holders of dMY IV Class A Common Stock who held such stock prior to the redemption deadline for the Business Combination, did not exercise the right to redeem their shares, and were allegedly injured. Defendants filed a motion to dismiss the complaint on November 12, 2024.
For many legal matters, particularly those in early stages, the Company cannot reasonably estimate the possible loss (or range of loss), if any. The Company records an accrual for legal matters at the time or times it determines that a loss is both probable and reasonably estimable. Regarding matters for which no accrual has been made (including the potential for losses in excess of amounts accrued), the Company currently believes, based on its own investigations, that any losses (or ranges of losses) that are reasonably possible and estimable will not, in the aggregate, have a material adverse effect on its financial position, results of operations, or cash flows. However, the ultimate outcome of legal proceedings involves judgments, estimates, and inherent uncertainties and cannot be predicted with certainty. Should the ultimate outcome of any legal matter be unfavorable, the Company's business, financial condition, results of operations, or cash flows could be materially and adversely affected. The Company may also incur substantial legal fees, which are expensed as incurred, in defending against legal claims.
Contingencies
The Company may have certain contingent liabilities that arise in the ordinary course of business activities including those arising from disputes and claims and events arising from revenue contracts entered into by the Company. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.
Indemnification
The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent, or other intellectual property infringement claim by any third-party with respect to its technology. The term of these indemnification agreements is generally perpetual after the execution of the agreement. The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement.
The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify them against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.
To date, we have not incurred any material costs and have not accrued any liabilities in the consolidated financial statements as a result of these provisions.
27


(11)Warrants
Public and Private Placement Warrants
In connection with dMY IV’s initial public offering, which occurred on March 9, 2021, dMY IV issued 34,500,000 units, each unit consisting of one share of Class A common stock of dMY IV and one-fifth of one redeemable warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (the “Public Warrants”). Simultaneously with the closing of its initial public offering, dMY IV completed the private sale of 5,933,333 warrants to dMY Sponsor IV, LLC (the “dMY Sponsor”) at a purchase price of $1.50 per warrant (the “Private Placement Warrants”). Each Private Placement Warrant is exercisable for one share of Class A common stock at $11.50 per share.
Additionally, pursuant to a lock-up agreement entered into with the dMY Sponsor in connection with the Business Combination, 2,966,667 of the Private Placement Warrants are subject to vesting conditions (the “Private Placement Vesting Warrants”). The Private Placement Vesting Warrants vest in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. Any right to Private Placement Vesting Warrants that remains unvested on the first business day after five years from the closing of the Business Combination will be forfeited without any further consideration.
As of October 31, 2024 and January 31, 2024, there were 6,899,982 Public Warrants and 5,933,333 Private Placement Warrants, including 2,966,667 Private Placement Vesting Warrants, outstanding.
Warrants to Purchase Class A Common Stock
In addition to the Public and Private Placement Warrants, there were 1,065,594 warrants to purchase shares of Class A common stock with a weighted average exercise price of $9.384 which were outstanding and exercisable as of October 31, 2024 and January 31, 2024. As of October 31, 2024, the outstanding warrants have a weighted average remaining term of 5.4 years.

(12)Related Party Transactions
As of October 31, 2024 and January 31, 2024, Google held 31,942,641 shares of the Company’s Class A common stock, and, as such, owned greater than 10% of outstanding shares of the Company’s Class A common stock.
In April 2017, the Company and Google entered into a five year content license agreement pursuant to which the Company licensed content to Google. In April 2022, the agreement automatically renewed for a period of one year and in April 2023, the agreement expired. For the nine months ended October 31, 2023, the Company recognized revenue of $0.3 million related to this content license agreement.
In July 2023, the Company and Google entered into a one year content license agreement pursuant to which the Company agreed to license content to Google and provide certain of its products in exchange for a $1.0 million fee. The agreement also provides for the Company to receive up to $2.0 million in value of Google cloud credits that the Company can apply against the cost of Google cloud services it utilizes to fulfill its obligations under the agreement. The Company determined that the Google cloud credits represent non-cash variable consideration which is included in the transaction price for the agreement, subject to the guidance on estimating variable consideration within ASC 606, Revenue from Contracts with Customers. The agreement does not include extension or renewal terms. In August 2024, the content license agreement was amended to extend the term until November 2024 in exchange for a $0.3 million fee. For the three and nine months ended October 31, 2024, the Company recognized revenue of $0.3 million related to the content license agreement. The Company recognized immaterial revenue related to the content license agreement for the three months ended October 31, 2023 and recognized revenue of $1.0 million for the nine months ended October 31, 2023.
28

The Company purchases hosting and other services from Google, of which $11.8 million and $12.1 million is deferred as of October 31, 2024 and January 31, 2024, respectively. The Company recorded $6.2 million of expense during the three months ended October 31, 2024 relating to hosting and other services provided by Google, of which $5.6 million was classified as cost of revenue and $0.6 million was classified as research and development. The Company recorded $20.6 million of expense during the nine months ended October 31, 2024 relating to hosting and other services provided by Google, of which $18.5 million was classified as cost of revenue and $2.1 million was classified as research and development.
The Company recorded $7.5 million of expense during the three months ended October 31, 2023 relating to hosting and other services provided by Google, of which $6.7 million was classified as cost of revenue and $0.8 million was classified as research and development. The Company recorded $21.6 million of expense during the nine months ended October 31, 2023 relating to hosting and other services provided by Google, of which $19.4 million was classified as cost of revenue and $2.2 million was classified as research and development.
As of October 31, 2024 and January 31, 2024, the Company’s accrued and other current liabilities balance included $2.4 million and $2.5 million related to hosting and other services provided by Google, respectively.
On June 28, 2021, the Company amended the terms of its hosting agreement with Google. The amendment, among other things, increased the aggregate purchase commitments to $193.0 million. The amended agreement commenced on August 1, 2021 and extends through January 31, 2028. See Note 10, Commitments and Contingencies, for future Google hosting purchase commitments, including the amended commitments, as of October 31, 2024.

(13)Stock-based Compensation
The Company's equity incentive plans are described in Note 16, Stock-based Compensation, in the Notes to the Consolidated Financial Statements in the 2024 Form 10-K.
Stock-Based Compensation
The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows:
 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands)2024202320242023
Cost of revenue$897 $944 $2,981 $3,008 
Research and development4,643 6,042 13,495 20,253 
Sales and marketing1,655 1,626 6,863 7,827 
General and administrative5,135 4,429 14,921 15,374 
Total expense12,330 13,041 38,260 46,462 
Capitalized to internal-use software development costs and property and equipment(501)(443)(1,793)(1,851)
Total stock-based compensation expense$11,829 $12,598 $36,467 $44,611 
Stock Options
A summary of stock option activity is as follows:
 Options Outstanding
 Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (Years)
 
Aggregate
Intrinsic
Value
(in thousands)
Balances at January 31, 2024
26,956,953$5.34 5.7
Exercised(324,375)$1.02 
Granted $ 
Forfeited(1,022,576)$7.28 
Balances at October 31, 2024
25,610,002$5.32 4.8$453 
Vested and exercisable at October 31, 2024
24,137,280$5.06 4.7$453 
As of October 31, 2024, total unrecognized compensation cost related to stock options was $6.5 million, which is expected to be recognized over a period of 1.1 years.
29

Restricted Stock Units
A summary of Restricted Stock Unit (“RSU”) activity is as follows:
 
Number of
RSUs
 
Weighted
Average
Grant Date
Fair Value
Balances at January 31, 2024
26,718,766$4.45 
Vested(9,654,778)$4.01 
Granted26,642,464$2.34 
Forfeited(7,169,719)$3.70 
Balances at October 31, 2024
36,536,733$3.17 
During the nine months ended October 31, 2024, the Company granted 26,642,464 RSUs, which generally vest over four years, subject to the recipient’s continued service through each applicable vesting date.
Stock-based compensation expense recognized for RSUs during the three and nine months ended October 31, 2024 was $9.9 million and $30.2 million, respectively. Stock-based compensation expense recognized for RSUs during the three and nine months ended October 31, 2023 was $8.6 million and $29.2 million, respectively. As of October 31, 2024, total unrecognized compensation cost related to RSUs was $103.8 million. These costs are expected to be recognized over a period of approximately 2.8 years.
Performance Vesting Restricted Stock Units
During the nine months ended October 31, 2024, the Company granted 348,222 performance vesting restricted stock units (“PSUs”) to certain members of the Company’s senior management. A portion of the PSUs are subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the first half of the fiscal year ended January 31, 2025 and the remaining portion is subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the entire fiscal year ended January 31, 2025. Vesting is also subject to continued service through the applicable vesting dates, and the actual number of PSUs that may vest ranges from 0% to 125% of the PSUs granted based on achievement of the targets.
Stock-based compensation expense recognized for PSUs during the three and nine months ended October 31, 2024 was $0.3 million and $0.8 million, respectively. Stock-based compensation expense recognized for PSUs during the three and nine months ended October 31, 2023 was $0.3 million and $0.7 million, respectively. As of October 31, 2024, total unrecognized compensation cost related to PSUs was $0.2 million. These costs are expected to be recognized over a period of approximately 0.4 years.
Employee Stock Purchase Program
Beginning in April 2024, the Company's eligible employees were able to begin participating in the Company's Employee Stock Purchase Program (“ESPP”). The ESPP allows eligible participants to contribute up to 10% of their eligible compensation towards the purchase of Class A common stock at a discounted price, subject to certain limitations. The purchase price of the shares on each purchase date is equal to 85% of the lower of the fair market value of Class A common stock on the first and last trading days of each offering period. The offerings under the ESPP are currently designed to be intended to qualify under Section 423 of the Internal Revenue Code. The Company estimates the fair value of each purchase right under the ESPP on the date of grant using the Black-Scholes valuation model and uses the straight-line attribution approach to record the expense over the six-month offering period.
Stock-based compensation expense recognized related to ESPP during the three and nine months ended October 31, 2024 was $0.2 million and $0.4 million, respectively. As of October 31, 2024, total unrecognized compensation cost related to ESPP was $0.4 million. These costs are expected to be recognized over a period of approximately 0.4 years.
Early Exercises of Stock Options
The Planet Labs Inc. Amended and Restated 2011 Stock Incentive Plan provided for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Shares of common stock issued upon early exercises of unvested options are not deemed, for accounting purposes, to be issued until those shares vest according to their respective vesting schedules and accordingly, the consideration received for early exercises is initially recorded as a liability and reclassified to common stock and additional paid-in capital as the underlying awards vest. As of October 31, 2024, the Company had a $6.3 million liability recorded for the early exercise of unvested stock options, and the related number of unvested shares subject to repurchase was 643,370.
30

Earn-out Shares
Pursuant to the Merger Agreement, Former Planet equity award holders have the right to receive Earn-out Shares that are contingently issuable in shares of Class A common stock. The Earn-out Shares may be earned in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00.
No Earn-out Shares vested during the three and nine months ended October 31, 2024. As of October 31, 2024, there were 2,984,494 Earn-out Shares outstanding relating to Former Planet equity award holders.
During the three and nine months ended October 31, 2023, the Company recognized $0.4 million and $4.2 million of stock-based compensation expense related to the Earn-out Shares, respectively. As of October 31, 2024, there was no remaining unrecognized compensation cost related to the Earn-out Shares.
Other Stock-based Compensation
In connection with the acquisition of VanderSat B.V. (“VanderSat”) on December 13, 2021, the Company issued 543,391 shares of Class A common stock to an employee and former owner of VanderSat which are accounted for as stock-based compensation because the shares were subject to forfeiture based on post-acquisition time-based service vesting. The shares vested in quarterly increments over two years commencing on December 13, 2021. As of October 31, 2024 and January 31, 2024, there was no unrecognized compensation cost related to these shares. During the three and nine months ended October 31, 2023, the Company recognized $0.6 million and $1.9 million of stock-based compensation expense related to these shares, respectively.

(14) Income Taxes
During the three months ended October 31, 2024, the Company recorded an immaterial amount of income tax expense. During the nine months ended October 31, 2024, the Company recorded $1.4 million of income tax expense. During the three and nine months ended October 31, 2023, the Company recorded income tax expense of $0.4 million and $1.2 million, respectively. For the three and nine months ended October 31, 2024 and 2023, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rates for the three and nine months ended October 31, 2024 and 2023 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of the Company’s U.S. and foreign deferred tax assets and foreign rate differences.
The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. Gross unrecognized tax benefits were $9.8 million and $8.7 million as of October 31, 2024 and January 31, 2024, respectively. The gross unrecognized tax benefits, if recognized, would not affect the effective tax rate due to the valuation allowance against the deferred tax assets. The Company determined that no accrual for interest and penalties was required as of October 31, 2024 and January 31, 2024 and no such expenses were incurred in the periods presented.
The Company does not anticipate the total amounts of unrecognized tax benefits to significantly increase or decrease in the next twelve months.
The Company files U.S. federal, various state and foreign income tax returns. The Company is not currently under audit by any taxing authorities. All tax years remain open to examination by taxing jurisdictions to which the Company is subject.

31

(15)Net Loss Per Share Attributable to Common Stockholders
The Company computes net loss per share of the Class A common stock and Class B common stock using the two-class method required for participating securities. Basic and diluted net loss per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts):
 Three Months Ended October 31,Nine Months Ended October 31,
 2024202320242023
Numerator:
Net loss attributable to common stockholders$(20,081)$(38,004)$(88,042)$(110,423)
Denominator:
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders293,338,324284,197,733290,674,554277,252,951
       Basic and diluted net loss per share attributable to common stockholders$(0.07)$(0.13)$(0.30)$(0.40)

Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential Class A common stock and Class B common stock outstanding would have been anti-dilutive.
The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 As of October 31,
 20242023
Warrants to purchase Class A common stock1,065,5941,065,594
Common stock options25,610,00228,915,927
Restricted Stock Units36,536,73328,109,375
Performance vesting Restricted Stock Units365,428
Shares committed under ESPP85,216
Earn-out Shares24,443,50425,123,663
dMY Sponsor Earn-out Shares862,500862,500
Public Warrants6,899,9826,899,982
Private Placement Warrants5,933,3335,933,333
Early exercised common stock options, subject to future vesting643,3701,011,010
Shares issued in connection with acquisition, subject to future vesting67,923
Total102,445,66297,989,307
32

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF PLANET
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the results of operations and financial condition of Planet Labs PBC. The MD&A is provided as a supplement to and should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included in Part I, Item I of this Quarterly Report on Form 10-Q, as well as our audited annual consolidated financial statements and related notes as disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024 (the “2024 Form 10-K”). This discussion contains forward-looking statements and involves numerous risks and uncertainties, including, but not limited to, those described in Part II, Item 1A, “Risk Factors” in this Quarterly Report and Part I, Item 1A, “Risk Factors” of our 2024 Form 10-K. Actual results may differ materially from those contained in any forward-looking statements. Our historical results are not necessarily indicative of the results that may be expected for any period in the future.
Business and Overview
Our mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. Our platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about our evolving world.
As a public benefit corporation, our purpose is to accelerate humanity toward a more sustainable, secure, and prosperous world, by illuminating the most important forms of environmental and social change.
We deliver a differentiated data set: a new image of the entire Earth’s landmass, constantly refreshed. To collect this powerful data set, we design, build and operate hundreds of satellites, making our fleet the largest Earth observation fleet of satellites in history. Our daily stream of proprietary data and machine learning analytics, delivered through our cloud-native platform, helps companies, governments and civil society use satellite imagery to discover insights as change happens.
To help further our mission, we have developed advanced satellite technology that increases the cost performance of each satellite. This has enabled us to launch large fleets of satellites at lower cost and in turn record over 2,700 images on average for every point on Earth’s landmass, a non-replicable historical archive for analytics, machine learning, and insights. We have advanced data processing capabilities that enable us to produce “AI-ready” data sets. As this data set continues to grow, we believe its value to our customers will further increase.
We currently serve customers across large commercial and government verticals, including agriculture, mapping, energy, forestry, finance and insurance, as well as federal, civil, state, and local governments. Our customers in government and commercial markets leverage our product capabilities to monitor and manage global change over broad areas to take action.
Our proprietary data set and analytics are delivered pursuant to subscription and usage-based data licensing agreements and are accessed by our customers through our online platform and subscription APIs. We believe our efficient cost structure, one-to-many business model and differentiated data set have enabled us to grow our customer base across multiple vertical markets. As of October 31, 2024, our End of Period (“EoP”) Customer Count was 1,015 customers, which represented 4% year-over-year growth when compared to October 31, 2023. For a definition of EoP Customer Count see the section titled “Key Operational and Business Metrics.” Over 90% of our ACV Book of Business (as defined below) consists of annual or multi-year contracts. Our average contract length continues to be approximately two years, weighted on an annual contract value basis.
Our Business Model
We primarily generate revenue through selling licenses to our data and analytics to customers over an entirely cloud-based platform via fixed price subscription and usage-based contracts. Data licensing subscriptions and minimum commitment usage-based contracts provide a large recurring revenue base for our business with a low incremental cost to serve each additional customer. Payment terms of our customer agreements are most commonly in advance on an either quarterly or annual basis, although a small number of large contracts have required payment terms that are monthly or quarterly in arrears. Additionally, we also generate a small amount of revenue from sales of third-party imagery, professional services, and customer support.
We employ a “land-and-expand” go-to-market strategy with the goal to deliver increasing value to our customers and generate more revenue with each customer over time by expanding the scope of the services we offer. We work closely with our customers and partners to enable their early success, both from an account management and technical management perspective. Deeper adoption from our customers comes in many forms, including more users, more area coverage, and more advanced software analytics capabilities.
33

Key elements of our growth strategy include:
Scaling in Existing Verticals:
We plan to invest in sales, marketing, and software solutions to expand within our existing customer base and further penetrate vertical markets in which end users are early adopters of geospatial data, such as civil government, agriculture, and defense and intelligence.
Expansion into New Verticals and Applications:
We plan to invest in our offerings to make our data more actionable and accessible to a larger group of customers and users, including non-geospatial experts such as data and business analysts in government and commercial organizations. We believe this will help us address use cases in key emerging markets such as energy, infrastructure, finance, insurance, and consumer packaged goods. We also intend to partner with companies building vertical market solutions, such as independent software vendors, as well as business intelligence and analytics providers. While we have customers and partners today in many of these verticals, we believe enhancing our data to meet their needs has the potential to accelerate the proliferation of our data and analytics usage across more end users. Additionally, we currently have multiple partners with solutions that rapidly generate insights for customers using our proprietary data and AI technology. Their capabilities include training models on our proprietary data to find any object of interest to a user over broad areas of land or sea. We believe recent and ongoing advancements in AI will support making our datasets more accessible to customers and users across new and existing verticals by speeding customer time to value through these capabilities.
Continued Investment in Data Products:
We plan to scale and expand our existing products, as well as add new solutions, by building on our machine learning and computer vision capabilities with remote sensing techniques to fuse multiple data sources. These products allow our customers to consume simple, actionable time-series data within their existing workflows. We intend to create many of these key data sets internally, as well as in collaboration with our partners who have deep vertical expertise.
Establish Platform Ecosystem:
We plan to further develop our ecosystem of users and partners to build solutions leveraging our data and platform and to build software tools and APIs that make it even easier to do so. By developing a robust applications ecosystem, we believe we can create a network effect, potentially accelerating our growth and deepening our market penetration.
Factors Affecting the Results of Operations
We believe that our financial condition and result of operations have been, and will continue to be, affected by a number of factors that present significant opportunities for us but also pose risks and challenges, including those discussed below, in Part II, Item 1A “Risk Factors” of this Quarterly Report and in Part I, Item 1A, “Risk Factors” of our 2024 Form 10-K.
Recent Developments
Headcount Reduction
In June 2024, we committed to a plan to reduce our global headcount by approximately 17% of our total number of employees prior to the reduction (the “2024 headcount reduction”). This action was taken consistent with our ongoing focus on aligning the Company’s resources to the market opportunity, improving operational efficiency, and supporting the long-term growth and profitability of the business. As a result of the headcount reduction, during the three months ended October 31, 2024, the Company recognized immaterial costs for one-time employee termination benefits consisting of severance and other employee costs and a $1.4 million stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. During the nine months ended October 31, 2024, the Company recognized $10.5 million of costs for one-time employee termination benefits consisting of severance and other employee costs and a $1.4 million stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. The headcount reductions, including the remaining cash payments, are expected to be substantially complete by the end of the fiscal year ending January 31, 2025.
Continuing to Acquire New Customers
Attracting new customers is an important factor affecting our future growth and operating performance. We believe our ability to attract customers will be driven by our ability to continue to improve our data and offer software and analytic solutions that make our data easier to consume and integrate into our customers’ workflows, our success in offering new data sets and products to solve customer problems, increases in our global sales presence and increases
34

in our marketing investments. As part of this strategy, we have recently made Planet’s data available for purchase directly through our Planet Insights Platform, which facilitates rapid user adoption, particularly by empowering users to self-service our solutions without formal sales interaction. We believe this serves as a natural entry point for some of our smaller accounts, enabling them to realize the value of Planet’s offerings, leading to broader awareness of our solutions throughout their networks and organizations.
In addition, we plan to continue investing in making our data more digestible and accessible to non-technical business users and to build solutions to address more use cases and expand our addressable market. As a result of this strategy, we anticipate our research and development expenditures may generally increase over time. We will also aim to expand our reach with customers by partnering with independent software vendors and solution providers who are building vertical market-specific solutions. While we have customers and partners today in many markets, we believe that our increased investment in developing software analytics solutions has the potential to accelerate the usage of our data and analytics across broader audiences. Additionally, the timing of securing new customer contracts, including when it occurs during the year and the length of the sales cycle, as well as the size of the contracts, can impact our operating performance.
Retention and Expansion of Existing Customers
To increase customer retention and expansion of revenue from existing customers, we are making a number of investments in our operations. Customer retention and expansion is driven by the speed with which our customers realize the value of our data once they become customers, our ability to cross-sell our different products to our existing customers and our ability to offer new products to our customers. Therefore, to increase customer retention and sales to existing customers, we have invested in our customer success function, continuous improvements to our existing data, and the software tools and analytic tools that make our data easier to consume. As a result of such investments, we anticipate our cost of revenue, operating expenses, and capital expenditures may generally increase as we continue to prioritize customer retention and expansion and consequently, we are likely to experience losses in the near term, delaying our ability to achieve profitability and adversely affecting cash flows.
Developing New Sensors and Data Sets
We plan to make strategic investments in building new sensors to capture additional data sets from space. As we grow our customer base and the use cases we can address, we believe we can better understand what additional data sets our customers are eager to access and therefore which sensors might enable us to capture additional data that is valuable to such customers. By leveraging our agile aerospace approach to space systems, we believe we are well-positioned to introduce new Earth observation sensors into orbit to capture new types of data with greater capital efficiency and speed than other satellite data providers. Having these capabilities can deepen our value proposition to customers and help us both acquire new customers and expand our offering to existing customers.
Investment Decisions
We regularly review our existing customers and target markets to determine where we should invest in our product and technology roadmap, both for our space systems engineering to enable new geospatial coverage models, as well as our software engineering focused on providing sophisticated analytics models and tools to service an expanding set of markets and use cases. Our financial performance relies heavily on effective balance between driving continued growth, maintaining technology leadership, and improving margins across the business.
Seasonality
We have experienced, and expect to continue to experience, seasonality in our business and fluctuations in our operating results due to customer behavior, buying patterns and usage-based contracts. For example, we typically have customers who increase their usage of our data services when they need more frequent data monitoring over broader areas during peak agricultural seasons, during natural disasters or other global events, or when commodity prices are at certain levels. These customers may expand their usage and then subsequently scale back. We believe that the seasonal trends that we have experienced in the past may occur in the future. To the extent that we experience seasonality, it may impact our operating results and financial metrics, as well as our ability to forecast future operating results and financial metrics. Additionally, when we introduce new products to the market, we may not have sufficient experience in selling certain products to determine if demand for these products are or will be subject to material seasonality.
Key Operational and Business Metrics
In addition to the measures presented in our consolidated financial statements, we use the following key operational and business metrics to evaluate our business, measure our performance, develop financial forecasts, and make strategic decisions.
35

ACV and EoP ACV Book of Business
In connection with the calculation of several of the key operational and business metrics we utilize, we calculate Annual Contract Value (“ACV”) for contracts of one year or greater as the total amount of value that a customer has contracted to pay for the most recent 12 month period for the contract, excluding customers that are exclusively Sentinel Hub self-service paying users. For short-term contracts (contracts less than 12 months), ACV is equal to total contract value.
We also calculate EoP ACV Book of Business in connection with the calculation of several of the key operational and business metrics we utilize. We define EoP ACV Book of Business as the sum of the ACV of all contracts that are active on the last day of the period pursuant to the effective dates and end dates of such contracts, excluding customers that are exclusively Sentinel Hub self-service paying users. Active contracts exclude any contract that has been canceled, expired prior to the last day of the period without renewing, or for any other reason is not expected to generate revenue in the subsequent period. For contracts ending on the last day of the period, the ACV is either updated to reflect the ACV of the renewed contract or, if the contract has not yet renewed or extended, the ACV is excluded from the EoP ACV Book of Business. We do not annualize short-term contracts in calculating our EoP ACV Book of Business. We calculate the ACV of usage-based contracts based on the committed contracted revenue or the revenue achieved on the usage-based contract in the prior 12-month period.
Net Dollar Retention Rate
Nine Months Ended October 31,
20242023
Net Dollar Retention Rate104 %104 %
We define Net Dollar Retention Rate as the percentage of ACV generated by existing customers in a given period as compared to the ACV of all contracts at the beginning of the fiscal year from the same set of existing customers. We define existing customers as customers with an active contract with Planet. We believe our Net Dollar Retention Rate is a useful metric for investors as it can be used to measure our ability to retain and grow revenue generated from our existing customers, on which our ability to drive long-term growth and profitability is, in part, dependent. We use Net Dollar Retention Rate to assess customer adoption of new products, inform opportunities to make improvements across our products, identify opportunities to improve operations, and manage go to market functions, as well as to understand how much future growth may come from cross-selling and up-selling customers. Management applies judgment in determining the value of active contracts in a given period, as set forth in the definition of ACV above. Net Dollar Retention Rate remained flat at 104% for both the nine months ended October 31, 2024 and 2023. This was primarily due to expansion of a large international contract, offset by delay in renewal of a certain government contract.
Net Dollar Retention Rate including Winbacks
Nine Months Ended October 31,
20242023
Net Dollar Retention Rate including Winbacks105 %105 %
We assess two metrics for net dollar retention—Net Dollar Retention Rate, as described above, and Net Dollar Retention Rate including winbacks. A winback is a previously existing customer that was inactive at the start of the measurement period but has reactivated during the measurement period. The reactivation period must be within 24 months from the last active contract with the customer; otherwise, the customer is counted as a new customer and therefore excluded from the retention rate metrics. We define Net Dollar Retention Rate including winbacks as the percentage of ACV generated by existing customers and winbacks in a given period as compared to the ACV of all contracts at the beginning of the fiscal year from the same set of existing customers. We believe this metric is useful to investors as it captures the value of customer contracts that resume business with Planet after being inactive and thereby provides a quantification of Planet’s ability to recapture lost business. Management uses this metric to understand the adoption of our products and long-term customer retention, as well as the success of marketing campaigns and sales initiatives in re-engaging inactive customers. Beyond the judgments underlying managements’ calculation of Net Dollar Retention Rate set forth above, there are no additional assumptions or estimates made in connection with Net Dollar Retention Rate including winbacks. Net Dollar Retention Rate including winbacks remained flat at 105% for both the nine months ended October 31, 2024 and 2023. This was primarily due to expansion with a large international contract, offset by delay in renewal of a certain government contract.
36

EoP Customer Count
As of October 31,
20242023
EoP Customer Count1,015976
We define EoP Customer Count as the total count of all existing customers at the end of the period excluding customers that are exclusively Sentinel Hub self-service paying users. For EoP Customer Count, we define existing customers as customers with an active contract with us at the end of the reported period. For the purpose of this metric, we define a customer as a distinct entity that uses our data or services. We sell directly to customers, as well as indirectly through our partner network. If a partner does not provide the end customer’s name, then the partner is reported as the customer. Each customer, regardless of the number of active opportunities with us, is counted only once. For example, if a customer utilizes multiple products of Planet, we only count that customer once for purposes of EoP Customer Count. A customer with multiple divisions, segments, or subsidiaries are also counted as a single unique customer based on the parent organization or parent account. For EoP Customer Count, we do not include users that only utilize our self-service Sentinel Hub web based ordering system, which we acquired in August 2023, and which offers standard starter packages on a monthly or annual basis. We believe excluding these users from EoP Customer Count creates a more useful metric, as we view the Sentinel Hub starter packages as entry points for smaller accounts, leading to broader awareness of our solutions throughout their networks and organizations. We believe EoP Customer Count is a useful metric for investors and management to track as it is an important indicator of the broader adoption of our platform and is a measure of our success in growing our market presence and penetration. Management applies judgment as to which customers are deemed to have an active contract in a period, as well as whether a customer is a distinct entity that uses our data or services. The EoP Customer Count increased to 1,015 as of October 31, 2024, as compared to 976 as of October 31, 2023. The increase was primarily attributable to the increased demand for our data.
Percent of Recurring ACV
As of October 31,
20242023
Percent of Recurring ACV97 %94 %
Percent of Recurring ACV is the portion of the total EoP ACV Book of Business that is recurring in nature. We define EoP ACV Book of Business as the sum of the ACV of all contracts that are active on the last day of the period pursuant to the effective dates and end dates of such contracts, excluding customers that are exclusively Sentinel Hub self-service paying users. We define Percent of Recurring ACV as the dollar value of all data subscription contracts and the committed portion of usage-based contracts (excluding customers that are exclusively Sentinel Hub self-service paying users) divided by the total dollar value of all contracts in our EoP ACV Book of Business. We believe Percent of Recurring ACV is useful to investors to better understand how much of our revenue is from customers that have the potential to renew their contracts over multiple years rather than being one-time in nature. We track Percent of Recurring ACV to inform estimates for the future revenue growth potential of our business and improve the predictability of our financial results. There are no significant estimates underlying management’s calculation of Percent of Recurring ACV, but management applies judgment as to which customers have an active contract at a period end for the purpose of determining EoP ACV Book of Business, which is used as part of the calculation of Percent of Recurring ACV. Percent of Recurring ACV increased to 97% for the six months ended October 31, 2024, as compared to 94% for the six months ended October 31, 2023. The increase was primarily attributable to expansions on existing contracts in the Government and Commercial Verticals.
Capital Expenditures as a Percentage of Revenue
Three Months Ended October 31,Nine Months Ended October 31,
2024202320242023
Capital Expenditures as Percentage of Revenue14 %16 %20 %20 %
We define capital expenditures as purchases of property and equipment plus capitalized internally developed software development costs, which are included in our statements of cash flows from investing activities. We define Capital Expenditures as a Percentage of Revenue as the total amount of capital expenditures divided by total revenue in the reported period. Capital Expenditures as a Percentage of Revenue is a performance measure that we use to evaluate the appropriate level of capital expenditures needed to support demand for our data services and related revenue, and to provide a comparable view of our performance relative to other earth observation companies, which may invest significantly greater amounts in their satellites to deliver their data to customers. We use an agile space systems strategy, which means we invest in a larger number of significantly lower cost satellites and software
37

infrastructure to automate the management of the satellites and to deliver our data to clients. As a result of our strategy and our business model, our capital expenditures may be more similar to software companies with large data center infrastructure costs. Therefore, we believe it is important to look at our level of capital expenditure investments relative to revenue when evaluating our performance relative to other earth observation companies or to other software and data companies with significant data center infrastructure investment requirements. We believe Capital Expenditures as a Percentage of Revenue is a useful metric for investors because it provides visibility to the level of capital expenditures required to operate our business and our relative capital efficiency. Capital Expenditures as a Percentage of Revenue decreased to 14% for the three months ended October 31, 2024, as compared to 16% for the three months ended October 31, 2023. The decrease was primarily attributable to an increase in revenue primarily driven by growth in the Civil Government and Defense and Intelligence Verticals. Capital Expenditures as a Percentage of Revenue remained flat at 20% for both the nine months ended October 31, 2024 and 2023.
Components of Results of Operations
Revenue
We derive revenue principally from licensing rights to use our imagery that is delivered digitally through our online platform in addition to providing related services. Imagery licensing agreements vary by contract, but generally have annual or multi-year contractual terms. The data licenses are generally purchased via a fixed price contract on a subscription or usage basis, whereby a customer pays for access to our imagery or derived imagery data, delivered by Planet or through partners, which may be downloaded over a specific period of time, or, less frequently, on a transactional basis, whereby the customer pays for individual content licenses.
We also provide a small amount of other services to customers, including professional services such as training, analytical services, and other value-added activities related to our imagery, data and technology. These revenues are recognized as the services are rendered, on a proportional performance basis for fixed price contracts or ratably over the contract term for subscription professional services and analytics contracts. Training revenues are recognized as the services are performed.
Cost of Revenue
Cost of revenue consists of employee-related costs of performing account and data provisioning, customer support, satellite and engineering operations, as well as the costs of operating and retrieving information from the satellites, processing and storing the data retrieved, third party imagery expenses, depreciation of satellites and ground stations, amortization of acquired intangibles and amortization of capitalized internal-use software related to creating imagery provided to customers. Employee-related costs include salaries, benefits, bonuses and stock-based compensation. To a lesser extent, cost of revenue includes costs from professional services, including costs paid to subcontractors, solution partners and certain third-party fees.
We expect cost of revenue to continue to increase as we invest in our delivery organization, incorporate third-party products into our solutions and introduce future product sets that may require higher compute capacity. As we continue to grow our subscription revenue contracts and increase the revenue associated with our analytic capabilities, we anticipate further economies of scale on our satellites and other infrastructure costs as we incur lower marginal cost with each new customer we add to our platform.
Research and Development
Research and development expenses primarily include personnel related expenses for employees and consultants, hardware costs, supplies costs, contractor fees and administrative expenses. Employee-related costs include salaries, benefits, bonuses and stock-based compensation. Expenses classified as research and development are expensed as incurred and attributable to advancing technology research, platform and infrastructure development and the research and development of new product iterations. Funding for our performance of research and development services under certain arrangements are recognized as a reduction of research and development expenses based on a cost incurred method.
We continue to iterate on the design of our satellites and the capabilities of our automated operations to optimize for efficiency and technical capability of each satellite. Costs associated with satellite and other space related research and development activities are expensed as incurred.
We intend to continue to invest in our software platform development, machine learning and analytic tools and applications and new satellite technologies for both the satellite fleet operations and data collection capabilities to drive incremental value to our existing customers and to enable us to expand our traction in emerging markets and with new customers. As a result of the foregoing, research and development expenditures may increase in future periods.
38

Sales and Marketing
Sales and marketing expenses primarily include costs incurred to market and distribute our products. Such costs include expenses related to advertising and conferences, sales commissions, salaries, benefits and stock-based compensation for our sales and marketing personnel and sales office expenses. Sales and marketing expenses also include fees for professional and consulting services principally consisting of public relations and independent contractor expenses. Sales and marketing costs are expensed as incurred.
We intend to continue to invest in our selling and marketing capabilities in the future and may increase this expense in future periods as we look to upsell new product features and expand into new market verticals. Selling and marketing expenses as a percentage of total revenue may fluctuate from period to period based on total revenue and the timing of our investments.
General and Administrative
General and administrative expenses include personnel-related expenses and facilities-related costs primarily for our executive, finance, accounting, legal and human resources functions. General and administrative expenses also include fees for professional services principally consisting of legal, audit, tax, and insurance, as well as executive management expenses. General and administrative costs are expensed as incurred.
We expect to incur additional general and administrative expenses as a result of operating as a public company, including expenses related to compliance and reporting obligations of public companies, and increased costs for insurance, investor relations, and professional services. As the company grows, our general and administrative expenses may increase in future periods and vary from period to period as a percentage of revenue, but we expect to realize operating scale with respect to these expenses over time as we grow our revenue.
Interest Income
Interest income primarily consists of interest earned on our cash, cash equivalents and short-term investments. Our cash equivalent and short-term investment portfolio is invested with a goal of preserving our access to capital, and generally consists of money market funds, commercial paper, corporate debt securities and U.S. government and U.S. government agency debt securities.
Change in Fair Value of Warrant Liabilities
The change in fair value of warrant liabilities consists of the change in fair value of the public and private placement warrant liabilities. We expect to incur other incremental income or expense for fair value adjustments resulting from warrant liabilities that remain outstanding.
Other Income, net
Other income, net, primarily consists of net gains or losses on foreign currency.
Provision for Income Taxes
Our income tax provision consists of an estimate for U.S. federal and state income taxes, as well as those foreign jurisdictions where we have business operations, based on enacted tax rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in the tax law. We believe that it is more likely than not that the majority of the U.S. and foreign deferred tax assets will not be realized. Accordingly, we recorded a valuation allowance against our deferred tax assets in these jurisdictions.

39

Results of Operations
Three months ended October 31, 2024 compared to three months ended October 31, 2023
The following table sets forth a summary of our consolidated results of operations for the interim periods indicated and the changes between such periods.

  Three Months Ended October 31, 
$
 
%
(in thousands, except percentages) 20242023 
Change
 
Change
Revenue$61,266  $55,380 $5,886 11 %
Cost of revenue23,749  29,350 (5,601)(19)%
Gross profit37,517 26,030 11,487 44 %
Operating expenses
Research and development25,21633,002 (7,786)(24)%
Sales and marketing 16,79520,774  (3,979)(19)%
General and administrative 18,11420,112  (1,998)(10)%
Total operating expenses 60,125 73,888  (13,763)(19)%
Loss from operations (22,608)(47,858) 25,250 (53)%
Interest income 2,4143,445  (1,031)(30)%
Change in fair value of warrant liabilities 1986,833  (6,635)(97)%
Other income (expense), net (60)(69) (13)%
Total other income, net 2,552 10,209  (7,657)(75)%
Loss before provision for income taxes (20,056) (37,649) 17,593 (47)%
Provision for income taxes 25355  (330)(93)%
Net loss $(20,081) $(38,004) $17,923 (47)%
Revenue
Revenue increased $5.9 million, or 11%, to $61.3 million for the three months ended October 31, 2024 from $55.4 million for the three months ended October 31, 2023. The increase was primarily due to a $6.2 million increase from total customer growth worldwide, which was partially offset by a $0.3 million reduction of existing customer contracts primarily in the Commercial Vertical. EoP Customer Count increased approximately 4% to 1,015 as of October 31, 2024 from 976 as of October 31, 2023. The increase in revenue from new customers was primarily driven by growth in the Civil Government and Defense and Intelligence Verticals.
Cost of Revenue
Cost of revenue decreased $5.6 million, or 19%, to $23.7 million for the three months ended October 31, 2024, from $29.4 million for the three months ended October 31, 2023. The decrease was primarily due to a $4.7 million decrease in depreciation expense, which was primarily due to certain high resolution satellites that have fully depreciated. The decrease was also partially due to a $1.1 million decrease in employee-related costs due to reduced headcount and a $1.0 million decrease in hosting costs. These decreases were partially offset by a $1.2 million increase in costs paid to solution partners and subcontractors.
Research and Development
Research and development expenses decreased $7.8 million, or 24%, to $25.2 million for the three months ended October 31, 2024, from $33.0 million for the three months ended October 31, 2023. The decrease was primarily due to a $3.7 million decrease in purchases of material utilized for research and development activities and a $3.3 million decrease in severance and termination benefits charges associated with the 2023 headcount reduction. The decrease was also partially due to a $2.6 million decrease in employee-related costs due to reduced headcount and a $1.9 million decrease in non-recurring expenses related to transaction bonuses paid to Sinergise employees, which was allocated from the purchase consideration we paid in connection with the Sinergise acquisition in August 2023. These decreases were partially offset by a $2.3 million decrease in funding recognized for our research and development arrangements, and a $1.7 million increase in launch provider costs associated with the launch of a satellite classified as experimental.
40

Sales and Marketing
Sales and marketing expenses decreased $4.0 million, or 19%, to $16.8 million, for the three months ended October 31, 2024, from $20.8 million for the three months ended October 31, 2023. The decrease was primarily due to a $2.0 million decrease in employee-related costs due to reduced headcount and a $1.9 million decrease in severance and termination benefits charges associated with the 2023 headcount reduction.
General and Administrative
General and administrative expenses decreased $2.0 million, or 10%, to $18.1 million for the three months ended October 31, 2024, from $20.1 million for the three months ended October 31, 2023. The decrease was primarily due to a $1.6 million decrease in severance and termination benefits charges associated with the 2023 headcount reduction. The decrease was also partially due to a $0.9 million decrease in employee-related costs due to reduced headcount, a $0.6 million decrease in our allowance for expected credit losses for accounts receivable, and a $0.5 million decrease related to recovery of previously written-off accounts receivable. These decreases were partially offset by a $1.1 million increase in legal costs and a $0.7 million increase in stock-based compensation.
Interest Income
Interest income decreased $1.0 million to $2.4 million for the three months ended October 31, 2024, from $3.4 million for the three months ended October 31, 2023. The decrease was primarily due to a decrease in our short-term investment balances.
Change in Fair Value of Warrant Liabilities
The change in fair value of warrant liabilities for both the three months ended October 31, 2024 and 2023 represents the change in fair value of the public and private placement warrants, which primarily fluctuates based on the change in trading price of our Class A common stock.
Other Income (Expense), net
Other income (expense), net for the three months ended October 31, 2024 and October 31, 2023, primarily reflects realized and unrealized foreign currency exchange gains and losses.
Provision for Income Taxes
Provision for income taxes was immaterial for the three months ended October 31, 2024 and $0.4 million for the three months ended October 31, 2023, respectively. For the three months ended October 31, 2024 and 2023, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rate for the three months ended October 31, 2024 and 2023 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of our U.S. and foreign deferred tax assets and foreign rate differences.

41

Nine months ended October 31, 2024 compared to nine months ended October 31, 2023
The following table sets forth a summary of our consolidated results of operations for the interim periods indicated and the changes between such periods.

  Nine Months Ended October 31, 
$
 
%
(in thousands, except percentages) 20242023 
Change
 
Change
Revenue$182,798 $161,844 $20,954 13 %
Cost of revenue81,288 81,375 (87)— %
Gross profit101,51080,469 21,041 26 %
Operating expenses
Research and development78,05587,929 (9,874)(11)%
Sales and marketing 62,01366,209  (4,196)(6)%
General and administrative 58,19862,161  (3,963)(6)%
Total operating expenses 198,266216,299  (18,033)(8)%
Loss from operations (96,756)(135,830) 39,074 (29)%
Interest income 8,29211,753  (3,461)(29)%
Change in fair value of warrant liabilities 1,12614,004  (12,878)(92)%
Other income (expense), net 660894  (234)(26)%
Total other income (expense), net 10,07826,651  (16,573)(62)%
Loss before provision for income taxes (86,678)(109,179) 22,501 (21)%
Provision for income taxes 1,3641,244  120 10 %
Net loss $(88,042)$(110,423) $22,381 (20)%
Revenue
Revenue increased $21.0 million, or 13%, to $182.8 million for the nine months ended October 31, 2024 from $161.8 million for the nine months ended October 31, 2023. The increase was primarily due to a $12.6 million increase from total customer growth worldwide, including new customers acquired from the Sinergise acquisition and net expansion of existing customer contracts of $8.4 million. EoP Customer Count increased approximately 4% to 1,015 as of October 31, 2024 from 976 as of October 31, 2023. The increase in revenue was primarily driven by growth in the Civil Government and Defense and Intelligence Verticals.
Cost of Revenue
Cost of revenue remained relatively flat, decreasing $0.1 million to $81.3 million, for the nine months ended October 31, 2024, from $81.4 million for the nine months ended October 31, 2023. The decrease was primarily due to a $4.0 million decrease in depreciation expense, which was primarily due to certain high resolution satellites that have fully depreciated. This decrease was partially offset by a $4.0 million increase in costs paid to solution partners and subcontractors.
Research and Development
Research and development expenses decreased $9.9 million, or 11%, to $78.1 million for the nine months ended October 31, 2024, from $87.9 million for the nine months ended October 31, 2023. The decrease was primarily due to a $8.7 million decrease in purchases of material utilized for research and development activities, a $6.4 million decrease in stock-based compensation expense, a $4.5 million decrease in employee-related costs due to reduced headcount, a $1.9 million decrease in non-recurring expenses related to transaction bonuses paid to Sinergise employees, which was allocated from the purchase consideration we paid in connection with the Sinergise acquisition in August 2023, and a $1.1 million decrease in consulting costs. These decreases were partially offset by a $7.5 million decrease in funding recognized for our research and development arrangements, a $2.8 million increase in depreciation expense associated with satellites classified as experimental, and a $1.7 million increase in launch provider costs associated with the launch of a satellite classified as experimental.
42

Sales and Marketing
Sales and marketing expenses decreased $4.2 million, or 6%, to $62.0 million, for the nine months ended October 31, 2024, from $66.2 million for the nine months ended October 31, 2023. The decrease was primarily due to a $3.8 million decrease in employee-related costs due to reduced headcount. The decrease was also partially due to a $1.0 million decrease in stock-based compensation expense, a $0.8 million decrease in marketing expense, and a $0.8 million decrease in employee travel and entertainment costs. These decreases were partially offset by a $2.5 million increase in severance and termination benefits charges associated with our headcount reductions.
General and Administrative
General and administrative expenses decreased $4.0 million, or 6%, to $58.2 million for the nine months ended October 31, 2024, from $62.2 million for the nine months ended October 31, 2023. The decrease was primarily due to a $1.7 million decrease in employee-related costs due to reduced headcount, a $1.1 million decrease in our allowance for expected credit losses for accounts receivable, a $0.8 million decrease in insurance costs, a $0.8 million decrease in consulting costs, and a $0.5 million decrease related to recovery of previously-written off accounts receivable. These decreases were partially offset by a $1.6 million of expense associated with the revaluation of the contingent consideration liability for the Sinergise acquisition customer consent escrow.
Interest Income
Interest income decreased $3.5 million, to $8.3 million for the nine months ended October 31, 2024, from $11.8 million for the nine months ended October 31, 2023. The decrease was primarily due to a decrease in our short-term investment balances.
Change in Fair Value of Warrant Liabilities
The change in fair value of warrant liabilities for both the nine months ended October 31, 2024 and 2023 represents the change in fair value of the public and private placement warrants, which primarily fluctuates based on the change in trading price of our Class A common stock.
Other Income (Expense), net
Other income (expense), net of $0.7 million for the nine months ended October 31, 2024 includes the derecognition of a $1.3 million liability for which settlement is not considered probable. Other income (expense), net of $0.9 million for the nine months ended October 31, 2023 includes the recognition of an insurance claim recovery of $0.8 million associated with a high resolution satellite.
Provision for Income Taxes
Provision for income taxes was $1.4 million and $1.2 million for the nine months ended October 31, 2024 and 2023, respectively. For the nine months ended October 31, 2024 and 2023, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rate for the nine months ended October 31, 2024 and 2023 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of our U.S. and foreign deferred tax assets and foreign rate differences.
Non-GAAP Information
This Quarterly Report on Form 10-Q includes Non-GAAP Gross Profit, Non-GAAP Gross Margin, Adjusted EBITDA, and Backlog, which are non-GAAP measures that we use to supplement our results presented in accordance with U.S. GAAP. We include these non-GAAP financial measures because they are used by management to evaluate our core operating performance and trends and to make strategic decisions regarding the allocation of capital and new investments.
We define and calculate Non-GAAP Gross Profit as gross profit adjusted for stock-based compensation, amortization of acquired intangible assets classified as cost of revenue, restructuring costs, and employee transaction bonuses in connection with the Sinergise business combination. We define Non-GAAP Gross Margin as Non-GAAP Gross Profit divided by revenue.
We define and calculate Adjusted EBITDA as net income (loss) before the impact of interest income and expense, income tax expense and depreciation and amortization, and further adjusted for the following items: stock-based compensation, change in fair value of warrant liabilities, non-operating income and expenses such as foreign currency exchange gain or loss, restructuring costs, certain litigation expenses, and employee transaction bonuses in connection with the Sinergise business combination.
We present Non-GAAP Gross Profit, Non-GAAP Gross Margin and Adjusted EBITDA because we believe these measures are frequently used by analysts, investors and other interested parties to evaluate companies in our industry and facilitates comparisons on a consistent basis across reporting periods. Further, we believe these measures are
43

helpful in highlighting trends in our operating results because they exclude items that are not indicative of our core operating performance.
We define and calculate Backlog as remaining performance obligations plus the cancellable portion of the contract value for contracts that provide the customer with a right to terminate for convenience without incurring a substantive termination penalty and written orders where funding has not been appropriated. Backlog does not include unexercised contract options. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. Remaining performance obligations do not include contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty, written orders where funding has not been appropriated and unexercised contract options.
An increasing and meaningful portion of our revenue is generated from contracts with the U.S. government and other government customers. Cancellation provisions, such as termination for convenience clauses, are common in contracts with the U.S. government and certain other government customers. We present Backlog because the portion of our customer contracts with such cancellation provisions represents a meaningful amount of our expected future revenues. Management uses backlog to more effectively forecast our future business and results, which supports decisions around capital allocation. It also helps us identify future growth or operating trends that may not otherwise be apparent. We also believe Backlog is useful for investors in forecasting our future results and understanding the growth of our business. Customer cancellation provisions relating to termination for convenience clauses and funding appropriation requirements are outside of our control, and as a result, we may fail to realize the full value of such contracts.
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, as a substitute for, or superior to, measures of financial performance prepared in accordance with U.S. GAAP. The non-GAAP financial measures presented are not based on any standardized methodology prescribed by U.S. GAAP and are not necessarily comparable to similarly-titled measures presented by other companies, which may have different definitions from ours. Further, certain of the non-GAAP financial measures presented exclude stock-based compensation expenses, which has recently been, and will continue to be for the foreseeable future, a significant recurring expense for our business and an important part of our compensation strategy.
Non-GAAP Gross Profit and Non-GAAP Gross Margin
The table below reconciles Non-GAAP Gross Profit and Non-GAAP Gross Margin to Gross Profit and Gross Margin (the most directly comparable U.S. GAAP measure), for the periods indicated:

  Three Months Ended October 31,Nine Months Ended October 31,
(in thousands, except percentages) 2024202320242023
Gross Profit $37,517 $26,030 $101,510 $80,469 
Cost of revenue—Stock-based compensation 745 888 2,563 2,855 
Amortization of acquired intangible assets759 796 2,298 1,674 
Restructuring costs(1)
128 563 1,312 563 
Employee transaction bonuses in connection with the Sinergise business combination(2)
— 267 — 267 
Non-GAAP Gross Profit $39,149  $28,544  $107,683 $85,828 
Gross Margin
 61 % 47 % 56 %50 %
Non-GAAP Gross Margin
 64 % 52 % 59 %53 %
(1) As part of the 2024 headcount reduction, we recognized $0.1 million and $1.3 million of severance and other employee costs within cost of revenue for the three and nine months ended October 31, 2024, respectively. For the three and nine months ended October 31, 2024, the restructuring related stock-based compensation benefit recognized within cost of revenue of $0.2 million is included on its respective line item. As part of the 2023 headcount reduction, we recognized $0.6 million of severance and other employee costs within cost of revenue for the three and nine months ended October 31, 2023. For the three and nine months ended October 31, 2023, the restructuring related stock-based compensation benefit recognized within cost of revenue of $0.1 million is included on its respective line item. Refer to Note 7 “Restructuring” to the condensed consolidated financial statements for further information.
(2) Certain employees of Sinergise, which became employees of Planet, were paid cash transaction bonuses in connection with the closing of the Sinergise acquisition. The cost of the transaction bonuses was allocated from the purchase consideration we paid for the acquisition. Refer to Note 5 “Acquisition” to the condensed consolidated financial statements for further information.
44

Adjusted EBITDA
The table below reconciles Adjusted EBITDA to net loss (the most directly comparable U.S. GAAP measure), for the periods indicated:
  Three Months Ended October 31,Nine Months Ended October 31,
(in thousands) 2024202320242023
Net loss $(20,081)$(38,004)$(88,042)$(110,423)
Interest income (2,414)(3,445)(8,292)(11,753)
Income tax provision 253551,3641,244
Depreciation and amortization 10,11713,62536,36536,033
Change in fair value of warrant liabilities (198)(6,833)(1,126)(14,004)
Stock-based compensation 11,82912,59836,46744,611
Restructuring costs(1)
257,34110,5247,341
Employee transaction bonuses in connection with the Sinergise business combination(2)
2,3172,317
Certain litigation expenses(3)
395395
Other (income) expense, net 6069(660)(894)
Adjusted EBITDA $(242) $(11,977)$(13,005)$(45,528)
(1) As part of the 2024 headcount reduction, we recognized immaterial severance and other employee costs for the three months ended October 31, 2024 and $10.5 million of severance and other employee costs for the nine months ended October 31, 2024. For the three and nine months ended October 31, 2024, the restructuring related stock-based compensation benefit of $1.4 million is included on its respective line item. As part of the 2023 headcount reduction, we recognized $7.3 million of severance and other employee costs for the three and nine months ended October 31, 2023. For the three and nine months ended October 31, 2023, the restructuring related stock-based compensation benefit of $1.5 million is included on its respective line item. Refer to Note 7 “Restructuring” to the condensed consolidated financial statements for further information.
(2) Certain employees of Sinergise, which became employees of Planet, were paid cash transaction bonuses in connection with the closing of the Sinergise acquisition. The cost of the transaction bonuses was allocated from the purchase consideration we paid for the acquisition. Refer to Note 5 “Acquisition” to the condensed consolidated financial statements for further information.
(3) Expenses relating to the Delaware class action lawsuit. Refer to Note 10 “Commitments and Contingencies” to the condensed consolidated financial statements for further information.
There are a number of limitations related to the use of Adjusted EBITDA, including:
Adjusted EBITDA excludes stock-based compensation, which has recently been, and will continue to be for the foreseeable future, a significant recurring expense for our business and an important part of our compensation strategy;
Adjusted EBITDA excludes depreciation and amortization expense and, although these are non-cash expenses, the assets being depreciated and amortized will have to be replaced in the future;
Adjusted EBITDA does not reflect interest expense, or the cash requirements necessary to service interest or principal payments on debt, which reduces cash available to us;
Adjusted EBITDA does not include severance expense in conjunction with a reduction in headcount, which reduces cash available to us;
Adjusted EBITDA does not reflect income tax expense that reduces cash available to us; and
the expenses and other items that we exclude in our calculation of Adjusted EBITDA may differ from the expenses and other items, if any, that other companies may exclude from similar measures when they report their operating results.
45

Backlog
The table below reconciles Backlog to remaining performance obligations for the periods indicated:
 (in thousands)
October 31, 2024January 31, 2024
Remaining performance obligations$145,890 $132,571 
Cancellable amount of contract value86,250 109,821 
Backlog$232,140 $242,392 
For remaining performance obligations as of October 31, 2024, the Company expects to recognize approximately 82% over the next 12 months, approximately 98% over the next 24 months, and the remainder thereafter. For Backlog as of October 31, 2024, the Company expects to recognize approximately 70% over the next 12 months, approximately 91% over the next 24 months, and the remainder thereafter.
Liquidity and Capital Resources
Since inception, we have incurred net losses and negative cash flows from operations. Our operations have historically been primarily funded by the net proceeds from the sale of our equity securities and borrowings under credit facilities, as well as cash received from our customers. We currently have no debt outstanding.
We measure liquidity in terms of our ability to fund the cash requirements of our business operations, including working capital and capital expenditure needs, contractual obligations, including debt obligations, and other commitments, with cash flows from operations and other sources of funding. Our current working capital needs relate mainly to our continued development of our platform and product offerings in new markets, as well as compensation and benefits of our employees. Our ability to expand and grow our business will depend on many factors, including our working capital needs and the evolution of our operating cash flows.
As of October 31, 2024 and January 31, 2024, we had $139.0 million and $83.9 million, respectively, in cash and cash equivalents. Additionally, as of October 31, 2024 and January 31, 2024, we had short-term investments of $103.3 million and $215.0 million, respectively, which are highly liquid in nature and available for current operations. We believe our anticipated operating cash flows together with our cash on hand provide us with the ability to meet our obligations as they become due during the next 12 months.
We expect our capital expenditures and working capital requirements to continue to increase in the foreseeable future as we seek to grow our business. We could also need additional cash resources due to significant acquisitions, an accelerated manufacturing timeline for new satellites, competitive pressures or regulatory requirements. We may need to seek additional equity, equity-linked or debt financing. The issuance of additional shares may create additional dilution to our stockholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating or financial covenants that would restrict our operations. We cannot assure you that any such financing will be available on favorable terms, or at all. If needed financing is not available, or if the terms of financing are less desirable than we expect, we may be forced to decrease our level of investment in software and market expansion efforts or to scale back our existing operations, which could have an adverse impact on our business and financial prospects.
As of October 31, 2024, our principal contractual obligations and commitments include lease obligations for real estate and ground stations and minimum purchase commitments for hosting services from Google, LLC. Refer to Notes 8, 10, and 12 to our unaudited condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information regarding these cash requirements.
We do not engage in any off-balance sheet activities or have any arrangements or relationships with unconsolidated entities, such as variable interest, special purpose, and structured finance entities.
Statement of Cash Flows
The following tables present a summary of cash flows from operating, investing and financing activities for the following comparative periods. For additional detail, refer to the unaudited condensed consolidated statements of cash flows as presented within the unaudited condensed consolidated financial statements.
  Nine Months Ended October 31,
(in thousands) 20242023
Net cash provided by (used in)  
Operating activities $(8,079)$(43,874)
Investing activities $71,040 $(24,032)
Financing activities $(15,302)$(357)
46

Net cash used in operating activities
Net cash used in operating activities for the nine months ended October 31, 2024, primarily consisted of the net loss of $88.0 million, adjusted for non-cash items and changes in operating assets and liabilities. Non-cash items primarily included stock-based compensation expense of $36.5 million and depreciation and amortization expense of $36.4 million. The net change in operating assets and liabilities primarily consisted of a $8.5 million decrease in prepaid expenses and other assets and a $5.5 million decrease in accounts receivable, which were partially offset by a $7.7 million decrease in accounts payable, accrued and other liabilities.
Net cash used in operating activities for the nine months ended October 31, 2023, primarily consisted of the net loss of $110.4 million, adjusted for non-cash items and changes in operating assets and liabilities. Non-cash items primarily included stock-based compensation expense of $44.6 million and depreciation and amortization expense of $36.0 million, which were partially offset by a change in fair value of warrant liabilities of $14.0 million. The net change in operating assets and liabilities primarily consisted of a $19.6 million increase in deferred revenue and a $9.5 million decrease in prepaid expenses and other assets, which were partially offset by a $20.7 million decrease in accounts payable, accrued and other liabilities, and a $3.9 million increase in accounts receivable.
Net cash provided by (used in) investing activities
Net cash provided by investing activities for the nine months ended October 31, 2024, primarily consisted of sales of available-for-sale securities of $162.3 million and maturities of available-for-sale securities of $57.0 million, which were partially offset by purchases of available-for-sale securities of $105.6 million, purchases of property and equipment of $32.7 million, and purchases of licensed imagery of $4.6 million.
Net cash used in investing activities for the nine months ended October 31, 2023, primarily consisted of purchases of available-for-sale securities of $166.2 million, purchases of property and equipment of $29.1 million, and $7.5 million of consideration paid related to the acquisition of Sinergise, which were partially offset by maturities of available-for-sale securities of $142.9 million and sales of available-for-sale securities of $40.1 million.
Net cash used in financing activities
Net cash used in financing activities for the nine months ended October 31, 2024 included $8.8 million of contingent consideration payments for business acquisitions, of which $7.5 million relates to the settlement of the customer consent contingent consideration liability for the Sinergise acquisition. Net cash used in financing activities for the nine months ended October 31, 2024 also included payments for withholding taxes related to the net share settlement of equity awards of $7.3 million, which was partially offset by proceeds from our employee stock purchase program of $1.1 million.
Net cash used in financing activities for the nine months ended October 31, 2023, consisted of payments for withholding taxes related to the net share settlement of equity awards of $7.1 million, which was partially offset by proceeds from the exercise of common stock options of $6.8 million.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of our unaudited condensed consolidated financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures. The accounting policies that have been identified as critical to our business operations and to understanding the results of our operations pertain to revenue recognition, stock-based compensation, public and private placement warrant liabilities, property and equipment and long-lived assets, business combinations, and goodwill. The application of each of these critical accounting policies and estimates is discussed in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2024 Form 10-K.
Recent Accounting Pronouncements
Refer to Note 2 to our unaudited condensed consolidated financial statements included elsewhere in Part I, Item 1 of this Form 10-Q for information regarding recently issued accounting pronouncements.

47

Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We have in the past and may in the future be exposed to certain market risks, including foreign currency exchange risk, interest rate risk and inflation risk, in the ordinary course of our business. For information relating to quantitative and qualitative disclosures about these market risks, refer to Item 7A “Quantitative and Qualitative Disclosures About Market Risk” contained in Part II of our 2024 Form 10-K. Our exposure to market risk has not changed materially since January 31, 2024.

Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective as of October 31, 2024 at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the three months ended October 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on the Effectiveness of Disclosure Controls and Procedures
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and implemented, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues within a company are detected. The inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

Part II - Other Information

Item 1. Legal Proceedings.
See discussion of Legal Proceedings in Note 10 to the condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q

Item 1A. Risk Factors.
In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A, "Risk Factors" in our Annual Report on Form 10-K, for the fiscal year ended January 31, 2024. Other than the risk factor set forth below, there have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K.
Risks Related to Ownership of Our Securities and Operating as a Public Company
Any outstanding or potential stockholder litigation may result in substantial costs and diversion of our management’s attention and resources.
The market price of our Class A common stock may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We are and may continue to be subject to stockholder litigation against us and we may be the target of this type of litigation in the future. Any such litigation against us could result in substantial costs and divert management’s attention from other business concerns, which could seriously harm our business or reputation.

48

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None, other than the shares repurchased pursuant to net settlement by employees in satisfaction of income tax withholding obligations incurred through the vesting of restricted stock units.

Item 3. Defaults Upon Senior Securities.
Not applicable.

Item 4. Mine Safety Disclosures.
Not applicable.

Item 5. Other Information.
Securities Trading Plans of Directors and Executive Officers
During our last fiscal quarter, no director or officer, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Regulation S-K Item 408.

49

Item 6. Exhibits.

Exhibit    Description
10.1^
31.1
31.2
32.1*
32.2*
101.INSInline XBRL Instance Document (the instance document does not appear in the Interactive Data File because iXBRL tags are embedded within the Inline XBRL document).
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL)
^     Portions of this exhibit (indicated by asterisks) have been omitted under rules of the SEC permitting the confidential treatment of select information.
*    Furnished herewith.

50

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: December 9, 2024
PLANET LABS PBC
By:/s/ Ashley Johnson
Ashley Johnson
President and Chief Financial Officer
(Duly Authorized Officer, Principal Financial Officer and Principal Accounting Officer)



51
Certain confidential information contained in this document, marked by brackets and asterisks, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because the Company customarily and actually treats such information as private or confidential and the omitted information is not material.

Exhibit 10.1
Planet Labs PBC - Pricing Reference ID: 1711050921336
CONFIDENTIAL ~ DMS Template ID: 4759304 (v3.4)

Amendment 4 to Google Cloud Platform Addendum

This Amendment (“Amendment”) is between Google LLC (“Google”) and the Customer in the signature block below (“Customer”) and amends the Google Cloud Platform License Agreement previously entered into by the parties with an effective date on December 15, 2016 (as amended, the “Agreement”). Such Agreement includes the Google Cloud Platform Addendum entered into by the parties with an effective date on February 13, 2020 (as amended, the “Addendum”). Capitalized terms used but not defined in this Amendment have the meaning given to them in the Agreement. This Amendment will be effective from the date countersigned by the last party (“Amendment 4 Effective Date”).

The parties agree as follows:

1.    Amendments. From the Amendment 4 Effective Date, the Addendum is amended as follows:

1.1    Additional Definitions. The following new subsection P is added to Addendum Section 1 (Definitions):

P. “Amendment 4 Implementation Date” means a Google-selected date that is no later than 5 business days after the Amendment 4 Effective Date.

1.2     Additional Discount. From the Amendment 4 Implementation Date until the end of the Discount Period, Customer will receive a discount off the list price as of the Amendment 4 Implementation Date for the following SKU(s):

[*****]

2.     Miscellaneous. All other terms and conditions of the Agreement (including the Addendum) remain unchanged and in full force and effect. This Amendment 4 may be executed in one or more counterparts including facsimile, PDF or other electronic copies, which when taken together upon proper delivery shall constitute a single instrument. In the event of a conflict between the terms and conditions of the Agreement and the terms and conditions of this Amendment 4, the terms and conditions of this Amendment 4 shall govern.

Signed by the parties’ authorized representatives on the dates below.

GOOGLE                              CUSTOMER: Planet Labs PBC

By:    /s/ Philipp Schindler     2024.04.24        By:    /s/ Ashley Johnson
Name:    Philipp Schindler            10:18:21 -07’00’        Name:    Ashley Johnson
Title:    Authorized Signatory                      Title:    CFO/COO
Date:                                  Date:    23 April 2024
imagea.jpg

Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a) AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, William Marshall, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Planet Labs PBC;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: December 9, 2024    
            



By: /s/William Marshall             
William Marshall
Chief Executive Officer
(Principal Executive Officer)



Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a) AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Ashley Johnson, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Planet Labs PBC;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: December 9, 2024    
                



By: /s/Ashley Johnson                
Ashley Johnson
President and Chief Financial Officer
(Principal Financial Officer)



Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q (the “Form 10-Q”) of Planet Labs PBC (the “Company”) for the period ended October 31, 2024, William Marshall, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

1.the Company’s Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: December 9, 2024    
            
By: /s/William Marshall             
William Marshall
Chief Executive Officer
(Principal Executive Officer)


Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q (the “Form 10-Q”) of Planet Labs PBC (the “Company”) for the period ended October 31, 2024, Ashley Johnson, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of her knowledge:

1.the Company’s Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: December 9, 2024    
                
By: /s/ Ashley Johnson                
Ashley Johnson
President and Chief Financial Officer
(Principal Financial Officer)




v3.24.3
Cover - shares
9 Months Ended
Oct. 31, 2024
Dec. 03, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Oct. 31, 2024  
Document Transition Report false  
Entity File Number 001-40166  
Entity Registrant Name Planet Labs PBC  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 85-4299396  
Entity Address, Address Line One 645 Harrison Street  
Entity Address, Address Line Two Floor 4  
Entity Address, City or Town San Francisco  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94107  
City Area Code 415  
Local Phone Number 829-3313  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001836833  
Amendment Flag false  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --01-31  
Common Class A    
Document Information [Line Items]    
Title of 12(b) Security Class A common stock, par value $0.0001 per share  
Trading Symbol PL  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   275,551,243
Warrant    
Document Information [Line Items]    
Title of 12(b) Security Warrants to purchase Class A common stock, at an exercise price of $11.50 per share  
Trading Symbol PL WS  
Security Exchange Name NYSE  
Common Class B    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   21,157,586
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Current assets    
Cash and cash equivalents $ 138,969 $ 83,866
Restricted cash and cash equivalents, current 6,525 8,360
Short-term investments 103,255 215,041
Accounts receivable, net of allowance of $446 and $1,539, respectively 38,853 43,320
Prepaid expenses and other current assets 13,992 19,564
Total current assets 301,594 370,151
Property and equipment, net 116,920 113,429
Capitalized internal-use software, net 18,259 14,973
Goodwill 137,411 136,256
Intangible assets, net 29,231 32,448
Restricted cash and cash equivalents, non-current 4,437 9,972
Operating lease right-of-use assets 20,829 22,339
Other non-current assets 2,083 2,429
Total assets 630,764 701,997
Current liabilities    
Accounts payable 3,572 2,601
Accrued and other current liabilities 43,670 44,779
Deferred revenue 66,462 72,327
Liability from early exercise of stock options 6,275 8,964
Operating lease liabilities, current 9,105 7,978
Total current liabilities 129,084 136,649
Deferred revenue 11,230 5,293
Deferred hosting costs 6,665 7,101
Public and private placement warrant liabilities 1,835 2,961
Operating lease liabilities, non-current 13,819 16,952
Contingent consideration 2,871 5,885
Other non-current liabilities 655 9,138
Total liabilities 166,159 183,979
Commitments and contingencies (Note 10)
Stockholders’ equity    
Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at October 31, 2024 and January 31, 2024, 275,274,858 and 268,117,905 Class A shares issued and outstanding at October 31, 2024 and January 31, 2024, respectively, 21,157,586 Class B shares issued and outstanding at October 31, 2024 and January 31, 2024, 0 Class C shares issued and outstanding at October 31, 2024 and January 31, 2024 28 28
Additional paid-in capital 1,631,077 1,596,201
Accumulated other comprehensive income 1,347 1,594
Accumulated deficit (1,167,847) (1,079,805)
Total stockholders’ equity 464,605 518,018
Total liabilities and stockholders’ equity $ 630,764 $ 701,997
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Accounts receivable, allowance $ 446 $ 1,539
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common Class A    
Common stock, shares authorized (in shares) 570,000,000 570,000,000
Common stock, shares issued (in shares) 275,274,858 268,117,905
Common stock, shares outstanding (in shares) 275,274,858 268,117,905
Common Class B    
Common stock, shares authorized (in shares) 30,000,000 30,000,000
Common stock, shares issued (in shares) 21,157,586 21,157,586
Common stock, shares outstanding (in shares) 21,157,586 21,157,586
Common Class C    
Common stock, shares authorized (in shares) 30,000,000 30,000,000
Common stock, shares issued (in shares) 0 0
Common stock, shares outstanding (in shares) 0 0
v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Income Statement [Abstract]        
Revenue $ 61,266 $ 55,380 $ 182,798 $ 161,844
Cost of revenue 23,749 29,350 81,288 81,375
Gross profit 37,517 26,030 101,510 80,469
Operating expenses        
Research and development 25,216 33,002 78,055 87,929
Sales and marketing 16,795 20,774 62,013 66,209
General and administrative 18,114 20,112 58,198 62,161
Total operating expenses 60,125 73,888 198,266 216,299
Loss from operations (22,608) (47,858) (96,756) (135,830)
Interest income 2,414 3,445 8,292 11,753
Change in fair value of warrant liabilities 198 6,833 1,126 14,004
Other income (expense), net (60) (69) 660 894
Total other income, net 2,552 10,209 10,078 26,651
Loss before provision for income taxes (20,056) (37,649) (86,678) (109,179)
Provision for income taxes 25 355 1,364 1,244
Net loss $ (20,081) $ (38,004) $ (88,042) $ (110,423)
Basic net loss per share attributable to common stockholders (in dollars per share) $ (0.07) $ (0.13) $ (0.30) $ (0.40)
Diluted net loss per share attributable to common stockholders (in dollars per share) $ (0.07) $ (0.13) $ (0.30) $ (0.40)
Basic weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares) 293,338,324 284,197,733 290,674,554 277,252,951
Diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares) 293,338,324 284,197,733 290,674,554 277,252,951
v3.24.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Statement of Comprehensive Income [Abstract]        
Net loss $ (20,081) $ (38,004) $ (88,042) $ (110,423)
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustment 52 (1,667) (159) (1,543)
Change in fair value of available-for-sale securities 48 89 (88) (970)
Other comprehensive income (loss), net of tax 100 (1,578) (247) (2,513)
Comprehensive loss $ (19,981) $ (39,582) $ (88,289) $ (112,936)
v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023   271,783,561      
Beginning balance at Jan. 31, 2023 $ 576,104 $ 27 $ 1,513,102 $ 2,271 $ (939,296)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock from the exercise of common stock options (in shares)   1,018,385      
Issuance of Class A common stock from the exercise of common stock options 3,295   3,295    
Issuance of Class A common stock upon vesting of restricted stock units (in shares)   1,278,161      
Vesting of early exercised stock options (in shares)   91,911      
Vesting of early exercised stock options 896   896    
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)   (472,136)      
Class A common stock withheld to satisfy employee tax withholding obligations (1,896)   (1,896)    
Stock-based compensation 15,983   15,983    
Net unrealized gain (loss) on available-for-sale securities, net of taxes (544)     (544)  
Change in translation (45)     (45)  
Net loss (34,444)       (34,444)
Ending balance (in shares) at Apr. 30, 2023   273,699,882      
Ending balance at Apr. 30, 2023 559,349 $ 27 1,531,380 1,682 (973,740)
Beginning balance (in shares) at Jan. 31, 2023   271,783,561      
Beginning balance at Jan. 31, 2023 576,104 $ 27 1,513,102 2,271 (939,296)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net unrealized gain (loss) on available-for-sale securities, net of taxes (970)        
Change in translation (1,543)        
Net loss (110,423)        
Ending balance (in shares) at Oct. 31, 2023   285,532,707      
Ending balance at Oct. 31, 2023 533,598 $ 28 1,583,531 (242) (1,049,719)
Beginning balance (in shares) at Apr. 30, 2023   273,699,882      
Beginning balance at Apr. 30, 2023 559,349 $ 27 1,531,380 1,682 (973,740)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock from the exercise of common stock options (in shares)   1,383,413      
Issuance of Class A common stock from the exercise of common stock options 3,063   3,063    
Issuance of Class A common stock upon vesting of restricted stock units (in shares)   2,597,964      
Vesting of early exercised stock options (in shares)   91,910      
Vesting of early exercised stock options 896   896    
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)   (827,964)      
Class A common stock withheld to satisfy employee tax withholding obligations (2,857)   (2,857)    
Stock-based compensation 17,438   17,438    
Net unrealized gain (loss) on available-for-sale securities, net of taxes (515)     (515)  
Change in translation 169     169  
Net loss (37,975)       (37,975)
Ending balance (in shares) at Jul. 31, 2023   276,945,205      
Ending balance at Jul. 31, 2023 539,568 $ 27 1,549,920 1,336 (1,011,715)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock from the exercise of common stock options (in shares)   226,505      
Issuance of Class A common stock from the exercise of common stock options 412   412    
Issuance of Class A common stock upon vesting of restricted stock units (in shares)   2,349,577      
Issuance of Class A common stock related to business combination (in shares)   6,745,438      
Issuance of Class A common stock related to business combination 21,622 $ 1 21,621    
Vesting of early exercised stock options (in shares)   91,910      
Vesting of early exercised stock options 896   896    
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)   (825,928)      
Class A common stock withheld to satisfy employee tax withholding obligations (2,359)   (2,359)    
Stock-based compensation 13,041   13,041    
Net unrealized gain (loss) on available-for-sale securities, net of taxes 89     89  
Change in translation (1,667)     (1,667)  
Net loss (38,004)       (38,004)
Ending balance (in shares) at Oct. 31, 2023   285,532,707      
Ending balance at Oct. 31, 2023 533,598 $ 28 1,583,531 (242) (1,049,719)
Beginning balance (in shares) at Jan. 31, 2024   289,275,491      
Beginning balance at Jan. 31, 2024 518,018 $ 28 1,596,201 1,594 (1,079,805)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock from the exercise of common stock options (in shares)   35,318      
Issuance of Class A common stock from the exercise of common stock options 20   20    
Issuance of Class A common stock upon vesting of restricted stock units (in shares)   2,334,916      
Vesting of early exercised stock options 896   896    
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)   (908,417)      
Class A common stock withheld to satisfy employee tax withholding obligations (2,015)   (2,015)    
Stock-based compensation 13,745   13,745    
Net unrealized gain (loss) on available-for-sale securities, net of taxes (512)     (512)  
Change in translation (534)     (534)  
Net loss (29,293)       (29,293)
Ending balance (in shares) at Apr. 30, 2024   290,737,308      
Ending balance at Apr. 30, 2024 500,325 $ 28 1,608,847 548 (1,109,098)
Beginning balance (in shares) at Jan. 31, 2024   289,275,491      
Beginning balance at Jan. 31, 2024 $ 518,018 $ 28 1,596,201 1,594 (1,079,805)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock from the exercise of common stock options (in shares) 324,375        
Net unrealized gain (loss) on available-for-sale securities, net of taxes $ (88)        
Change in translation (159)        
Net loss (88,042)        
Ending balance (in shares) at Oct. 31, 2024   296,432,444      
Ending balance at Oct. 31, 2024 464,605 $ 28 1,631,077 1,347 (1,167,847)
Beginning balance (in shares) at Apr. 30, 2024   290,737,308      
Beginning balance at Apr. 30, 2024 500,325 $ 28 1,608,847 548 (1,109,098)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock from the exercise of common stock options (in shares)   234,443      
Issuance of Class A common stock from the exercise of common stock options 280   280    
Issuance of Class A common stock upon vesting of restricted stock units (in shares)   3,834,734      
Vesting of early exercised stock options 896   896    
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)   (1,330,082)      
Class A common stock withheld to satisfy employee tax withholding obligations (2,470)   (2,470)    
Stock-based compensation 12,185   12,185    
Net unrealized gain (loss) on available-for-sale securities, net of taxes 376     376  
Change in translation 323     323  
Net loss (38,668)       (38,668)
Ending balance (in shares) at Jul. 31, 2024   293,476,403      
Ending balance at Jul. 31, 2024 473,247 $ 28 1,619,738 1,247 (1,147,766)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class A common stock from the exercise of common stock options (in shares)   54,614      
Issuance of Class A common stock from the exercise of common stock options 32   32    
Issuance of Class A common stock upon vesting of restricted stock units (in shares)   3,757,861      
Issuance of Class A common stock for employee stock purchase program (in shares)   487,557      
Issuance of Class A common stock for employee stock purchase program 924   924    
Vesting of early exercised stock options 896   896    
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)   (1,343,991)      
Class A common stock withheld to satisfy employee tax withholding obligations (2,843)   (2,843)    
Stock-based compensation 12,330   12,330    
Net unrealized gain (loss) on available-for-sale securities, net of taxes 48     48  
Change in translation 52     52  
Net loss (20,081)       (20,081)
Ending balance (in shares) at Oct. 31, 2024   296,432,444      
Ending balance at Oct. 31, 2024 $ 464,605 $ 28 $ 1,631,077 $ 1,347 $ (1,167,847)
v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Operating activities    
Net loss $ (88,042) $ (110,423)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 36,365 36,033
Stock-based compensation, net of capitalized cost of $1,793 and $1,851, respectively 36,467 44,611
Change in fair value of warrant liabilities (1,126) (14,004)
Change in fair value of contingent consideration 3,161 (923)
Other (932) (3,538)
Changes in operating assets and liabilities    
Accounts receivable 5,487 (3,872)
Prepaid expenses and other assets 8,499 9,483
Accounts payable, accrued and other liabilities (7,731) (20,706)
Deferred revenue 71 19,557
Deferred hosting costs (298) (92)
Net cash used in operating activities (8,079) (43,874)
Investing activities    
Purchases of property and equipment (32,694) (29,086)
Capitalized internal-use software (4,145) (3,266)
Maturities of available-for-sale securities 57,046 142,903
Sales of available-for-sale securities 162,341 40,072
Purchases of available-for-sale securities (105,582) (166,169)
Business acquisition, net of cash acquired (1,068) (7,542)
Purchases of licensed imagery intangible assets (4,558) 0
Other (300) (944)
Net cash provided by (used in) investing activities 71,040 (24,032)
Financing activities    
Proceeds from the exercise of common stock options 332 6,770
Payments for withholding taxes related to the net share settlement of equity awards (7,328) (7,112)
Proceeds from employee stock purchase program 1,083 0
Payments of contingent consideration for business acquisitions (8,783) 0
Other (606) (15)
Net cash used in financing activities (15,302) (357)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents 74 (65)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents 47,733 (68,328)
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period 102,198 188,076
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period $ 149,931 $ 119,748
v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Statement of Cash Flows [Abstract]        
Share-based payment arrangement, capitalized costs $ 501 $ 443 $ 1,793 $ 1,851
v3.24.3
Organization
9 Months Ended
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization Organization
Planet Labs PBC (“Planet,” or the “Company”) was founded to design, construct, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers via an online platform. The Company’s mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. The Company is headquartered in San Francisco, California, with operations throughout the United States (U.S.”), Canada, Asia and Europe.
On July 7, 2021, Planet Labs Inc. (“Former Planet”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with dMY Technology Group, Inc. IV (“dMY IV”), a special purpose acquisition company (“SPAC”) incorporated in Delaware on December 15, 2020, Photon Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of dMY IV (“First Merger Sub”), and Photon Merger Sub Two, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of dMY IV (“Second Merger Sub”). Pursuant to the Merger Agreement, upon the favorable vote of dMY IV’s stockholders on December 3, 2021, on December 7, 2021, First Merger Sub merged with and into Former Planet (the “Surviving Corporation”), with Former Planet surviving the merger as a wholly owned subsidiary of dMY IV (the “First Merger”), and pursuant to Former Planet’s election immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into dMY IV, with dMY IV surviving the merger (the “Business Combination”). Following the completion of the Business Combination, dMY IV was renamed Planet Labs PBC.
Former Planet was incorporated in the state of Delaware on December 28, 2010. Former Planet was originally incorporated as Cosmogia Inc., and the name was subsequently changed to Planet Labs Inc. on June 24, 2013.
v3.24.3
Basis of Presentation and Summary of Significant Accounting Policies
9 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three and nine months ended October 31, 2024 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2025 or any other future period.
The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31.
Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 (the “2024 Form 10-K”).
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, the Company’s incremental borrowing rate for operating leases, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of private placement warrant liabilities, the fair value of assets acquired and liabilities assumed from business combinations, the fair value of contingent consideration for business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies.
These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material.
Due to current geopolitical events, including the war in Ukraine and the Israel-Hamas conflict, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained.
Segments
Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
See Note 3, Revenue, for revenue by geographic region. See Note 6, Balance Sheet Components, for long-lived assets by geographic region.
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands, Slovenia, Austria, and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at October 31, 2024 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $239.8 million.
Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. One customer accounted for 10% of accounts receivable as of October 31, 2024. As of January 31, 2024, no customer accounted for 10% or more of accounts receivable.
For the three and nine months ended October 31, 2024, one customer accounted for 19% of revenue. For the three and nine months ended October 31, 2023, one customer accounted for 21% and 22% of revenue, respectively.
The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations.
Significant Accounting Policies
The Company’s significant accounting policies are included in Note 2 of its Consolidated Financial Statements included in the 2024 Form 10-K.
Recent Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures, which clarifies that entities with a single reportable segment are subject to both new and existing segment reporting requirements under ASC 280, and modifies certain segment disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (“Topic 740”): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures, primarily through changes around the effective tax rate reconciliation and income taxes paid information. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
v3.24.3
Revenue
9 Months Ended
Oct. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Deferred Revenue
During the nine months ended October 31, 2024 and 2023, the Company recognized revenue of $61.6 million and $45.7 million, respectively, that had been included in deferred revenue as of January 31, 2024 and 2023, respectively.

Remaining Performance Obligations
The Company often enters into multi-year imagery licensing arrangements with its customers, whereby the Company generally invoices the amount for the first year of the contract at signing followed by subsequent annual invoices. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. The Company’s remaining performance obligations were $145.9 million as of October 31, 2024, which consists of both deferred revenue of $77.7 million and non-cancelable contracted revenue that will be invoiced in future periods of $68.2 million. The Company expects to recognize approximately 82% of the remaining performance obligation over the next 12 months, approximately 98% of the remaining obligation over the next 24 months, and the remainder thereafter.
Remaining performance obligations do not include unexercised contract options, written orders where funding has not been appropriated and contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty.

Disaggregation of Revenue
The following table disaggregates revenue by major geographic region:
 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands)2024202320242023
United States$25,294 $23,348 $83,109 $73,513 
Rest of world35,97232,03299,68988,331
Total revenue$61,266 $55,380 $182,798 $161,844 
No single country other than the U.S. accounted for more than 10% of revenue for the three and nine months ended October 31, 2024 and 2023.

Costs to Obtain and Fulfill a Contract
Commissions paid to the Company’s direct sales force are considered incremental costs of obtaining a contract with a customer. Accordingly, commissions are capitalized when incurred and amortized to sales and marketing expense over the period of benefit from the underlying contracts. The period of benefit from the underlying contract is consistent with the timing of transfer to the performance obligations to which the capitalized costs relate, and is generally consistent with the contract term.
During the three and nine months ended October 31, 2024, the Company capitalized $0.7 million and $1.4 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.8 million and $2.1 million for the three and nine month periods ended October 31, 2024, respectively.
During the three and nine months ended October 31, 2023, the Company capitalized $0.6 million and $1.1 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.4 million and $1.7 million for the three and nine month periods ended October 31, 2023, respectively.
As of October 31, 2024 and January 31, 2024, deferred commissions consisted of the following:
(in thousands)October 31, 2024January 31, 2024
Deferred commission, current$1,884 $2,296 
Deferred commission, non-current1,2321,578
Total deferred commission$3,116 $3,874 
The current portion of deferred commissions are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The non-current portion of deferred commissions are included in other non-current assets on the condensed consolidated balance sheets.
v3.24.3
Fair Value of Financial Assets and Liabilities
9 Months Ended
Oct. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Financial Assets and Liabilities Fair Value of Financial Assets and Liabilities
Assets and liabilities recognized or disclosed at fair value in the financial statements are categorized based upon the level of judgment associated with the inputs used to measure their respective fair values.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for recognition or disclosure purposes as of October 31, 2024 and January 31, 2024 by level within the fair value hierarchy. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability.
 October 31, 2024
(in thousands)Level 1 Level 2 Level 3
Assets
Cash equivalents:
Money market funds$38,503 $— $— 
Restricted cash equivalents: money market funds9,439 — — 
Short-term investments:
U.S. Treasury securities19,466 $— $— 
Commercial paper— 2,943 $— 
Corporate bonds— 78,732 $— 
Certificates of deposit— 2,114 $— 
Total assets$67,408 $83,789 $— 
Liabilities
Public Warrants$1,242 $— $— 
Private Placement Warrants— $— 593 
Contingent consideration for acquisitions— $— 7,282 
Total liabilities$1,242 $— $7,875 
 January 31, 2024
(in thousands)Level 1Level 2Level 3
Assets
Cash equivalents:
Money market funds$28,722 $— $— 
Restricted cash equivalents: money market funds17,301
Short-term investments:
U.S. Treasury securities46,211
Commercial paper11,126
Corporate bonds144,340
U.S. government agency securities9,933
Certificates of deposit3,431
Total assets$92,234 $168,830 $— 
Liabilities
Public Warrants$1,656 $— $— 
Private Placement Warrants1,305
Contingent consideration for acquisitions— — 12,891 
Total liabilities$1,656 $— $14,196 
The fair value of cash held in banks and accrued and other current liabilities approximate the stated carrying value due to the short time to maturity and are excluded from the tables above.
Money Market Funds
The fair value of the Company’s money market funds is based on quoted active market prices for the funds and is determined using the market approach. There were no realized or unrealized gains or losses on money market funds for the three and nine months ended October 31, 2024 and 2023.
Short-term Investments
The fair value of the Company’s short-term investments classified within Level 1 are valued using quoted active market prices for the securities. The fair value of the Company’s short-term investments classified within Level 2 are valued using third-party pricing services. The pricing services utilize industry standard valuation models. Inputs utilized include market pricing based on real-time trade data for the same or similar securities and other significant inputs derived from or corroborated by observable market data.
Public and Private Placement Warrants
The Public Warrants are classified within Level 1 as they are publicly traded and had an observable market price in an active market.
The Private Placement Warrants (excluding the Private Placement Vesting Warrants) were valued based on a Black-Scholes option pricing model. Due to the market condition vesting requirements, the fair value of the Private Placement Vesting Warrants were valued using a model based on multiple stock price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the market condition targets may not be satisfied. The Private Placement Warrants were collectively classified as a Level 3 measurement within the fair value hierarchy because these valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility. The expected volatility input utilized for the fair value measurements of the Private Placement Warrants as of October 31, 2024 and January 31, 2024 was 70%.
Contingent Consideration for Acquisitions
The Company has recorded contingent consideration liabilities in connection with its acquisitions of Salo Sciences and Sinergise (see Note 5, Acquisitions, for the acquisition of Sinergise. See Note 6 of the Company’s Consolidated Financial Statements included in the 2024 Form 10-K). The Company measures the fair value of the contingent consideration liabilities based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy.
The fair value of the contingent consideration liability for the Salo Sciences technical milestone payments is determined based on the present value of the probability-weighted payments for each of the two milestones. The significant unobservable inputs used in the fair value measurement are management’s estimate of the probability to achieve the technical milestone criteria and the discount rate. The Company determined that both of the technical milestone criteria were achieved during the nine months ended October 31, 2024.
The fair value of the contingent consideration liability for the Salo Sciences customer contract earnout payments is determined using a Monte Carlo simulation. The fair value estimate involves a simulation of future customer contract cash collections during the four-year performance period, the probability of entering into contracts with the named customers and discounting the probability-weighed earnout payments to present value. The significant unobservable inputs used in the fair value measurement are management’s estimate of obtaining the customer contracts, including probabilities, timing and contract values, and management’s estimate of the discount rate.
The fair value of the contingent consideration liability for the Sinergise customer consent escrow is determined based on the present value of the probability-weighted payments based on the likelihood of the customer consent being achieved. The significant unobservable input used in the fair value measurement is management’s estimate of the likelihood of the customer consent being achieved.
Level 3 Disclosures
The following is a roll-forward of Level 3 liabilities measured at fair value for the three and nine months ended October 31, 2024 and 2023:
(in thousands)Private Placement WarrantsTechnical Milestone Contingent Consideration*Customer Contract Earnout Contingent Consideration*Customer Consent Escrow Contingent Consideration*
Fair value at end of year, January 31, 2023$9,701 $4,433 $3,597 $— 
Change in fair value(3,323)5(428)
Fair value at April 30, 2023$6,378 $4,438 $3,169 $— 
Change in fair value(1,364)211(315)
Fair value at July 31, 2023$5,014 $4,649 $2,854 $— 
Additions5,842
Payments(160)
Change in fair value(3,590)6(478)76
Fair value at October 31, 20231,4244,6552,2165,918
Fair value at end of year, January 31, 2024$1,305 $5,114 $1,926 $5,851 
Payments(180)
Change in fair value(771)(183)1369
Fair value at April 30, 2024$534 $4,931 $1,759 $5,920 
Payments(1,090)
Change in fair value3265791551,291
Fair value at July 31, 2024$860 $5,510 $824 $7,211 
Payments$— $— $— $(7,500)
Change in fair value$(267)$362 $586 $289 
Fair value at October 31, 2024$593 $5,872 $1,410 $— 
* The current portion of the contingent consideration liabilities balances of $4.4 million and $7.0 million as of October 31, 2024 and January 31, 2024, respectively, are included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for the Salo Sciences technical milestone payments are included within research and development expenses. Changes in fair value of the Salo Sciences contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Changes in fair value of the contingent consideration liability for the Sinergise acquisition customer consent escrow payments are included within general and administrative expenses. During the three months ended October 31, 2024, evidence of the Sinergise acquisition customer consent was received and the $7.5 million in escrow was released to Sinergise.
Other
The Company measures certain non-financial assets including property and equipment, and other intangible assets at fair value on a non-recurring basis in periods after initial measurement in circumstances when the fair value of such assets are impaired below their recorded cost. As of October 31, 2024 and January 31, 2024, there were no material non-financial assets recorded at fair value.
v3.24.3
Acquisition
9 Months Ended
Oct. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisition Acquisition
Sinergise
On March 26, 2023, the Company entered into an asset purchase agreement with Holding Sinergise d.o.o., a company existing under the laws of Slovenia (“Sinergise”), and its subsidiaries and certain shareholders of Sinergise, to acquire the cloud-based geo-spatial analysis products, platforms and solutions business from Sinergise. On August 4, 2023, the Company completed the acquisition.
The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. The acquisition date fair value of the consideration transferred was approximately $41.1 million, and consisted of the following:
(in thousands)Fair Value
Cash$8,609 
Class A common stock issued
21,622 
Liabilities for cash consideration placed in escrow account10,842 
Total$41,073 
The common stock issued consisted of 6,745,438 shares of the Company’s Class A common stock. The fair value of the Class A common stock was determined based on the closing market price on the date of the acquisition.
In April 2024, the Company paid $1.1 million of additional consideration in connection with the finalization of the net working capital adjustment relating to the Company’s acquisition of Sinergise. The additional amount was accounted for as a measurement period adjustment and resulted in a $1.1 million addition of goodwill during the nine months ended October 31, 2024.
Pursuant to the terms of the asset purchase agreement, the Company placed $5.0 million of cash consideration into an escrow account to secure potential indemnification obligations and any customary post-closing adjustments for working capital and indebtedness (the “Indemnity Escrow”). The amount held in the escrow account is to be released to Sinergise upon the two-year anniversary of the acquisition close date. The Company recorded a liability of $5.0 million for the Indemnity Escrow.
Pursuant to the terms of the asset purchase agreement, the Company placed an additional $7.5 million of cash consideration into an escrow account related to obtaining customer consent for a contract acquired in connection with the acquisition (the “Customer Consent Escrow”). The amount held in the escrow account is to be released to Sinergise upon the Company receiving evidence of the customer consent. If evidence of the customer consent is not received on or prior to the two year anniversary of the acquisition close date, the amount held in the Customer Consent Escrow is to be released to the Company. Additionally, the amount held in the Customer Consent Escrow is to be released to the Company if the customer contract is terminated or suspended on or prior to the two year anniversary of the acquisition close date. The Company determined that the customer consent contingency represents contingent consideration. The fair value of the contingent consideration liability as of the acquisition date was determined to be $5.8 million. Refer to Note 4 for information relating to the valuation of the Customer Consent Escrow contingent consideration.
Cash held in escrow related to the acquisition is recorded within restricted cash and cash equivalents in the Company’s condensed consolidated balance sheets.
The following table summarizes the fair value of the assets acquired and liabilities assumed as of the date of acquisition, after considering the measurement period adjustment described above:

(in thousands)
Goodwill$24,815 
Identifiable intangible assets acquired
Developed technology11,811
Customer relationships2,208
Other110
Accounts receivable3,013
Other assets, current652
Other assets, non-current414
Total assets acquired$43,023 
Deferred revenue, current(585)
Accrued and other current liabilities(984)
Other liabilities, current(213)
Other liabilities, non-current(167)
Total liabilities assumed$(1,949)
Net assets acquired$41,074 

The identifiable intangible assets were measured at fair value. The developed technology was valued using the royalty method under the income approach. The customer relationships were valued using the excess earnings method under the income approach. The developed technology was assigned an estimated useful life of 8 years and the customer relationships were assigned an estimated useful life of 9 years.
The excess of purchase consideration over the fair value of other assets acquired and liabilities assumed was recorded as goodwill. The goodwill primarily represents the value expected from the synergies created through the operational enhancement benefits resulting from the integration of Sinergise into the Company and the combination of Sinergise’s products and solutions with the Company’s existing products. Approximately $0.7 million of the goodwill is deductible for tax purposes.
The financial results of Sinergise are included in the condensed consolidated financial statements from the date of acquisition. Pro forma results of operations have not been presented as the effect of this acquisition was not material to the condensed consolidated financial statements.
Acquisition-related costs associated with the transaction were $0.2 million and $2.1 million for the three and nine months ended October 31, 2023, respectively. These costs were recorded within selling, general and administrative expenses.

Certain employees of Sinergise, which became employees of the Company, were paid cash transaction bonuses totaling $2.3 million in connection with the closing of the acquisition. The transaction bonuses were accounted for as a transaction separate from the business combination. Accordingly, $2.3 million of the consideration paid by the Company was allocated to the transaction bonuses and was recorded within the Company’s condensed consolidated statements of operations as summarized in the table below:

(in thousands)Three and Nine Months Ended October 31, 2023
Cost of revenue$267 
Research and development1,891 
Sales and marketing41 
General and administrative118 
Total$2,317 
v3.24.3
Balance Sheet Components
9 Months Ended
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Cash and Cash Equivalents, and Restricted Cash and Cash Equivalents
Cash and cash equivalents include interest-bearing bank deposits, money market funds and other highly liquid investments with maturities of 90 days or less at the date of purchase.
The Company had restricted cash and cash equivalents balances of $11.0 million and $18.3 million as of October 31, 2024 and January 31, 2024, respectively.
The restricted cash and cash equivalents balances as of October 31, 2024 primarily consisted of $5.0 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases. The restricted cash and cash equivalents balances as of January 31, 2024 primarily consisted of $12.5 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases.
A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of October 31, 2024 and January 31, 2024 is as follows:
 
(in thousands)October 31, 2024January 31, 2024
Cash and cash equivalents$138,969 $83,866 
Restricted cash and cash equivalents, current6,525 8,360
Restricted cash and cash equivalents, non-current4,437 9,972
Total cash, cash equivalents, and restricted cash and cash equivalents$149,931 $102,198 
Short-term Investments
Short-term investments consisted of the following as of October 31, 2024 and January 31, 2024:
October 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$19,533 $$(69)$19,466 
Commercial paper2,943 — — 2,943 
Corporate bonds78,502 265 (35)78,732 
Certificates of deposit2,114 — — 2,114 
Total short-term investments$103,092 $267 $(104)$103,255 
January 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$46,185 $118 $(92)$46,211 
Commercial paper11,126 — — 11,126 
Corporate bonds144,119 376 (155)144,340 
U.S. government agency securities9,928 17 (13)9,932 
Certificates of deposit3,432 — — 3,432 
Total short-term investments$214,790 $511 $(260)$215,041 
The following table summarizes the contracted maturities of the Company’s short-term investments as of October 31, 2024 and January 31, 2024:
October 31, 2024January 31, 2024
(in thousands)Amortized CostFair ValueAmortized CostFair Value
Due in 1 year or less$69,910 $70,127 $148,396 $148,296 
Due in 1-2 years33,182 33,128 66,394 66,745 
$103,092 $103,255 $214,790 $215,041 
Property and Equipment, Net
Property and equipment, net consists of the following:
(in thousands)October 31, 2024January 31, 2024
Satellites$244,501 $300,203 
Satellites in process and not placed into service55,979 32,468 
Leasehold improvements17,125 17,089 
Ground stations and ground station equipment20,048 19,098 
Office furniture, equipment and fixtures10,146 8,044 
Computer equipment and purchased software9,657 9,446 
Total property and equipment, gross$357,456 $386,348 
Less: Accumulated depreciation(240,536)(272,919)
Total property and equipment, net$116,920 $113,429 
Property and equipment, net as of October 31, 2024 included $2.8 million of satellite manufacturing costs that were previously classified as prepaid expenses and other current assets as of January 31, 2024.
The Company’s long-lived assets by geographic region are as follows:
(in thousands)October 31, 2024January 31, 2024
United States$110,901 $107,070 
Rest of world
6,0196,359
Total property and equipment, net$116,920 $113,429 
The Company concluded that satellites in service continue to be owned by the U.S. entity and accordingly are classified as U.S. assets in the table above. No single country other than the U.S. accounted for more than 10% of total property and equipment, net, as of October 31, 2024 and January 31, 2024.
Total depreciation expense for the three and nine months ended October 31, 2024 was $8.0 million and $30.3 million, respectively, of which $7.2 million and $27.9 million, respectively, was depreciation expense specific to satellites. Total depreciation expense for the three and nine months ended October 31, 2023 was $11.9 million and $31.4 million, respectively, of which $11.1 million and $29.5 million, respectively, was depreciation expense specific to satellites.
Capitalized Internal-Use Software Development Costs
Capitalized internal-use software costs, net of accumulated amortization consists of the following:
(in thousands)October 31, 2024January 31, 2024
Capitalized internal-use software$50,074 $45,010 
Less: Accumulated amortization(31,815)(30,037)
Capitalized internal-use software, net$18,259 $14,973 
Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2024 was $0.6 million and $1.8 million, respectively. Amortization expense for capitalized internal-use software for the three and nine months ended October 31, 2023 was $0.5 million and $1.4 million, respectively.
Goodwill and Intangible Assets
Goodwill and Intangible assets consists of the following:
 October 31, 2024
January 31, 2024
(in thousands)Gross
Carrying
Amount
Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
 Gross
Carrying
Amount
 Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
Developed technology$30,429 $(13,131)$(195)$17,103 $30,429 $(11,085)$(220)$19,124 
Image library19,949(13,008)3467,28719,324(11,852)2187,690
Customer relationships7,143(4,160)(63)2,9207,143(3,715)(42)3,386
Trade names and other6,389(4,499)311,9216,089(3,877)362,248
Total intangible assets$63,910 $(34,798)$119 $29,231 $62,985 $(30,529)$(8)$32,448 
Goodwill$135,981 $— $1,430 $137,411 $134,914 $— $1,342 $136,256 
Amortization expense for intangible assets for the three and nine months ended October 31, 2024 was $1.5 million and $4.3 million, respectively. Amortization expense for intangible assets for the three and nine months ended October 31, 2023 was $1.3 million and $3.3 million, respectively.
The change in the carrying amount of goodwill during the nine months ended October 31, 2024 and 2023 is as follows:
Nine Months Ended
October 31,
(in thousands)20242023
Beginning of period$136,256 $112,748 
Addition1,068 23,747 
Currency translation adjustment87 (794)
End of period$137,411 $135,701 
In April 2024, the Company paid $1.1 million of additional consideration in connection with the finalization of the net working capital adjustment relating to the Company’s acquisition of Sinergise. The additional amount was accounted for as a measurement period adjustment and resulted in a $1.1 million addition of goodwill during the nine months ended October 31, 2024.
Accrued and Other Current Liabilities
Accrued liabilities and other current liabilities consist of the following:
(in thousands)October 31, 2024January 31, 2024
Deferred R&D service liability (see Note 9)$8,237 $9,923 
Payroll and related expenses6,636 6,859 
Deferred hosting costs5,145 5,007 
Withholding taxes and other taxes payable1,560 3,152 
Contingent consideration
4,4117,006
Severance and other employee termination costs91123
Other accruals
16,77012,809
Total accrued and other current liabilities$43,670 $44,779 
v3.24.3
Restructuring
9 Months Ended
Oct. 31, 2024
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
2024 Headcount Reduction
In June 2024, the Company announced a plan to reduce its global headcount by approximately 17% of the Company’s total number of employees prior to the reduction (the “2024 headcount reduction”). This action was taken consistent with the Company’s ongoing focus on aligning its resources to the market opportunity, improving operational efficiency, and supporting the long-term growth of the business.
As a result of the 2024 headcount reduction, the Company recognized costs for one-time employee termination benefits consisting of severance and other employee costs. The Company also recognized a stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. A summary of the restructuring charges recognized during the three and nine months ended October 31, 2024 is provided in the tables below:
Three Months Ended October 31, 2024
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$128 $(176)$(48)
Research and development(76)(426)(502)
Sales and marketing24 (680)(656)
General and administrative(51)(71)(122)
Total restructuring charges$25 $(1,353)$(1,328)
Nine Months Ended October 31, 2024
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$1,312 $(176)$1,136 
Research and development3,464 (426)3,038 
Sales and marketing4,457 (680)3,777 
General and administrative1,291 (71)1,220 
Total restructuring charges$10,524 $(1,353)$9,171 
There were no restructuring charges recognized during the three and nine months ended October 31, 2023 related to the 2024 headcount reduction.
The following table summarizes the Company’s liability recognized in connection with the 2024 headcount reduction, which is recorded within accrued and other current liabilities in the condensed consolidated balance sheets:
(in thousands)
Balance as of January 31, 2024$— 
Severance and other employee costs10,524 
Cash payments(9,613)
Balance as of October 31, 2024$911 
The headcount reductions, including the remaining cash payments, are expected to be substantially complete by the end of the fiscal year ending January 31, 2025.
2023 Headcount Reduction
In August 2023, the Company announced a plan to reduce its global headcount by approximately 10% of the Company’s total number of employees prior to the reduction (the “2023 headcount reduction”). This action was taken to increase the Company’s focus on its high priority growth opportunities and operational efficiency.
As a result of the 2023 headcount reduction, the Company recognized costs for one-time employee termination benefits consisting of severance and other employee costs. The Company also recognized a stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. A summary of the restructuring charges recognized during the three and nine months ended October 31, 2023 is provided in the table below:
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$563 $(62)$501 
Research and development3,297 (398)2,899 
Sales and marketing1,943 (815)1,128 
General and administrative1,538 (253)1,285 
Total restructuring charges$7,341 $(1,528)$5,813 
There were no restructuring charges recognized during the three and nine months ended October 31, 2024 related to the 2023 headcount reduction.
The 2023 headcount reduction, including cash payments, was substantially complete as of January 31, 2024.
v3.24.3
Leases
9 Months Ended
Oct. 31, 2024
Leases [Abstract]  
Leases Leases
The Company’s leasing activities primarily consist of real estate leases for its operations, including office space, and certain ground station service agreements that convey the right to control the use of specified equipment and facilities. The Company assesses whether each lease is an operating or finance lease at the lease commencement date. As of October 31, 2024, the Company had no finance leases.
Operating lease costs were $2.4 million and $7.1 million for the three and nine months ended October 31, 2024, respectively. Operating lease costs were $2.1 million and $6.1 million for the three and nine months ended October 31, 2023, respectively. Variable lease expenses and short-term lease expenses were immaterial for the three and nine months ended October 31, 2024 and 2023.
Operating cash flows from operating leases were $2.6 million and $7.5 million for the three and nine months ended October 31, 2024, respectively. Operating cash flows from operating leases were $2.3 million and $5.0 million for the three and nine months ended October 31, 2023, respectively.
Right of use assets obtained in exchange for operating lease liabilities were $1.2 million and $4.3 million for the three and nine months ended October 31, 2024, respectively. Right of use assets obtained in exchange for operating lease liabilities were $0.3 million and $6.5 million for the three and nine months ended October 31, 2023, respectively.
Maturities of operating lease liabilities as of October 31, 2024 were as follows:
(in thousands)
Remainder of Fiscal Year 2025$2,629
202610,217
20277,104
20282,951
20291,837
Thereafter817
Total lease payments$25,555
Less: Imputed interest(2,630)
Total lease liabilities$22,925
Weighted average remaining lease term (years)3.0
Weighted average discount rate%
v3.24.3
Research and Development Arrangements
9 Months Ended
Oct. 31, 2024
Research and Development [Abstract]  
Research and Development Arrangements Research and Development Arrangements
Research and Development Services Agreement
In December 2020, the Company entered into a development services agreement, whereby the Company agreed to provide the technical knowledge and services to design and develop certain prototype satellites and deliver and test early data collected (the “R&D Services Agreement”). The R&D Services Agreement, including subsequent amendments to such agreement, provides for funding of $46.4 million to be paid to the Company as specified milestones are achieved. The R&D Services Agreement is unrelated to the Company’s ordinary business activities. The Company has discretion in managing the activities under the R&D Services Agreement and retains all developed intellectual property. The Company has no obligation to repay any of the funds received regardless of the outcome of the development work; therefore, the arrangement is accounted for as funded research and development pursuant to ASC 730-20, Research and Development. As ASC 730-20 does not indicate the accounting model for research and development services, the Company determined the total transaction price is recognized over the agreement term as a reduction of research and development expenses based on a cost incurred method.
During the three and nine months ended October 31, 2024, the Company recognized $2.9 million and $7.2 million of funding and incurred $2.9 million and $6.5 million of research and development expenses, respectively, in connection with the R&D Services Agreement. During the three and nine months ended October 31, 2023, the Company recognized $6.8 million and $14.8 million of funding and incurred $7.6 million and $15.6 million of research and development expenses, respectively. As of October 31, 2024 and January 31, 2024, the Company had received a total of $46.4 million and $45.8 million, respectively, of funding under the R&D Services Agreement.
NASA Communication Services Project
In connection with its Communication Services Project (“CSP”), the National Aeronautics and Space Administration (“NASA”) selected certain satellite communications providers that NASA will fund to develop and demonstrate near-Earth space communication services that may support future NASA missions using commercial technology. In June 2022 and August 2022, the Company entered into separate agreements with two of the satellite communications providers selected by NASA whereby the Company agreed to participate in the NASA CSP as a subcontractor. The agreements provide for the Company to receive aggregate funding of $40.5 million to be paid as milestones are completed. The Company determined that the agreements are in the scope of ASC 912-730, Contractors – Federal Government – Research and Development (“ASC 912-730”). In accordance with ASC 912-730, funding is recognized over the term of each agreement as a reduction of research and development expenses based on a cost incurred method.
During the three and nine months ended October 31, 2024, the Company recognized $2.5 million and $7.6 million of funding, respectively, and incurred $2.5 million and $7.6 million of research and development expenses, respectively, in connection with the NASA CSP. During the three and nine months ended October 31, 2023, the Company recognized $1.2 million and $9.2 million of funding, respectively, and incurred $1.2 million and $8.4 million of research and development expenses, respectively, in connection with the NASA CSP. As of October 31, 2024 and January 31, 2024, the Company had received a total of $27.6 million and $13.9 million, respectively, of funding in connection with the NASA CSP.
In July 2023, projected costs related to certain of our research and development arrangements were revised down as a result of operational decisions. This change in estimate resulted in a $2.2 million cumulative increase of funding recognized for certain of our research and development arrangements for the nine months ended October 31, 2023.
v3.24.3
Commitment and Contingencies
9 Months Ended
Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Other
The Company has minimum purchase commitments for hosting services from Google through January 31, 2028 (see Note 12). Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of October 31, 2024 are as follows:
(in thousands) 
Remainder of Fiscal Year 2025$9,428 
202631,190 
202732,725 
202833,427 
Total purchase commitments$106,770 

Legal Proceedings
Delaware Class Action
A stockholder class action was filed in the Court of Chancery of the State of Delaware on August 19, 2024, against the former officers and directors of dMY IV and the Company. The complaint alleges that the individual defendants breached various fiduciary duties to the dMY IV stockholders and that the Company aided and abetted such breaches. The case is brought on behalf of a purported class of holders of dMY IV Class A Common Stock who held such stock prior to the redemption deadline for the Business Combination, did not exercise the right to redeem their shares, and were allegedly injured. Defendants filed a motion to dismiss the complaint on November 12, 2024.
For many legal matters, particularly those in early stages, the Company cannot reasonably estimate the possible loss (or range of loss), if any. The Company records an accrual for legal matters at the time or times it determines that a loss is both probable and reasonably estimable. Regarding matters for which no accrual has been made (including the potential for losses in excess of amounts accrued), the Company currently believes, based on its own investigations, that any losses (or ranges of losses) that are reasonably possible and estimable will not, in the aggregate, have a material adverse effect on its financial position, results of operations, or cash flows. However, the ultimate outcome of legal proceedings involves judgments, estimates, and inherent uncertainties and cannot be predicted with certainty. Should the ultimate outcome of any legal matter be unfavorable, the Company's business, financial condition, results of operations, or cash flows could be materially and adversely affected. The Company may also incur substantial legal fees, which are expensed as incurred, in defending against legal claims.
Contingencies
The Company may have certain contingent liabilities that arise in the ordinary course of business activities including those arising from disputes and claims and events arising from revenue contracts entered into by the Company. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.
Indemnification
The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent, or other intellectual property infringement claim by any third-party with respect to its technology. The term of these indemnification agreements is generally perpetual after the execution of the agreement. The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement.
The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify them against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.
To date, we have not incurred any material costs and have not accrued any liabilities in the consolidated financial statements as a result of these provisions.
v3.24.3
Warrants
9 Months Ended
Oct. 31, 2024
Warrants [Abstract]  
Warrants Warrants
Public and Private Placement Warrants
In connection with dMY IV’s initial public offering, which occurred on March 9, 2021, dMY IV issued 34,500,000 units, each unit consisting of one share of Class A common stock of dMY IV and one-fifth of one redeemable warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (the “Public Warrants”). Simultaneously with the closing of its initial public offering, dMY IV completed the private sale of 5,933,333 warrants to dMY Sponsor IV, LLC (the “dMY Sponsor”) at a purchase price of $1.50 per warrant (the “Private Placement Warrants”). Each Private Placement Warrant is exercisable for one share of Class A common stock at $11.50 per share.
Additionally, pursuant to a lock-up agreement entered into with the dMY Sponsor in connection with the Business Combination, 2,966,667 of the Private Placement Warrants are subject to vesting conditions (the “Private Placement Vesting Warrants”). The Private Placement Vesting Warrants vest in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. Any right to Private Placement Vesting Warrants that remains unvested on the first business day after five years from the closing of the Business Combination will be forfeited without any further consideration.
As of October 31, 2024 and January 31, 2024, there were 6,899,982 Public Warrants and 5,933,333 Private Placement Warrants, including 2,966,667 Private Placement Vesting Warrants, outstanding.
Warrants to Purchase Class A Common Stock
In addition to the Public and Private Placement Warrants, there were 1,065,594 warrants to purchase shares of Class A common stock with a weighted average exercise price of $9.384 which were outstanding and exercisable as of October 31, 2024 and January 31, 2024. As of October 31, 2024, the outstanding warrants have a weighted average remaining term of 5.4 years.
v3.24.3
Related Party Transactions
9 Months Ended
Oct. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
As of October 31, 2024 and January 31, 2024, Google held 31,942,641 shares of the Company’s Class A common stock, and, as such, owned greater than 10% of outstanding shares of the Company’s Class A common stock.
In April 2017, the Company and Google entered into a five year content license agreement pursuant to which the Company licensed content to Google. In April 2022, the agreement automatically renewed for a period of one year and in April 2023, the agreement expired. For the nine months ended October 31, 2023, the Company recognized revenue of $0.3 million related to this content license agreement.
In July 2023, the Company and Google entered into a one year content license agreement pursuant to which the Company agreed to license content to Google and provide certain of its products in exchange for a $1.0 million fee. The agreement also provides for the Company to receive up to $2.0 million in value of Google cloud credits that the Company can apply against the cost of Google cloud services it utilizes to fulfill its obligations under the agreement. The Company determined that the Google cloud credits represent non-cash variable consideration which is included in the transaction price for the agreement, subject to the guidance on estimating variable consideration within ASC 606, Revenue from Contracts with Customers. The agreement does not include extension or renewal terms. In August 2024, the content license agreement was amended to extend the term until November 2024 in exchange for a $0.3 million fee. For the three and nine months ended October 31, 2024, the Company recognized revenue of $0.3 million related to the content license agreement. The Company recognized immaterial revenue related to the content license agreement for the three months ended October 31, 2023 and recognized revenue of $1.0 million for the nine months ended October 31, 2023.
The Company purchases hosting and other services from Google, of which $11.8 million and $12.1 million is deferred as of October 31, 2024 and January 31, 2024, respectively. The Company recorded $6.2 million of expense during the three months ended October 31, 2024 relating to hosting and other services provided by Google, of which $5.6 million was classified as cost of revenue and $0.6 million was classified as research and development. The Company recorded $20.6 million of expense during the nine months ended October 31, 2024 relating to hosting and other services provided by Google, of which $18.5 million was classified as cost of revenue and $2.1 million was classified as research and development.
The Company recorded $7.5 million of expense during the three months ended October 31, 2023 relating to hosting and other services provided by Google, of which $6.7 million was classified as cost of revenue and $0.8 million was classified as research and development. The Company recorded $21.6 million of expense during the nine months ended October 31, 2023 relating to hosting and other services provided by Google, of which $19.4 million was classified as cost of revenue and $2.2 million was classified as research and development.
As of October 31, 2024 and January 31, 2024, the Company’s accrued and other current liabilities balance included $2.4 million and $2.5 million related to hosting and other services provided by Google, respectively.
On June 28, 2021, the Company amended the terms of its hosting agreement with Google. The amendment, among other things, increased the aggregate purchase commitments to $193.0 million. The amended agreement commenced on August 1, 2021 and extends through January 31, 2028. See Note 10, Commitments and Contingencies, for future Google hosting purchase commitments, including the amended commitments, as of October 31, 2024.
v3.24.3
Stock-based Compensation
9 Months Ended
Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation Stock-based Compensation
The Company's equity incentive plans are described in Note 16, Stock-based Compensation, in the Notes to the Consolidated Financial Statements in the 2024 Form 10-K.
Stock-Based Compensation
The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows:
 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands)2024202320242023
Cost of revenue$897 $944 $2,981 $3,008 
Research and development4,643 6,042 13,495 20,253 
Sales and marketing1,655 1,626 6,863 7,827 
General and administrative5,135 4,429 14,921 15,374 
Total expense12,330 13,041 38,260 46,462 
Capitalized to internal-use software development costs and property and equipment(501)(443)(1,793)(1,851)
Total stock-based compensation expense$11,829 $12,598 $36,467 $44,611 
Stock Options
A summary of stock option activity is as follows:
 Options Outstanding
 Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (Years)
 
Aggregate
Intrinsic
Value
(in thousands)
Balances at January 31, 2024
26,956,953$5.34 5.7
Exercised(324,375)$1.02 
Granted— $— 
Forfeited(1,022,576)$7.28 
Balances at October 31, 2024
25,610,002$5.32 4.8$453 
Vested and exercisable at October 31, 2024
24,137,280$5.06 4.7$453 
As of October 31, 2024, total unrecognized compensation cost related to stock options was $6.5 million, which is expected to be recognized over a period of 1.1 years.
Restricted Stock Units
A summary of Restricted Stock Unit (“RSU”) activity is as follows:
 
Number of
RSUs
 
Weighted
Average
Grant Date
Fair Value
Balances at January 31, 2024
26,718,766$4.45 
Vested(9,654,778)$4.01 
Granted26,642,464$2.34 
Forfeited(7,169,719)$3.70 
Balances at October 31, 2024
36,536,733$3.17 
During the nine months ended October 31, 2024, the Company granted 26,642,464 RSUs, which generally vest over four years, subject to the recipient’s continued service through each applicable vesting date.
Stock-based compensation expense recognized for RSUs during the three and nine months ended October 31, 2024 was $9.9 million and $30.2 million, respectively. Stock-based compensation expense recognized for RSUs during the three and nine months ended October 31, 2023 was $8.6 million and $29.2 million, respectively. As of October 31, 2024, total unrecognized compensation cost related to RSUs was $103.8 million. These costs are expected to be recognized over a period of approximately 2.8 years.
Performance Vesting Restricted Stock Units
During the nine months ended October 31, 2024, the Company granted 348,222 performance vesting restricted stock units (“PSUs”) to certain members of the Company’s senior management. A portion of the PSUs are subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the first half of the fiscal year ended January 31, 2025 and the remaining portion is subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the entire fiscal year ended January 31, 2025. Vesting is also subject to continued service through the applicable vesting dates, and the actual number of PSUs that may vest ranges from 0% to 125% of the PSUs granted based on achievement of the targets.
Stock-based compensation expense recognized for PSUs during the three and nine months ended October 31, 2024 was $0.3 million and $0.8 million, respectively. Stock-based compensation expense recognized for PSUs during the three and nine months ended October 31, 2023 was $0.3 million and $0.7 million, respectively. As of October 31, 2024, total unrecognized compensation cost related to PSUs was $0.2 million. These costs are expected to be recognized over a period of approximately 0.4 years.
Employee Stock Purchase Program
Beginning in April 2024, the Company's eligible employees were able to begin participating in the Company's Employee Stock Purchase Program (“ESPP”). The ESPP allows eligible participants to contribute up to 10% of their eligible compensation towards the purchase of Class A common stock at a discounted price, subject to certain limitations. The purchase price of the shares on each purchase date is equal to 85% of the lower of the fair market value of Class A common stock on the first and last trading days of each offering period. The offerings under the ESPP are currently designed to be intended to qualify under Section 423 of the Internal Revenue Code. The Company estimates the fair value of each purchase right under the ESPP on the date of grant using the Black-Scholes valuation model and uses the straight-line attribution approach to record the expense over the six-month offering period.
Stock-based compensation expense recognized related to ESPP during the three and nine months ended October 31, 2024 was $0.2 million and $0.4 million, respectively. As of October 31, 2024, total unrecognized compensation cost related to ESPP was $0.4 million. These costs are expected to be recognized over a period of approximately 0.4 years.
Early Exercises of Stock Options
The Planet Labs Inc. Amended and Restated 2011 Stock Incentive Plan provided for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Shares of common stock issued upon early exercises of unvested options are not deemed, for accounting purposes, to be issued until those shares vest according to their respective vesting schedules and accordingly, the consideration received for early exercises is initially recorded as a liability and reclassified to common stock and additional paid-in capital as the underlying awards vest. As of October 31, 2024, the Company had a $6.3 million liability recorded for the early exercise of unvested stock options, and the related number of unvested shares subject to repurchase was 643,370.
Earn-out Shares
Pursuant to the Merger Agreement, Former Planet equity award holders have the right to receive Earn-out Shares that are contingently issuable in shares of Class A common stock. The Earn-out Shares may be earned in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00.
No Earn-out Shares vested during the three and nine months ended October 31, 2024. As of October 31, 2024, there were 2,984,494 Earn-out Shares outstanding relating to Former Planet equity award holders.
During the three and nine months ended October 31, 2023, the Company recognized $0.4 million and $4.2 million of stock-based compensation expense related to the Earn-out Shares, respectively. As of October 31, 2024, there was no remaining unrecognized compensation cost related to the Earn-out Shares.
Other Stock-based Compensation
In connection with the acquisition of VanderSat B.V. (“VanderSat”) on December 13, 2021, the Company issued 543,391 shares of Class A common stock to an employee and former owner of VanderSat which are accounted for as stock-based compensation because the shares were subject to forfeiture based on post-acquisition time-based service vesting. The shares vested in quarterly increments over two years commencing on December 13, 2021. As of October 31, 2024 and January 31, 2024, there was no unrecognized compensation cost related to these shares. During the three and nine months ended October 31, 2023, the Company recognized $0.6 million and $1.9 million of stock-based compensation expense related to these shares, respectively.
v3.24.3
Income Taxes
9 Months Ended
Oct. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
During the three months ended October 31, 2024, the Company recorded an immaterial amount of income tax expense. During the nine months ended October 31, 2024, the Company recorded $1.4 million of income tax expense. During the three and nine months ended October 31, 2023, the Company recorded income tax expense of $0.4 million and $1.2 million, respectively. For the three and nine months ended October 31, 2024 and 2023, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rates for the three and nine months ended October 31, 2024 and 2023 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of the Company’s U.S. and foreign deferred tax assets and foreign rate differences.
The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. Gross unrecognized tax benefits were $9.8 million and $8.7 million as of October 31, 2024 and January 31, 2024, respectively. The gross unrecognized tax benefits, if recognized, would not affect the effective tax rate due to the valuation allowance against the deferred tax assets. The Company determined that no accrual for interest and penalties was required as of October 31, 2024 and January 31, 2024 and no such expenses were incurred in the periods presented.
The Company does not anticipate the total amounts of unrecognized tax benefits to significantly increase or decrease in the next twelve months.
The Company files U.S. federal, various state and foreign income tax returns. The Company is not currently under audit by any taxing authorities. All tax years remain open to examination by taxing jurisdictions to which the Company is subject.
v3.24.3
Net Loss Per Share Attributable to Common Stockholders
9 Months Ended
Oct. 31, 2024
Earnings Per Share [Abstract]  
Net Loss Per Share Attributable to Common Stockholders Net Loss Per Share Attributable to Common Stockholders
The Company computes net loss per share of the Class A common stock and Class B common stock using the two-class method required for participating securities. Basic and diluted net loss per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts):
 Three Months Ended October 31,Nine Months Ended October 31,
 2024202320242023
Numerator:
Net loss attributable to common stockholders$(20,081)$(38,004)$(88,042)$(110,423)
Denominator:
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders293,338,324284,197,733290,674,554277,252,951
       Basic and diluted net loss per share attributable to common stockholders$(0.07)$(0.13)$(0.30)$(0.40)

Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential Class A common stock and Class B common stock outstanding would have been anti-dilutive.
The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 As of October 31,
 20242023
Warrants to purchase Class A common stock1,065,5941,065,594
Common stock options25,610,00228,915,927
Restricted Stock Units36,536,73328,109,375
Performance vesting Restricted Stock Units365,428
Shares committed under ESPP85,216
Earn-out Shares24,443,50425,123,663
dMY Sponsor Earn-out Shares862,500862,500
Public Warrants6,899,9826,899,982
Private Placement Warrants5,933,3335,933,333
Early exercised common stock options, subject to future vesting643,3701,011,010
Shares issued in connection with acquisition, subject to future vesting67,923
Total102,445,66297,989,307
v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2024
Jul. 31, 2024
Apr. 30, 2024
Oct. 31, 2023
Jul. 31, 2023
Apr. 30, 2023
Oct. 31, 2024
Oct. 31, 2023
Pay vs Performance Disclosure                
Net loss $ (20,081) $ (38,668) $ (29,293) $ (38,004) $ (37,975) $ (34,444) $ (88,042) $ (110,423)
v3.24.3
Insider Trading Arrangements
3 Months Ended
Oct. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three and nine months ended October 31, 2024 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2025 or any other future period.
The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31.
Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 (the “2024 Form 10-K”).
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, the Company’s incremental borrowing rate for operating leases, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of private placement warrant liabilities, the fair value of assets acquired and liabilities assumed from business combinations, the fair value of contingent consideration for business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies.
These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material.
Due to current geopolitical events, including the war in Ukraine and the Israel-Hamas conflict, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained.
Segments
Segments
Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Concentration of Credit Risk and Other Risks and Uncertainties
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands, Slovenia, Austria, and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at October 31, 2024 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $239.8 million.
Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. One customer accounted for 10% of accounts receivable as of October 31, 2024. As of January 31, 2024, no customer accounted for 10% or more of accounts receivable.
For the three and nine months ended October 31, 2024, one customer accounted for 19% of revenue. For the three and nine months ended October 31, 2023, one customer accounted for 21% and 22% of revenue, respectively.
The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations.
Recent Pronouncements Not Yet Adopted
Recent Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures, which clarifies that entities with a single reportable segment are subject to both new and existing segment reporting requirements under ASC 280, and modifies certain segment disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (“Topic 740”): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures, primarily through changes around the effective tax rate reconciliation and income taxes paid information. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
v3.24.3
Revenue (Tables)
9 Months Ended
Oct. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table disaggregates revenue by major geographic region:
 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands)2024202320242023
United States$25,294 $23,348 $83,109 $73,513 
Rest of world35,97232,03299,68988,331
Total revenue$61,266 $55,380 $182,798 $161,844 
Schedule of Deferred Commissions
As of October 31, 2024 and January 31, 2024, deferred commissions consisted of the following:
(in thousands)October 31, 2024January 31, 2024
Deferred commission, current$1,884 $2,296 
Deferred commission, non-current1,2321,578
Total deferred commission$3,116 $3,874 
v3.24.3
Fair Value of Financial Assets and Liabilities (Tables)
9 Months Ended
Oct. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability.
 October 31, 2024
(in thousands)Level 1 Level 2 Level 3
Assets
Cash equivalents:
Money market funds$38,503 $— $— 
Restricted cash equivalents: money market funds9,439 — — 
Short-term investments:
U.S. Treasury securities19,466 $— $— 
Commercial paper— 2,943 $— 
Corporate bonds— 78,732 $— 
Certificates of deposit— 2,114 $— 
Total assets$67,408 $83,789 $— 
Liabilities
Public Warrants$1,242 $— $— 
Private Placement Warrants— $— 593 
Contingent consideration for acquisitions— $— 7,282 
Total liabilities$1,242 $— $7,875 
 January 31, 2024
(in thousands)Level 1Level 2Level 3
Assets
Cash equivalents:
Money market funds$28,722 $— $— 
Restricted cash equivalents: money market funds17,301
Short-term investments:
U.S. Treasury securities46,211
Commercial paper11,126
Corporate bonds144,340
U.S. government agency securities9,933
Certificates of deposit3,431
Total assets$92,234 $168,830 $— 
Liabilities
Public Warrants$1,656 $— $— 
Private Placement Warrants1,305
Contingent consideration for acquisitions— — 12,891 
Total liabilities$1,656 $— $14,196 
Schedule of Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following is a roll-forward of Level 3 liabilities measured at fair value for the three and nine months ended October 31, 2024 and 2023:
(in thousands)Private Placement WarrantsTechnical Milestone Contingent Consideration*Customer Contract Earnout Contingent Consideration*Customer Consent Escrow Contingent Consideration*
Fair value at end of year, January 31, 2023$9,701 $4,433 $3,597 $— 
Change in fair value(3,323)5(428)
Fair value at April 30, 2023$6,378 $4,438 $3,169 $— 
Change in fair value(1,364)211(315)
Fair value at July 31, 2023$5,014 $4,649 $2,854 $— 
Additions5,842
Payments(160)
Change in fair value(3,590)6(478)76
Fair value at October 31, 20231,4244,6552,2165,918
Fair value at end of year, January 31, 2024$1,305 $5,114 $1,926 $5,851 
Payments(180)
Change in fair value(771)(183)1369
Fair value at April 30, 2024$534 $4,931 $1,759 $5,920 
Payments(1,090)
Change in fair value3265791551,291
Fair value at July 31, 2024$860 $5,510 $824 $7,211 
Payments$— $— $— $(7,500)
Change in fair value$(267)$362 $586 $289 
Fair value at October 31, 2024$593 $5,872 $1,410 $— 
* The current portion of the contingent consideration liabilities balances of $4.4 million and $7.0 million as of October 31, 2024 and January 31, 2024, respectively, are included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for the Salo Sciences technical milestone payments are included within research and development expenses. Changes in fair value of the Salo Sciences contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Changes in fair value of the contingent consideration liability for the Sinergise acquisition customer consent escrow payments are included within general and administrative expenses. During the three months ended October 31, 2024, evidence of the Sinergise acquisition customer consent was received and the $7.5 million in escrow was released to Sinergise.
v3.24.3
Acquisition (Tables)
9 Months Ended
Oct. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Business Acquisitions The acquisition date fair value of the consideration transferred was approximately $41.1 million, and consisted of the following:
(in thousands)Fair Value
Cash$8,609 
Class A common stock issued
21,622 
Liabilities for cash consideration placed in escrow account10,842 
Total$41,073 
The following table summarizes the fair value of the assets acquired and liabilities assumed as of the date of acquisition, after considering the measurement period adjustment described above:

(in thousands)
Goodwill$24,815 
Identifiable intangible assets acquired
Developed technology11,811
Customer relationships2,208
Other110
Accounts receivable3,013
Other assets, current652
Other assets, non-current414
Total assets acquired$43,023 
Deferred revenue, current(585)
Accrued and other current liabilities(984)
Other liabilities, current(213)
Other liabilities, non-current(167)
Total liabilities assumed$(1,949)
Net assets acquired$41,074 
Schedule of Transaction Bonuses Accordingly, $2.3 million of the consideration paid by the Company was allocated to the transaction bonuses and was recorded within the Company’s condensed consolidated statements of operations as summarized in the table below:
(in thousands)Three and Nine Months Ended October 31, 2023
Cost of revenue$267 
Research and development1,891 
Sales and marketing41 
General and administrative118 
Total$2,317 
v3.24.3
Balance Sheet Components (Tables)
9 Months Ended
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents
A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of October 31, 2024 and January 31, 2024 is as follows:
 
(in thousands)October 31, 2024January 31, 2024
Cash and cash equivalents$138,969 $83,866 
Restricted cash and cash equivalents, current6,525 8,360
Restricted cash and cash equivalents, non-current4,437 9,972
Total cash, cash equivalents, and restricted cash and cash equivalents$149,931 $102,198 
Schedule of Restrictions on Cash and Cash Equivalents
A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of October 31, 2024 and January 31, 2024 is as follows:
 
(in thousands)October 31, 2024January 31, 2024
Cash and cash equivalents$138,969 $83,866 
Restricted cash and cash equivalents, current6,525 8,360
Restricted cash and cash equivalents, non-current4,437 9,972
Total cash, cash equivalents, and restricted cash and cash equivalents$149,931 $102,198 
Schedule of Short-term Investments
Short-term investments consisted of the following as of October 31, 2024 and January 31, 2024:
October 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$19,533 $$(69)$19,466 
Commercial paper2,943 — — 2,943 
Corporate bonds78,502 265 (35)78,732 
Certificates of deposit2,114 — — 2,114 
Total short-term investments$103,092 $267 $(104)$103,255 
January 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$46,185 $118 $(92)$46,211 
Commercial paper11,126 — — 11,126 
Corporate bonds144,119 376 (155)144,340 
U.S. government agency securities9,928 17 (13)9,932 
Certificates of deposit3,432 — — 3,432 
Total short-term investments$214,790 $511 $(260)$215,041 
Schedule of Short-term Investments, Contractual Maturity
The following table summarizes the contracted maturities of the Company’s short-term investments as of October 31, 2024 and January 31, 2024:
October 31, 2024January 31, 2024
(in thousands)Amortized CostFair ValueAmortized CostFair Value
Due in 1 year or less$69,910 $70,127 $148,396 $148,296 
Due in 1-2 years33,182 33,128 66,394 66,745 
$103,092 $103,255 $214,790 $215,041 
Schedule of Property and Equipment
Property and equipment, net consists of the following:
(in thousands)October 31, 2024January 31, 2024
Satellites$244,501 $300,203 
Satellites in process and not placed into service55,979 32,468 
Leasehold improvements17,125 17,089 
Ground stations and ground station equipment20,048 19,098 
Office furniture, equipment and fixtures10,146 8,044 
Computer equipment and purchased software9,657 9,446 
Total property and equipment, gross$357,456 $386,348 
Less: Accumulated depreciation(240,536)(272,919)
Total property and equipment, net$116,920 $113,429 
Property and equipment, net as of October 31, 2024 included $2.8 million of satellite manufacturing costs that were previously classified as prepaid expenses and other current assets as of January 31, 2024.
Schedule of Long-lived Assets by Geographic Areas
The Company’s long-lived assets by geographic region are as follows:
(in thousands)October 31, 2024January 31, 2024
United States$110,901 $107,070 
Rest of world
6,0196,359
Total property and equipment, net$116,920 $113,429 
Schedule of Capitalized Computer Software
Capitalized internal-use software costs, net of accumulated amortization consists of the following:
(in thousands)October 31, 2024January 31, 2024
Capitalized internal-use software$50,074 $45,010 
Less: Accumulated amortization(31,815)(30,037)
Capitalized internal-use software, net$18,259 $14,973 
Schedule of Goodwill and Intangible Assets
Goodwill and Intangible assets consists of the following:
 October 31, 2024
January 31, 2024
(in thousands)Gross
Carrying
Amount
Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
 Gross
Carrying
Amount
 Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
Developed technology$30,429 $(13,131)$(195)$17,103 $30,429 $(11,085)$(220)$19,124 
Image library19,949(13,008)3467,28719,324(11,852)2187,690
Customer relationships7,143(4,160)(63)2,9207,143(3,715)(42)3,386
Trade names and other6,389(4,499)311,9216,089(3,877)362,248
Total intangible assets$63,910 $(34,798)$119 $29,231 $62,985 $(30,529)$(8)$32,448 
Goodwill$135,981 $— $1,430 $137,411 $134,914 $— $1,342 $136,256 
Schedule of Changes in Goodwill
The change in the carrying amount of goodwill during the nine months ended October 31, 2024 and 2023 is as follows:
Nine Months Ended
October 31,
(in thousands)20242023
Beginning of period$136,256 $112,748 
Addition1,068 23,747 
Currency translation adjustment87 (794)
End of period$137,411 $135,701 
Schedule of Accrued Liabilities and Other Current Liabilities
Accrued liabilities and other current liabilities consist of the following:
(in thousands)October 31, 2024January 31, 2024
Deferred R&D service liability (see Note 9)$8,237 $9,923 
Payroll and related expenses6,636 6,859 
Deferred hosting costs5,145 5,007 
Withholding taxes and other taxes payable1,560 3,152 
Contingent consideration
4,4117,006
Severance and other employee termination costs91123
Other accruals
16,77012,809
Total accrued and other current liabilities$43,670 $44,779 
v3.24.3
Restructuring (Tables)
9 Months Ended
Oct. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Charges Recorded as an Operating Expense A summary of the restructuring charges recognized during the three and nine months ended October 31, 2024 is provided in the tables below:
Three Months Ended October 31, 2024
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$128 $(176)$(48)
Research and development(76)(426)(502)
Sales and marketing24 (680)(656)
General and administrative(51)(71)(122)
Total restructuring charges$25 $(1,353)$(1,328)
Nine Months Ended October 31, 2024
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$1,312 $(176)$1,136 
Research and development3,464 (426)3,038 
Sales and marketing4,457 (680)3,777 
General and administrative1,291 (71)1,220 
Total restructuring charges$10,524 $(1,353)$9,171 
A summary of the restructuring charges recognized during the three and nine months ended October 31, 2023 is provided in the table below:
(in thousands)Severance and Other Employee CostsStock-Based CompensationTotal
Cost of revenue$563 $(62)$501 
Research and development3,297 (398)2,899 
Sales and marketing1,943 (815)1,128 
General and administrative1,538 (253)1,285 
Total restructuring charges$7,341 $(1,528)$5,813 
Schedule of Restructuring Liability
The following table summarizes the Company’s liability recognized in connection with the 2024 headcount reduction, which is recorded within accrued and other current liabilities in the condensed consolidated balance sheets:
(in thousands)
Balance as of January 31, 2024$— 
Severance and other employee costs10,524 
Cash payments(9,613)
Balance as of October 31, 2024$911 
v3.24.3
Leases (Tables)
9 Months Ended
Oct. 31, 2024
Leases [Abstract]  
Schedule of Maturities of Operating Lease Liabilities
Maturities of operating lease liabilities as of October 31, 2024 were as follows:
(in thousands)
Remainder of Fiscal Year 2025$2,629
202610,217
20277,104
20282,951
20291,837
Thereafter817
Total lease payments$25,555
Less: Imputed interest(2,630)
Total lease liabilities$22,925
Weighted average remaining lease term (years)3.0
Weighted average discount rate%
v3.24.3
Commitment and Contingencies (Tables)
9 Months Ended
Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Other Commitments Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of October 31, 2024 are as follows:
(in thousands) 
Remainder of Fiscal Year 2025$9,428 
202631,190 
202732,725 
202833,427 
Total purchase commitments$106,770 
v3.24.3
Stock-based Compensation (Tables)
9 Months Ended
Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows:
 Three Months Ended October 31,Nine Months Ended October 31,
(in thousands)2024202320242023
Cost of revenue$897 $944 $2,981 $3,008 
Research and development4,643 6,042 13,495 20,253 
Sales and marketing1,655 1,626 6,863 7,827 
General and administrative5,135 4,429 14,921 15,374 
Total expense12,330 13,041 38,260 46,462 
Capitalized to internal-use software development costs and property and equipment(501)(443)(1,793)(1,851)
Total stock-based compensation expense$11,829 $12,598 $36,467 $44,611 
Schedule of Stock Option Activity
A summary of stock option activity is as follows:
 Options Outstanding
 Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (Years)
 
Aggregate
Intrinsic
Value
(in thousands)
Balances at January 31, 2024
26,956,953$5.34 5.7
Exercised(324,375)$1.02 
Granted— $— 
Forfeited(1,022,576)$7.28 
Balances at October 31, 2024
25,610,002$5.32 4.8$453 
Vested and exercisable at October 31, 2024
24,137,280$5.06 4.7$453 
Schedule of Restricted Stock Unit ("RSU") Activity
A summary of Restricted Stock Unit (“RSU”) activity is as follows:
 
Number of
RSUs
 
Weighted
Average
Grant Date
Fair Value
Balances at January 31, 2024
26,718,766$4.45 
Vested(9,654,778)$4.01 
Granted26,642,464$2.34 
Forfeited(7,169,719)$3.70 
Balances at October 31, 2024
36,536,733$3.17 
v3.24.3
Net Loss Per Share Attributable to Common Stockholders (Tables)
9 Months Ended
Oct. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts):
 Three Months Ended October 31,Nine Months Ended October 31,
 2024202320242023
Numerator:
Net loss attributable to common stockholders$(20,081)$(38,004)$(88,042)$(110,423)
Denominator:
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders293,338,324284,197,733290,674,554277,252,951
       Basic and diluted net loss per share attributable to common stockholders$(0.07)$(0.13)$(0.30)$(0.40)
Schedule of Antidilutive Securities
The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 As of October 31,
 20242023
Warrants to purchase Class A common stock1,065,5941,065,594
Common stock options25,610,00228,915,927
Restricted Stock Units36,536,73328,109,375
Performance vesting Restricted Stock Units365,428
Shares committed under ESPP85,216
Earn-out Shares24,443,50425,123,663
dMY Sponsor Earn-out Shares862,500862,500
Public Warrants6,899,9826,899,982
Private Placement Warrants5,933,3335,933,333
Early exercised common stock options, subject to future vesting643,3701,011,010
Shares issued in connection with acquisition, subject to future vesting67,923
Total102,445,66297,989,307
v3.24.3
Basis of Presentation and Summary of Significant Accounting Policies - Segments (Details)
9 Months Ended
Oct. 31, 2024
segment
Accounting Policies [Abstract]  
Number of operating segments 1
Number of reportable segments 1
v3.24.3
Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Concentration Risk [Line Items]        
Concentration risk, credit risk, maximum exposure     $ 239.8  
Customer Concentration Risk | Accounts Receivable | Customer 1        
Concentration Risk [Line Items]        
Concentration risk     10.00%  
Customer Concentration Risk | Revenue from Contract with Customer Benchmark | Customer 1        
Concentration Risk [Line Items]        
Concentration risk 19.00% 21.00% 19.00% 22.00%
v3.24.3
Revenue - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Disaggregation of Revenue [Line Items]        
Deferred revenue, revenue recognized     $ 61.6 $ 45.7
Remaining performance obligation, amount $ 145.9   145.9  
Deferred revenue 77.7   77.7  
Non-cancelable contract revenue     68.2  
Deferred commission expense 0.7 $ 0.6 1.4 1.1
Amortization of deferred commission $ 0.8 $ 0.4 $ 2.1 $ 1.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-11-01        
Disaggregation of Revenue [Line Items]        
Remaining performance obligation, percentage 82.00%   82.00%  
Remaining performance obligation, expected timing of satisfaction 12 months   12 months  
Remaining performance obligation, percentage, year 2 98.00%   98.00%  
Remaining performance obligation, expected timing of satisfaction, year two 24 months   24 months  
v3.24.3
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Disaggregation of Revenue [Line Items]        
Total revenue $ 61,266 $ 55,380 $ 182,798 $ 161,844
United States        
Disaggregation of Revenue [Line Items]        
Total revenue 25,294 23,348 83,109 73,513
Rest of world        
Disaggregation of Revenue [Line Items]        
Total revenue $ 35,972 $ 32,032 $ 99,689 $ 88,331
v3.24.3
Revenue - Schedule of Deferred Commissions (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Revenue from Contract with Customer [Abstract]    
Deferred commission, current $ 1,884 $ 2,296
Deferred commission, non-current 1,232 1,578
Total deferred commission $ 3,116 $ 3,874
v3.24.3
Fair Value of Financial Assets and Liabilities - Schedule of Fair Value by Balance Sheet Location (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Assets    
Short-term investments $ 103,255 $ 215,041
Liabilities    
Warrants 1,835 2,961
Contingent consideration for acquisitions 2,871 5,885
U.S. Treasury securities    
Assets    
Short-term investments 19,466 46,211
Commercial paper    
Assets    
Short-term investments 2,943 11,126
Corporate bonds    
Assets    
Short-term investments 78,732 144,340
U.S. government agency securities    
Assets    
Short-term investments   9,932
Certificates of deposit    
Assets    
Short-term investments 2,114 3,432
Fair Value, Recurring | Level 1    
Assets    
Total assets 67,408 92,234
Liabilities    
Contingent consideration for acquisitions 0 0
Total liabilities 1,242 1,656
Fair Value, Recurring | Level 1 | Public Warrants    
Liabilities    
Warrants 1,242 1,656
Fair Value, Recurring | Level 1 | Private Placement Warrants    
Liabilities    
Warrants 0 0
Fair Value, Recurring | Level 1 | U.S. Treasury securities    
Assets    
Short-term investments 19,466 46,211
Fair Value, Recurring | Level 1 | Commercial paper    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 1 | Corporate bonds    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 1 | U.S. government agency securities    
Assets    
Short-term investments   0
Fair Value, Recurring | Level 1 | Certificates of deposit    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 1 | Money market funds    
Assets    
Cash equivalents 38,503 28,722
Restricted cash equivalents: money market funds 9,439 17,301
Fair Value, Recurring | Level 2    
Assets    
Total assets 83,789 168,830
Liabilities    
Contingent consideration for acquisitions 0 0
Total liabilities 0 0
Fair Value, Recurring | Level 2 | Public Warrants    
Liabilities    
Warrants 0 0
Fair Value, Recurring | Level 2 | Private Placement Warrants    
Liabilities    
Warrants 0 0
Fair Value, Recurring | Level 2 | U.S. Treasury securities    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 2 | Commercial paper    
Assets    
Short-term investments 2,943 11,126
Fair Value, Recurring | Level 2 | Corporate bonds    
Assets    
Short-term investments 78,732 144,340
Fair Value, Recurring | Level 2 | U.S. government agency securities    
Assets    
Short-term investments   9,933
Fair Value, Recurring | Level 2 | Certificates of deposit    
Assets    
Short-term investments 2,114 3,431
Fair Value, Recurring | Level 2 | Money market funds    
Assets    
Cash equivalents 0 0
Restricted cash equivalents: money market funds 0 0
Fair Value, Recurring | Level 3    
Assets    
Total assets 0 0
Liabilities    
Contingent consideration for acquisitions 7,282 12,891
Total liabilities 7,875 14,196
Fair Value, Recurring | Level 3 | Public Warrants    
Liabilities    
Warrants 0 0
Fair Value, Recurring | Level 3 | Private Placement Warrants    
Liabilities    
Warrants 593 1,305
Fair Value, Recurring | Level 3 | U.S. Treasury securities    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 3 | Commercial paper    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 3 | Corporate bonds    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 3 | U.S. government agency securities    
Assets    
Short-term investments   0
Fair Value, Recurring | Level 3 | Certificates of deposit    
Assets    
Short-term investments 0 0
Fair Value, Recurring | Level 3 | Money market funds    
Assets    
Cash equivalents 0 0
Restricted cash equivalents: money market funds $ 0 $ 0
v3.24.3
Fair Value of Financial Assets and Liabilities - Narrative (Details)
Oct. 31, 2024
yr
Jan. 31, 2024
Term | Salo Sciences    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Performance period 4  
Private Placement Warrants | Measurement Input, Price Volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Warrants, measurement input 0.70 0.70
v3.24.3
Fair Value of Financial Assets and Liabilities - Schedule of Liabilities with Unobservable Inputs (Details) - USD ($)
$ in Thousands
3 Months Ended
Aug. 04, 2023
Oct. 31, 2024
Jul. 31, 2024
Apr. 30, 2024
Oct. 31, 2023
Jul. 31, 2023
Apr. 30, 2023
Jan. 31, 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Contingent consideration   $ 4,411           $ 7,006
Sinergise                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Liabilities for cash consideration placed in escrow account $ 10,842              
Customer Consent Escrow | Sinergise                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Liabilities for cash consideration placed in escrow account   7,500            
Customer Contract Earnout Contingent Consideration                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Beginning balance   824 $ 1,759 $ 1,926 $ 2,854 $ 3,169 $ 3,597  
Additions         0      
Payments   0 (1,090) (180) (160)      
Change in fair value   586 155 13 (478) (315) (428)  
Ending balance   1,410 824 1,759 2,216 2,854 3,169  
Customer Consent Escrow Contingent Consideration                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Beginning balance   7,211 5,920 5,851 0 0 0  
Additions         5,842      
Payments   (7,500) 0 0 0      
Change in fair value   289 1,291 69 76 0 0  
Ending balance   0 7,211 5,920 5,918 0 0  
Customer Consent Escrow Contingent Consideration | Sinergise                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Additions $ 5,800              
Technical Milestone Contingent Consideration                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Beginning balance   5,510 4,931 5,114 4,649 4,438 4,433  
Additions         0      
Payments   0 0 0 0      
Change in fair value   362 579 (183) 6 211 5  
Ending balance   5,872 5,510 4,931 4,655 4,649 4,438  
Private Placement Warrants                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]                
Beginning balance   860 534 1,305 5,014 6,378 9,701  
Additions         0      
Payments   0 0 0 0      
Change in fair value   (267) 326 (771) (3,590) (1,364) (3,323)  
Ending balance   $ 593 $ 860 $ 534 $ 1,424 $ 5,014 $ 6,378  
v3.24.3
Acquisition - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 04, 2023
Apr. 30, 2024
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Business Acquisition [Line Items]              
Addition of goodwill   $ 1,100       $ 1,068 $ 23,747
Customer Consent Escrow Contingent Consideration              
Business Acquisition [Line Items]              
Fair value of the contingent consideration       $ 5,842      
Sinergise              
Business Acquisition [Line Items]              
Business combination, consideration transferred $ 41,073            
Issuance of shares for acquisition (in shares) 6,745,438            
Addition of goodwill   $ 1,100          
Liabilities for cash consideration placed in escrow account $ 10,842            
Goodwill expected to be deductible for tax purposes 700            
Acquisition related costs     $ 200     $ 2,100  
Transaction bonuses $ 2,300     $ 2,317 $ 2,300   $ 2,317
Sinergise | Developed technology              
Business Acquisition [Line Items]              
Estimated useful life 8 years            
Sinergise | Customer relationships              
Business Acquisition [Line Items]              
Estimated useful life 9 years            
Sinergise | Indemnity Escrow              
Business Acquisition [Line Items]              
Liabilities for cash consideration placed in escrow account $ 5,000            
Sinergise | Customer Consent Escrow              
Business Acquisition [Line Items]              
Liabilities for cash consideration placed in escrow account     $ 7,500        
Escrow term 2 years            
Sinergise | Customer Consent Escrow Contingent Consideration              
Business Acquisition [Line Items]              
Fair value of the contingent consideration $ 5,800            
v3.24.3
Acquisition - Fair Value Consideration (Details) - Sinergise
$ in Thousands
Aug. 04, 2023
USD ($)
Business Acquisition [Line Items]  
Cash $ 8,609
Class A common stock issued 21,622
Liabilities for cash consideration placed in escrow account 10,842
Total $ 41,073
v3.24.3
Acquisition - Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Oct. 31, 2023
Aug. 04, 2023
Jan. 31, 2023
Business Acquisition [Line Items]          
Goodwill $ 137,411 $ 136,256 $ 135,701   $ 112,748
Sinergise          
Business Acquisition [Line Items]          
Goodwill       $ 24,815  
Accounts receivable       3,013  
Other assets, current       652  
Other assets, non-current       414  
Total assets acquired       43,023  
Deferred revenue, current       (585)  
Accrued and other current liabilities       (984)  
Other liabilities, current       (213)  
Other liabilities, non-current       (167)  
Total liabilities assumed       (1,949)  
Net assets acquired       41,074  
Sinergise | Developed technology          
Business Acquisition [Line Items]          
Identifiable intangible assets acquired       11,811  
Sinergise | Customer relationships          
Business Acquisition [Line Items]          
Identifiable intangible assets acquired       2,208  
Sinergise | Other          
Business Acquisition [Line Items]          
Identifiable intangible assets acquired       $ 110  
v3.24.3
Acquisition - Transaction Bonuses (Details) - Sinergise - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 04, 2023
Oct. 31, 2023
Oct. 31, 2023
Oct. 31, 2023
Business Acquisition [Line Items]        
Total $ 2,300 $ 2,317 $ 2,300 $ 2,317
Cost of revenue        
Business Acquisition [Line Items]        
Total   267   267
Research and development        
Business Acquisition [Line Items]        
Total   1,891   1,891
Sales and marketing        
Business Acquisition [Line Items]        
Total   41   41
General and administrative        
Business Acquisition [Line Items]        
Total   $ 118   $ 118
v3.24.3
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2024
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Jan. 31, 2024
Property, Plant and Equipment [Line Items]            
Restricted cash   $ 11,000   $ 11,000   $ 18,300
Depreciation   8,000 $ 11,900 30,300 $ 31,400  
Capitalized computer software, amortization   600 500 1,800 1,400  
Amortization of intangible assets   1,500 1,300 4,300 3,300  
Addition of goodwill $ 1,100     1,068 23,747  
Satellites            
Property, Plant and Equipment [Line Items]            
Depreciation   7,200 $ 11,100 27,900 $ 29,500  
Sinergise            
Property, Plant and Equipment [Line Items]            
Restricted cash   5,000   5,000   12,500
Addition of goodwill $ 1,100          
Money market funds            
Property, Plant and Equipment [Line Items]            
Restricted cash   $ 4,000   $ 4,000   $ 4,000
v3.24.3
Balance Sheet Components - Schedule of Cash and Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Oct. 31, 2023
Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 138,969 $ 83,866    
Restricted cash and cash equivalents, current 6,525 8,360    
Restricted cash and cash equivalents, non-current 4,437 9,972    
Total cash, cash equivalents, and restricted cash and cash equivalents $ 149,931 $ 102,198 $ 119,748 $ 188,076
v3.24.3
Balance Sheet Components - Schedule of Short-term Investments (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 103,092 $ 214,790
Gross Unrealized Gains 267 511
Gross Unrealized Losses (104) (260)
Fair Value 103,255 215,041
U.S. Treasury securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 19,533 46,185
Gross Unrealized Gains 2 118
Gross Unrealized Losses (69) (92)
Fair Value 19,466 46,211
Commercial paper    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 2,943 11,126
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 2,943 11,126
Corporate bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 78,502 144,119
Gross Unrealized Gains 265 376
Gross Unrealized Losses (35) (155)
Fair Value 78,732 144,340
U.S. government agency securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost   9,928
Gross Unrealized Gains   17
Gross Unrealized Losses   (13)
Fair Value   9,932
Certificates of deposit    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 2,114 3,432
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value $ 2,114 $ 3,432
v3.24.3
Balance Sheet Components - Schedule of Contracted Maturities (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Amortized Cost    
Due in 1 year or less $ 69,910 $ 148,396
Due in 1-2 years 33,182 66,394
Amortized Cost 103,092 214,790
Fair Value    
Due in 1 year or less 70,127 148,296
Due in 1-2 years 33,128 66,745
Fair Value $ 103,255 $ 215,041
v3.24.3
Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 357,456 $ 386,348
Less: Accumulated depreciation (240,536) (272,919)
Property and equipment, net 116,920 113,429
United States    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 110,901 107,070
Rest of world    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 6,019 6,359
Satellites    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 244,501 300,203
Property and equipment, net 2,800  
Satellites in process and not placed into service    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 55,979 32,468
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 17,125 17,089
Ground stations and ground station equipment    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 20,048 19,098
Office furniture, equipment and fixtures    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 10,146 8,044
Computer equipment and purchased software    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 9,657 $ 9,446
v3.24.3
Balance Sheet Components - Schedule of Capitalized Software Development (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Capitalized internal-use software $ 50,074 $ 45,010
Less: Accumulated amortization (31,815) (30,037)
Capitalized internal-use software, net $ 18,259 $ 14,973
v3.24.3
Balance Sheet Components - Schedule of Goodwill and Intangibles (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 31, 2024
Jan. 31, 2024
Oct. 31, 2023
Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, gross carrying amount $ 63,910 $ 62,985    
Intangible assets, accumulated amortization (34,798) (30,529)    
Intangible assets, foreign currency translation 119 (8)    
Intangible assets, net carrying amount 29,231 32,448    
Goodwill, gross carrying amount 135,981 134,914    
Goodwill, foreign currency adjustment 1,430 1,342    
Goodwill, net carrying amount 137,411 136,256 $ 135,701 $ 112,748
Developed technology        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, gross carrying amount 30,429 30,429    
Intangible assets, accumulated amortization (13,131) (11,085)    
Intangible assets, foreign currency translation (195) (220)    
Intangible assets, net carrying amount 17,103 19,124    
Image library        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, gross carrying amount 19,949 19,324    
Intangible assets, accumulated amortization (13,008) (11,852)    
Intangible assets, foreign currency translation 346 218    
Intangible assets, net carrying amount 7,287 7,690    
Customer relationships        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, gross carrying amount 7,143 7,143    
Intangible assets, accumulated amortization (4,160) (3,715)    
Intangible assets, foreign currency translation (63) (42)    
Intangible assets, net carrying amount 2,920 3,386    
Trade names and other        
Finite-Lived Intangible Assets [Line Items]        
Intangible assets, gross carrying amount 6,389 6,089    
Intangible assets, accumulated amortization (4,499) (3,877)    
Intangible assets, foreign currency translation 31 36    
Intangible assets, net carrying amount $ 1,921 $ 2,248    
v3.24.3
Balance Sheet Components - Goodwill (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Apr. 30, 2024
Oct. 31, 2024
Oct. 31, 2023
Goodwill [Roll Forward]      
Beginning of period   $ 136,256 $ 112,748
Addition $ 1,100 1,068 23,747
Currency translation adjustment   87 (794)
End of period   $ 137,411 $ 135,701
v3.24.3
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Oct. 31, 2024
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Deferred R&D service liability (see Note 9) $ 8,237 $ 9,923
Payroll and related expenses 6,636 6,859
Deferred hosting costs 5,145 5,007
Withholding taxes and other taxes payable 1,560 3,152
Contingent consideration 4,411 7,006
Severance and other employee termination costs 911 23
Other accruals 16,770 12,809
Total accrued and other current liabilities $ 43,670 $ 44,779
v3.24.3
Restructuring - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2024
Aug. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Restructuring Cost and Reserve [Line Items]            
Percentage of positions eliminated 17.00% 10.00%        
Restructuring charges     $ (1,328,000) $ 5,813,000 $ 9,171,000  
Headcount Reduction, 2024            
Restructuring Cost and Reserve [Line Items]            
Restructuring charges       $ 0   $ 0
Headcount Reduction, 2023            
Restructuring Cost and Reserve [Line Items]            
Restructuring charges     $ 0   $ 0  
v3.24.3
Restructuring - Restructuring Expense (Details) - USD ($)
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges $ (1,328,000) $ 5,813,000 $ 9,171,000  
Headcount Reduction, 2024        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges   0   $ 0
Severance and Other Employee Costs        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges 25,000 7,341,000 10,524,000  
Stock-Based Compensation        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (1,353,000) (1,528,000) (1,353,000)  
Cost of revenue        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (48,000) 501,000 1,136,000  
Cost of revenue | Severance and Other Employee Costs        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges 128,000 563,000 1,312,000  
Cost of revenue | Stock-Based Compensation        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (176,000) (62,000) (176,000)  
Research and development        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (502,000) 2,899,000 3,038,000  
Research and development | Severance and Other Employee Costs        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (76,000) 3,297,000 3,464,000  
Research and development | Stock-Based Compensation        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (426,000) (398,000) (426,000)  
Sales and marketing        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (656,000) 1,128,000 3,777,000  
Sales and marketing | Severance and Other Employee Costs        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges 24,000 1,943,000 4,457,000  
Sales and marketing | Stock-Based Compensation        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (680,000) (815,000) (680,000)  
General and administrative        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (122,000) 1,285,000 1,220,000  
General and administrative | Severance and Other Employee Costs        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges (51,000) 1,538,000 1,291,000  
General and administrative | Stock-Based Compensation        
Restructuring Cost and Reserve [Line Items]        
Total restructuring charges $ (71,000) $ (253,000) $ (71,000)  
v3.24.3
Restructuring - Restructuring Liability (Details)
$ in Thousands
9 Months Ended
Oct. 31, 2024
USD ($)
Restructuring Reserve [Roll Forward]  
Beginning balance $ 0
Severance and other employee costs 10,524
Cash payments (9,613)
Ending balance $ 911
v3.24.3
Leases - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Leases [Abstract]        
Operating lease, cost $ 2.4 $ 2.1 $ 7.1 $ 6.1
Operating lease, payments 2.6 2.3 7.5 5.0
Right-of-use assets obtained $ 1.2 $ 0.3 $ 4.3 $ 6.5
v3.24.3
Leases - Maturities of Operating Lease Liabilities (Details)
$ in Thousands
Oct. 31, 2024
USD ($)
Leases [Abstract]  
Remainder of Fiscal Year 2025 $ 2,629
2026 10,217
2027 7,104
2028 2,951
2029 1,837
Thereafter 817
Total lease payments 25,555
Less: Imputed interest (2,630)
Total lease liabilities $ 22,925
Weighted average remaining lease term (years) 3 years
Weighted average discount rate 8.00%
v3.24.3
Research and Development Arrangements (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2023
USD ($)
Aug. 31, 2022
USD ($)
provider
Oct. 31, 2024
USD ($)
Oct. 31, 2023
USD ($)
Oct. 31, 2024
USD ($)
Oct. 31, 2023
USD ($)
Jan. 31, 2024
USD ($)
Dec. 31, 2020
USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Research and development     $ 25,216 $ 33,002 $ 78,055 $ 87,929    
R&D Services Agreement                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Research and development arrangement, fee provided               $ 46,400
Research and development fee recognized     2,900 6,800 7,200 14,800    
Research and development     2,900 7,600 6,500 15,600    
Proceeds from feeds received         46,400   $ 45,800  
NASA Communication Services Project                
Research and Development Arrangement, Contract to Perform for Others [Line Items]                
Research and development fee recognized $ 2,200   2,500 1,200 7,600 9,200    
Research and development     $ 2,500 $ 1,200 7,600 $ 8,400    
Number of satellites | provider   2            
Research and development arrangement, funding receivable   $ 40,500            
Funding for research and development         $ 27,600   $ 13,900  
v3.24.3
Commitment and Contingencies (Details)
$ in Thousands
Oct. 31, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Remainder of Fiscal Year 2025 $ 9,428
2026 31,190
2027 32,725
2028 33,427
Total purchase commitments $ 106,770
v3.24.3
Warrants (Details)
Dec. 07, 2021
tranche
tradingDay
$ / shares
shares
Mar. 09, 2021
$ / shares
shares
Oct. 31, 2024
$ / shares
shares
Jan. 31, 2024
$ / shares
shares
Class of Warrant or Right [Line Items]        
Number of tranches | tranche 4      
Threshold trading days | tradingDay 20      
Trading period days | tradingDay 30      
2020 Convertible Notes        
Class of Warrant or Right [Line Items]        
Weighted average remaining term in years     5 years 4 months 24 days  
Period 1        
Class of Warrant or Right [Line Items]        
Share price triggering share issuance (in dollars per share) $ 15.00      
Period 2        
Class of Warrant or Right [Line Items]        
Share price triggering share issuance (in dollars per share) 17.00      
Period 3        
Class of Warrant or Right [Line Items]        
Share price triggering share issuance (in dollars per share) 19.00      
Period 4        
Class of Warrant or Right [Line Items]        
Share price triggering share issuance (in dollars per share) $ 21.00      
Public Warrants        
Class of Warrant or Right [Line Items]        
Warrant outstanding (in shares) | shares     6,899,982 6,899,982
Private Placement Warrants        
Class of Warrant or Right [Line Items]        
Warrant outstanding (in shares) | shares 2,966,667   5,933,333 5,933,333
Weighted average remaining term in years 5 years      
Private Placement Warrants, Vesting        
Class of Warrant or Right [Line Items]        
Warrant outstanding (in shares) | shares     2,966,667 2,966,667
Common Class A | Public Warrants        
Class of Warrant or Right [Line Items]        
Warrant exercise price (in dollars per share)   $ 11.50    
Series D Convertible Preferred Stock | 2020 Convertible Notes        
Class of Warrant or Right [Line Items]        
Warrant outstanding (in shares) | shares     1,065,594 1,065,594
Series D Convertible Preferred Stock | 2020 Convertible Notes | Convertible Debt        
Class of Warrant or Right [Line Items]        
Warrant exercise price (in dollars per share)     $ 9.384 $ 9.384
dMY IV, LLC        
Class of Warrant or Right [Line Items]        
Equity units issued (in shares) | shares   34,500,000    
dMY IV, LLC | Redeemable Warrant        
Class of Warrant or Right [Line Items]        
Equity units issued, shares called per unit (in shares) | shares   0.2    
Warrant exercise price (in dollars per share)   $ 10.00    
dMY IV, LLC | Private Placement Warrants        
Class of Warrant or Right [Line Items]        
Warrant exercise price (in dollars per share)   $ 11.50    
Warrant outstanding (in shares) | shares   5,933,333    
Sale of stock, price per share (in dollars per share)   $ 1.50    
dMY IV, LLC | Common Class A        
Class of Warrant or Right [Line Items]        
Equity units issued, shares called per unit (in shares) | shares   1    
v3.24.3
Related Party Transactions (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2023
Apr. 30, 2022
Apr. 30, 2017
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Aug. 31, 2024
Jan. 31, 2024
Jun. 28, 2021
Related Party Transaction [Line Items]                    
Deferred revenue, revenue recognized           $ 61,600 $ 45,700      
Deferred revenue       $ 77,700   77,700        
Deferred hosting costs       5,145   5,145     $ 5,007  
Research and development       25,216 $ 33,002 78,055 87,929      
Accounts payable and accrued liabilities       2,400   2,400     $ 2,500  
Related Party                    
Related Party Transaction [Line Items]                    
Related party transaction, agreement term 1 year   5 years              
Related party transaction, renewal term   1 year                
Deferred revenue, revenue recognized       300 0 300 1,000      
Deferred revenue $ 1,000             $ 300    
Cost of revenue       5,600 6,700 18,500 19,400      
Research and development       600 800 2,100 2,200      
Purchase commitment                   $ 193,000
Related Party | Maximum                    
Related Party Transaction [Line Items]                    
Amount of consideration expected to be received (up to) $ 2,000                  
Related Party | Content Licensing                    
Related Party Transaction [Line Items]                    
Deferred revenue, revenue recognized             300      
Related Party | Hosting and Other Services                    
Related Party Transaction [Line Items]                    
Related party costs and expenses       $ 6,200 $ 7,500 $ 20,600 $ 21,600      
Common Class A                    
Related Party Transaction [Line Items]                    
Common stock, shares outstanding (in shares)       275,274,858   275,274,858     268,117,905  
Google                    
Related Party Transaction [Line Items]                    
Deferred hosting costs       $ 11,800   $ 11,800     $ 12,100  
Google | PlanetLabs                    
Related Party Transaction [Line Items]                    
Ownership percentage (greater than)       10.00%   10.00%     10.00%  
Google | PlanetLabs | Common Class A                    
Related Party Transaction [Line Items]                    
Common stock, shares outstanding (in shares)       31,942,641   31,942,641     31,942,641  
v3.24.3
Stock-based Compensation - Schedule of Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total expense $ 12,330 $ 13,041 $ 38,260 $ 46,462
Capitalized to internal-use software development costs and property and equipment (501) (443) (1,793) (1,851)
Total stock-based compensation expense 11,829 12,598 36,467 44,611
Cost of revenue        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total expense 897 944 2,981 3,008
Research and development        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total expense 4,643 6,042 13,495 20,253
Sales and marketing        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total expense 1,655 1,626 6,863 7,827
General and administrative        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total expense $ 5,135 $ 4,429 $ 14,921 $ 15,374
v3.24.3
Stock-based Compensation - Schedule of Option Activity (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Oct. 31, 2024
USD ($)
$ / shares
shares
Jan. 31, 2024
$ / shares
shares
Number of Options    
Outstanding, beginning balance (in shares) | shares 26,956,953  
Exercised (in shares) | shares (324,375)  
Granted (in shares) | shares 0  
Forfeited (in shares) | shares (1,022,576)  
Outstanding, ending balance (in shares) | shares 25,610,002 26,956,953
Vested and exercisable (in shares) | shares 24,137,280  
Weighted Average Exercise Price    
Outstanding, beginning balance (in dollars per share) | $ / shares $ 5.34  
Exercised (in dollars per share) | $ / shares 1.02  
Granted (in dollars per share) | $ / shares 0  
Forfeited (in dollars per share) | $ / shares 7.28  
Outstanding, beginning balance (in dollars per share) | $ / shares 5.32 $ 5.34
Vested and exercisable (in dollars per share) | $ / shares $ 5.06  
Weighted Average Remaining Term    
Outstanding, weighted average remaining term 4 years 9 months 18 days 5 years 8 months 12 days
Vested and exercisable, weighted average remaining term 4 years 8 months 12 days  
Aggregate Intrinsic Value    
Outstanding, aggregate intrinsic value | $ $ 453  
Vested and exercisable, aggregate intrinsic value | $ $ 453  
v3.24.3
Stock-based Compensation - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 13, 2021
shares
Dec. 07, 2021
tradingDay
tranche
$ / shares
Apr. 30, 2024
Oct. 31, 2024
USD ($)
shares
Oct. 31, 2023
USD ($)
Oct. 31, 2024
USD ($)
shares
Oct. 31, 2023
USD ($)
Jan. 31, 2024
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based compensation expense       $ 11,829 $ 12,598 $ 36,467 $ 44,611  
Liability from early exercise of stock options       6,275   $ 6,275   $ 8,964
Unvested shares subject to repurchase (in shares) | shares           643,370    
Number of tranches | tranche   4            
Threshold trading days | tradingDay   20            
Threshold trading days range | tradingDay   30            
VanderSat                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period 2 years              
Share-based compensation expense         600   1,900  
Period 1                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share price triggering share issuance (in dollars per share) | $ / shares   $ 15.00            
Period 2                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share price triggering share issuance (in dollars per share) | $ / shares   17.00            
Period 3                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share price triggering share issuance (in dollars per share) | $ / shares   19.00            
Period 4                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share price triggering share issuance (in dollars per share) | $ / shares   $ 21.00            
Stock Options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Costs not yet recognized, options       6,500   $ 6,500    
Costs not yet recognized, period for recognition           1 year 1 month 6 days    
Restricted Stock Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Costs not yet recognized, period for recognition           2 years 9 months 18 days    
Granted (in shares) | shares           26,642,464    
Award vesting period           4 years    
Share-based compensation expense       9,900 8,600 $ 30,200 29,200  
Costs not yet recognized, award other than options       103,800   $ 103,800    
Awards vested (in shares) | shares           9,654,778    
Performance vesting Restricted Stock Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Costs not yet recognized, period for recognition           4 months 24 days    
Granted (in shares) | shares           348,222    
Share-based compensation expense       300 300 $ 800 700  
Costs not yet recognized, award other than options       200   $ 200    
Performance vesting Restricted Stock Units | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting range, percentage           0.00%    
Performance vesting Restricted Stock Units | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting range, percentage           125.00%    
Shares committed under ESPP | 2024 Employee Stock Purchase Program                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Costs not yet recognized, period for recognition           4 months 24 days    
Share-based compensation expense       200   $ 400    
Costs not yet recognized, award other than options       400   400    
Contribution maximum     10.00%          
Purchase price percentage of lower fair market value of common stock     85.00%          
Offering period     6 months          
Earn-out Shares                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based compensation expense         $ 400   $ 4,200  
Costs not yet recognized, award other than options       $ 0   $ 0    
Awards vested (in shares) | shares       0   0    
Awards outstanding (in shares) | shares       2,984,494   2,984,494    
Share-based Payment Arrangement | VanderSat | Common Class A                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Business combination, equity interests issued and issuable (in shares) | shares 543,391              
v3.24.3
Stock-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units
9 Months Ended
Oct. 31, 2024
$ / shares
shares
Number of RSUs  
Outstanding, beginning balance (in shares) | shares 26,718,766
Vested (in shares) | shares (9,654,778)
Granted (in shares) | shares 26,642,464
Forfeited (in shares) | shares (7,169,719)
Outstanding, ending balance (in shares) | shares 36,536,733
Weighted Average Grant Date Fair Value  
Outstanding, beginning balance (in dollars per share) | $ / shares $ 4.45
Vested (in dollars per share) | $ / shares 4.01
Granted (in dollars per share) | $ / shares 2.34
Forfeited (in dollars per share) | $ / shares 3.70
Outstanding, ending balance (in dollars per share) | $ / shares $ 3.17
v3.24.3
Income Taxes (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Jan. 31, 2024
Income Tax Disclosure [Abstract]          
Income tax expense $ 25,000 $ 355,000 $ 1,364,000 $ 1,244,000  
Unrecognized tax benefits 9,800,000   9,800,000   $ 8,700,000
Income tax examination, penalties and interest accrued $ 0   0   0
Income tax examination, penalties and interest expense     $ 0   $ 0
v3.24.3
Net Loss Per Share Attributable to Common Stockholders - Schedule of Earnings per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Numerator:        
Net loss attributable to common stockholders $ (20,081) $ (38,004) $ (88,042) $ (110,423)
Denominator:        
Basic weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares) 293,338,324 284,197,733 290,674,554 277,252,951
Diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders (in shares) 293,338,324 284,197,733 290,674,554 277,252,951
Basic net loss per share attributable to common stockholders (in dollars per share) $ (0.07) $ (0.13) $ (0.30) $ (0.40)
Diluted net loss per share attributable to common stockholders (in dollars per share) $ (0.07) $ (0.13) $ (0.30) $ (0.40)
v3.24.3
Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - shares
9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 102,445,662 97,989,307
Warrants to purchase Class A common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 1,065,594 1,065,594
Common stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 25,610,002 28,915,927
Restricted Stock Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 36,536,733 28,109,375
Performance vesting Restricted Stock Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 365,428 0
Shares committed under ESPP    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 85,216 0
Earn-out Shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 24,443,504 25,123,663
dMY Sponsor Earn-out Shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 862,500 862,500
Public Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 6,899,982 6,899,982
Private Placement Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 5,933,333 5,933,333
Early exercised common stock options, subject to future vesting    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 643,370 1,011,010
Shares issued in connection with acquisition, subject to future vesting    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 0 67,923

Planet Labs PBC (NYSE:PL)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Planet Labs PBC Charts.
Planet Labs PBC (NYSE:PL)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Planet Labs PBC Charts.